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Dystonia  is  a  disabling  condition  characterised  by  involuntary  muscle  spasms  and 
abnormal postures.  Its pathophysiology is incompletely understood but most lines of 
evidence point to an underlying defect of basal ganglia function leading to abnormal 
corticomotor  output.  Various  abnormalities  have  been  shown,  including  abnormal 
neuronal activity in basal ganglia output nuclei, defective neural inhibition at the spinal, 
brainstem,  cortical  level  and  sensorimotor  misprocessing.  More  recently,  increased 
neural  plasticity  has  been  found  in  dystonia  patients  in  response  to  transcranial 
magnetic stimulation (TMS) protocols which induce motor cortex plasticity. Excessive 
plasticity might contribute to dystonia by promoting or reinforcing abnormal patterns of 
connectivity. The most significant advance in the treatment of generalised dystonia has 
been the development of globus pallidus intemus (GPi) deep brain stimulation (DBS). 
Interestingly its  beneficial  effects  are progressive  over weeks  to  months  rather than 
immediate. A plasticity effect has been implicated but physiological evidence has been 
lacking.  Furthermore  it  is  unknown  what  impact  GPi  DBS  has  on  the  underlying 
pathophysiology  such  as  defective  inhibition or excessive  plasticity.  The  aim  of the 
present work was to examine the impact of GPi DBS on underlying pathophysiological 
features  such  as  disinhibition and  abnormal  motor cortical  plasticity.  In this thesis, 
studies  in  a  consecutive  series  of  dystonia  patients,  mainly  those  with  primary 
generalised dystonia, who underwent bilateral GPi DBS, are presented. Patients were 
studied in a prospective, longitudinal manner with both clinical assessment of dystonia 
using  a validated rating  scale  and electrophysiological  studies  including blink reflex 
excitability  and  forearm  H-reflex  reciprocal  inhibition.  In  addition,  once  stable 
improvement had been achieved, the impact of GPi DBS on motor cortex plasticity was 
studied using TMS  paired associative  stimulation (PAS).  The  clinical  study of these
2patients confirmed the therapeutic efficacy of GPi DBS and provided direct evidence of 
the  superiority  of  the  posteroventral  globus  pallidus  as  the  optimal  target.  The 
longitudinal  studies  of  blink  and  H-reflex,  showed  progressive  normalisation  of 
brainstem  and  spinal  excitability,  which  correlated  with  the  time-course  of clinical 
improvement. These data provide the first evidence of reversal of underlying dystonia 
pathophysiology by  GPi  DBS  and  are  compatible with progressive  long-term neural 
reorganisation  (plasticity)  playing  a  role  in  the  mechanism  of action  of GPi  DBS. 
Furthermore, the result of TMS PAS experiments demonstrated that GPi DBS reduces 
the short-term plasticity of the motor cortex, the magnitude of this effect also correlated 
with  therapeutic  effect.  This  result  is  compatible  with  the  concept  that  excessive 
plasticity  promotes  dystonia  and  reversal  of  these  abnormalities  may  be  another 
mechanism  by  which  GPi  DBS  acts.  In  conclusion,  work  presented  in  this  thesis 
provides the  first  electrophysiological  correlates  of clinical  improvement  in dystonia 
after GPi DBS,  which collectively supports the notion that both long and  short-term 
plasticity within the central nervous system are involved in the mechanism of GPi DBS 
action.
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18Chapter 1. Introduction
1.1  Basal ganglia
The  basal  ganglia comprise  the  striatum  (caudate  nucleus  and putamen),  the  globus 
pallidus  (intemus,  GPi  and  extemus,  GPe),  the  subthalamic  nucleus  (STN)  and  the 
substantia nigra (reticulata,  SNr and compacta,  SNc).  The striatum is the main input 
structure and receives afferents from the cortex, thalamus and also SNc. GPi and SNr 
are the main output structures and project mainly to the thalamus and the brainstem. 
The basic scheme of basal ganglia organisation is one of topographically maintained 
projections  from  cortex  through the  basal  ganglia  nuclei,  thalamus  and  back  to  the 
cortex as parallel circuits, with additional output nodes to the brainstem.
1.1.1 Basic anatomy and neurotransmitters
1.1.1.1 Striatum
The striatum receives glutamatergic afferents from most areas of the cerebral cortex. 
These corticostriatal neurons synapse mainly with medium spiny neurons which are the 
main  striatal  efferent  neurons.  Within  the  striatum  a  sensorimotor,  associative  and 
limbic  territory  can  be  identified  according  to  the  cortical  origin  of  the  afferents 
(Alexander  et  al  1986,  Alexander  and  Crutcher  1990,  Parent  &  Hazard  1995a, 
Middleton & Strick 2000). The sensorimotor territory in the dorsolateral putamen and 
caudate receives projections from the primary motor cortex, the somatosensory cortex, 
premotor  cortex  and  supplementary  motor  area.  Primate  recordings  indicate  that 
neurons in the sensorimotor territory respond to movement and electrical stimulation in 
these  areas  can  cause  movements  (Alexander  &  DeLong  1985).  Within  the 
sensorimotor striatum (putamen) there is a somatotopic arrangement which respects the
19body map of the cortical afferents, such that the leg is more dorsal and the trunk, arm 
and head more ventral (Crutcher & DeLong 1984, Flaherty & Graybiel  1991, Miyachi 
et  al  2006).  Recent  work  suggests  that  the  sensorimotor  striatum  receives  not  only 
direct cortical afferents which terminate in the putamen but also collaterals of cortical 
afferents  destined  for  brainstem  targets  (Parent  &  Parent  2006).  The  associative 
territory receives inputs from frontal areas, temporal, inferior parietal, preoccipital and 
parahippocampal cortex and comprises mostly the caudate nucleus and the rostral part 
of the putamen (Alexander et al  1986). The limbic territory receives projections from 
the limbic cortex, paralimbic cortex, amygdala and hippocampus and is located in the 
ventral part of the  caudate and putamen, the nucleus  accumbens  and portions of the 
olfactory tubercle. The striatum receives dopaminergic afferents from the SNc and the 
VTA which play a critical neuromodulatory role in striatal function, as evidenced by 
the  consequence  of  their  loss  in  Parkinson's  disease.  The  striatum  receives 
glutamatergic  afferents  from  the  thalamus  mainly  the  centromedian/parafascicular 
(CM-Pf) complex (Sadikot et al 1992). The portion of the CM-Pf that receives afferents 
mainly from the motor cortex and GPi, projects mainly to the putamen.  The striatum 
also  receives  serotoninergic  projections  from  the  midline  Raphe  nuclei  and 
noradrenergic projections from the locus ceruleus.
The  majority  of efferent  neurons  from  the  striatum  are  GABAergic  medium  spiny 
neurons (Smith et al 1987), which project mainly to GPe, GPi or SNr where they inhibit 
the neurons within these target structures (Chavalier & Deniau  1990). Efferents to the 
pallidum  are  mainly  from  the  putamen  and  sensorimotor  and  those  to  the  SNr  are 
mainly from the caudate and associative (Parent & Hazrati 1995a).
201.1.1.2  Globus pallidus
The globus pallidus lies medial to the putamen and lateral to the internal capsule. It is 
divided into a smaller internal segment globus pallidus intemus (GPi) and an external 
segment  globus  pallidus  extemus  (GPe),  the  two  segments  separated  by  the  medial 
medullary lamina (MML). The lateral medullary lamina (LML) separates GPe from the 
putamen. The GPi is further divided into lateral (GPi-1) and medial (GPi-m) portions by 
the  accessory  medullary  lamina.  The  globus  pallidus  is  also  organised  in  parallel 
functional domains. The sensorimotor area of the pallidum receives mainly projections 
from the putamen. It is located in the ventrolateral two-thirds and posterior portion of 
the pallidum (Nauta & Mehler 1966, Parent et al 1984, Smith & Parent 1986, Hedreen 
& DeLong  1991). In the sensorimotor area, the same somatotopy as in the striatum is 
found  with  the  leg  being  dorsal,  the  head  ventral  and  the  upper  limb  in-between 
(DeLong et al  1985, Hamada et al  1990; Hedreen & DeLong  1991).  The associative 
territory receives  afferents  from the  caudate nucleus,  within  GPe  it is  located  at the 
level  of the  anterior  commissure  and  dorsomedially  within  GPi  (Nauta  et  al  1966, 
Parent et al 1984). The limbic area is in the ventral pallidum in the ventromedial part of 
GPi and GPe (Parent 1990). Most of pallidal afferents come from the striatum and are 
GABAergic and inhibitory. The entire globus pallidus receives glutamatergic excitatory 
input from the  STN.  There  are GABAergic reciprocal  connections  between  GPi  and 
GPe (Hazrati et al 1990). In GPi, afferents from GPe and STN project to the same cells. 
The  pallidum  also  receives  dopaminergic  afferents  from  SNc  and  serotoninergic 
afferents from the  anterior VTA  (Parent &  Smith  1987).  Both GPe  and  GPi receive 
afferent  input  from  the  thalamus,  mainly  CM-Pf nucleus  and  the  pedunculopontine 
nucleus.  Pallidal efferents are GABAergic and inhibitory upon their target structures. 
Efferents from GPe are mainly to STN and GPi/SNr (Hazrati et al 1990, Carpenter et al
211981a, Nauta & Mehler  1966).  GPe efferents to  STN complete the  indirect pathway 
from the striatum to the pallidum. Efferents from GPi project to the thalamus, VA (pars 
principalis), VL (pars medialis) and CM-Pf (Hazrati & Parent  1991; Kim et al  1976). 
The  efferents to  VA,  VL  from  GPi  maintain the  division  of motor,  associative  and 
limbic information, project to the thalamus and from there to motor cortex, premotor 
cortex  and  SMA  (Hoover  &  Strick  1993).  The  projection  from  GPi  to  CM-Pf and 
thence striatum provides a subcortical feedback loop between basal ganglia output and 
input  structures.  GPi  also  projects to  pedunculopontine  and  lateral  habenular nuclei. 
The major outflow tracts of efferent fibres from GPi are the lenticular fasiculus (LF) 
and the ansa lenticularis (AL) (Nauta & Mehler 1966). The LF and AL sweep medially 
to  merge  in  Forel’s  field  en  route  to  the thalamus.  The  LF  and  AL  were  originally 
thought to derive from the GPi-m and GPi-1 respectively (Kuo & Carpenter 1973, Kim 
et al  1976), however it is now clear that neurons from throughout GPi may contribute 
axons to the LF and AL (Parent & Parent 2004).
1.1.1.3 Substantia nigra reticulata
SNr is one of the major output structures of the basal ganglia.  The main afferents to 
SNr  come  from  the  striatum,  GPe  and  STN.  SNr  efferents  are  GABAergic  and 
inhibitory and project to the VA and VL thalamic nuclei, (Kilpatrick et al. 1980; Ilinsky 
et al 1985; Carpenter et al 1976), mesopontine tegmentum, SNc, superior colliculus and 
pedunculopontine nucleus.
1.1.1.4 Subthalamic nucleus
The  STN  receives  glutamatergic  afferents  from  primary  motor  cortex,  the 
somatosensory cortex, premotor cortex, prefrontal cortex and cingulum (Carpenter et al
221981b, Kunzle 1978, Kitai & Deniau 1981) as well as GABAergic afferents from GPe. 
There  is  also  some  glutamatergic  afferents  from  the  CM-Pf thalamic  nuclei.  The 
dorsolateral portion of the STN is the sensorimotor part (Wichmann & DeLong  1993) 
and constitutes 80% of the STN (Parent & Hazrati  1995b) and projects mainly to GPi. 
STN efferents  are  glutamatergic  excitatory and project mainly to  GPi,  GPe  and  SNr 
(Carpenter et al 1981a,b, Nauta & Cole 1978).
1.1.1.5  Direct and indirect pathway
As noted above, the striatum receives massive cortical input, which is then processed 
and projected through the other basal ganglia structures. The arrangement of the striatal 
output is  classically divided into the direct and  indirect pathway  (Albin et al  1989, 
DeLong  1990) Figure  1.1. The direct pathway projects from the striatum to the output 
nuclei of the basal ganglia, that is GPi and the SNr. The indirect pathway projects to 
GPi/SNr  via the  GPe  and  STN.  The  direct  and  indirect pathways  are  considered  to 
produce  opposing  effects  on  the  thalamic  targets  of  basal  ganglia  outflow  to 
respectively facilitate or suppress cortically initiated activity.  Activation of the direct 
pathway between the putamen and GPi/SNr results in disinhibition of thalamic nuclei, 
which, in turn facilitate cortically initiated activity. In contrast, the net effect of activity 
in the indirect pathway from the subthalamic nucleus to the GPi/SNr via the external 
segment of the  globus pallidus  (GPe)  is  increased  inhibition  of thalamic  targets  and 
consequently reduced thalamic input to cortical areas.  The direct and indirect pathway 
model has become widely accepted and provides a framework for understanding basal 
ganglia diseases  such  as Parkinson's  disease,  chorea and dystonia.  According to this 
model in  Parkinson's  disease,  loss  of striatal  dopamine  leads  to  underactivity  of the 
direct and overactivity of the indirect pathways resulting in overactivity  of STN  and
23GPi, which results in excessive thalamic inhibition and defacilitation of cortical motor 
areas.  In  hyperkinetic  movement  disorders  such  as  chorea  and  dystonia,  converse 
abnormalities of direct and indirect pathway activity result in underactivity of GPi/SNr 
and excessive facilitation of motor cortical areas. The direct/indirect pathway model, 
while providing a conceptual framework, has major limitations, perhaps best illustrated 
by the paradox that GPi lesions are beneficial for both Parkinson's disease and dystonia 
(Marsden & Obeso  1994). This led Marsden and Obeso to propose a major refinement 
of the model, namely that the pattern rather than the rate of activity within basal ganglia 
structures carries the information signal for both normal function and characterisation 
of disease states. This concept has found accumulating support from experimental data 
as will be reviewed in the next section.
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Figure  1.1  Schematic  diagram  of direct  and  indirect pathways  within  the  basal  ganglia. 
(Adaptedfrom Lewis et al 2003)
241.1.2  Physiology
The  basic  role  of  the  basal  ganglia  in  the  control  of  normal  movement  can  be 
summarised  as  a  secondary  processing  network  which  takes  cortical  information  of 
various types, integrates some of it, and then delivers temporally and topographically 
encoded output to assist cortical motor areas in controlling the movement within the 
prevailing sensory, experiential and motivational context.  This view of basal ganglia 
function  is  derived  from  the  known  anatomical  connections  and  experimental 
observations  of basal  ganglia  activity  and  effects  of basal  ganglia  lesions  in  awake 
performing monkeys and human subjects undergoing stereotactic interventions on the 
basal ganglia.  This  section will focus on these data and attempt to bridge them with 
putative derangements of basal ganglia function underlying dystonia.
1.1.2.1  Effects of basal ganglia lesions
Unilateral lesions of the sensorimotor GPi/GPe result in slowing of contralateral limb 
movement without altering the reaction time or sequence of specific muscles activated 
(Hore & Vilis 1980, Horak & Anderson 1984, Mink & Thach 1991a).  Cocontraction of 
agonists  and  antagonist  muscles,  tonic  postural  changes  across  a joint,  often  with  a 
flexor predominance, and degradation of the quality of movement also occur (Mink & 
Thach  1991a, Kato & Kimura 1992, Inase et al  1995). Inase et al (1995) showed that 
postural drifts at joints following GPi lesions are active and related to overactivity of 
the agonist muscle, which the animal could correct for when visually reminded of the 
target.  Furthermore,  the  postural  perturbations  were  associated  with  corresponding 
increases  in  VA/VL  thalamic  neuronal  activity,  suggesting  their  origin  to  be 
disinhibition of thalamocortical activity as consequence of the GPi lesion. Collectively, 
these  data suggest that basal  ganglia output  is  involved  in  scaling the  magnitude  of
25motor drive for an intended movement without necessarily dictating the overall pattern 
of muscles employed or the initial command to move. Furthermore, they suggest that 
the globus pallidus is involved in postural stability of limb movements.  The fact that 
even after pallidal lesions, movements can be executed correctly, albeit more slowly, 
particularly if visual cues are provided, illustrates the relative redundancy of the basal 
ganglia and the ability of other motor areas to compensate. It is tempting to extrapolate 
from  these  animal  studies  to  dystonia  where  cocontraction,  abnormal  postures  and 
slowness of movement are  often found.  Not  surprisingly,  pallidal  lesions  in humans 
may result in contralateral  hemidystonia after a variable  latency  (Bhatia &  Marsden 
1994).  Overall, these  observations  support the  view that  dystonia is  a basal  ganglia 
disorder, in which abnormal basal ganglia output plays an important role.
1.1.2.2  Basal ganglia activity during movement
Recordings  of  neuronal  activity  from  GPe/GPi  in  awake  monkeys  have  shown 
topographically  restricted  zones  of  neurons,  which  display  changes  in  firing  rate 
corresponding to passive movements and active movements of a joint.  (Delong  1971, 
Georgopoulos et al 1983, Anderson & Horak 1985, Hamada et al  1990, Mink & Thach 
1991b,  Turner &  Anderson  1997).  Typically,  these  changes  represent  an  increase  in 
firing  rate  above the  background  level  of high  frequency  tonic  activity,  or  in  some 
circumstances, a decrease. The modulation of pallidal neuronal activity depends on the 
direction,  amplitude  or  velocity  of  limb  movements  (Iansek  &  Porter  1980, 
Georgopoulos  et  al  1983,  Mitchell  et  al  1987,  Hamada  et  al  1990,  Mink  &  Thach 
1991b, Turner & Anderson 1997). Studies using limb loading to dissociate the effects 
of direction and pattern of muscle use have identified subpopulations of putamenal and 
pallidal neurons responding to movement direction or pattern of muscle use but usually
26not both (Crutcher and Alexander 1990, Mitchell et al  1987), suggesting the existence 
of subchannels within the motor circuit, processing different aspects of the movement 
(Alexander & Crutcher 1990). Individual pallidal neurons respond to a variety of types 
of movement  (Mink  &  Thach  1991b)  which  suggests  that the  basal  ganglia operate 
flexibly  using  a  similar  process  under  a  wide  range  of movement  parameters.  The 
neuronal activity in basal ganglia nuclei depends not only on the kinematic properties 
of the  movement  but  also  on  the  level  of familiarity  with  the  task,  whether  it  is 
spontaneous or cued and the level of reward,  in other words,  its behavioural context 
(Brotchie et al  1991a, Gdowski et al 2001, Samejima et al 2005, Turner & Anderson 
2005).  Temporally, changes in pallidal neuronal activity tend to occur after the onset 
of EMG activity in the agonist muscle (Anderson & Horak 1985, Mink & Thach 1991c, 
Brotchie et al 1991b, Turner & Anderson 1997), which indicates that the basal ganglia 
are  not  responsible  for  movement  initiation.  Instead,  they  appear  to  be  involved  in 
scaling the  amplitude  of corticomotor  output  during  movement  (Anderson  &  Horak 
1985,  Turner  &  Anderson  1997).  This  temporal  sequence  is  in  agreement  with 
recordings from primary and supplementary motor cortex and striatum during visually 
cued movements,  which show that cortical  neuronal  discharge usually occurs before 
that  in  the  putamen,  suggesting  motor  initiation  begins  in  the  cortex  (Alexander  & 
Crutcher 1990). While there does appear to be some evidence that the basal ganglia are 
involved  in on-line  modulation of movement,  particularly  with respect to  scaling  of 
amplitude,  this  may  not  be  their  main  function.  The  timing  of  movement-related 
changes in GPi neuronal activity and the fact that they are usually an increase in firing 
rate  (which  should  inhibit  ongoing  thalamocortical  activity)  have  led  to  alternative 
views  that  the  basal  ganglia  are  more  concerned  with  termination  of  movements 
(Brotchie et al 1991b) or the selective inhibition of unwanted competing motor activity
27(Mink  1996).  This  latter  concept  of  surround  inhibition  is  an  attractive  model  for 
conceptualising the possible derangement of basal ganglia function in dystonia where 
motor overflow and cocontraction might result from inefficient selective inhibition of 
competing motomeuronal pools.
Control of saccadic eye movement fits better with the basal  ganglia model based on 
disinhibition of output targets. Saccadic eye movements are associated with a transient 
reduction in  SNr output to  the  superior  colliculus,  which  is  disinhibited,  allowing  a 
saccade to be generated (Hikosaka & Wurtz 1983).  A refinement to the disinhibition 
model  in the  motor  circuit,  which helps  explain why the  pallidum tends  to  become 
more active with movement, has been put forward, based on the cortico-subthalamo- 
pallidal pathway which provides a rapid route  of GPi excitation (Nambu et al 2000, 
Nambu  et  al  2002).  Under  this  model,  cortically  generated  motor  commands  are 
initially sent via STN to GPi, resulting in thalamocortical inhibition of the desired and 
competing  motor  programs,  the  same  signal  arrives  later  via  the  putameno-pallidal 
route  releasing  the  desired  motor  program,  Figure  1.2.  Action  selection  by  these 
mechanisms  is  behaviourally  contextualised  by  the  basal  ganglia  so  that  movement 
achieves environmentally dictated objectives. There is accumulating evidence that the 
basal ganglia play an important role in motor learning which is dependent on dopamine 
(Kermadi  &  Joseph 2005,  Matsumoto  et al  1999).  Basal  ganglia  activity  appears  to 
encode the probability of reward associated with a particular action, weighting action 
selection at the cortical level in accordance with experience (learning) and expectation 
(Doya et al 2000, Samejima et al 2007). There is evidence that in the primate premotor 
cortex,  several  motor programs  for  alternative  actions  are  prepared  in  parallel,  then 
biasing  occurs  to  facilitate  the  desired  action  (Cisek  et  al  2005).  This  arrangement, 
although  computationally  wasteful,  has  the  advantage  of speed,  but  relies  on  intact
28basal  ganglia  instruction  to  selectively  suppress  and  facilitate  the  competing  motor 
programs. At the neuronal level, these processes are thought to involve corticostriatal 
synaptic plasticity,  which is critically modulated by dopamine  (Calabresi  et al  2007, 
Costa 2007).
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Figure  1.2  Modified  schema  for  basal  ganglia  circuitry  incorporating  the 
corticosubthalamopallidal pathway,  which primes  voluntary movement by effecting surround 
inhibition,  then  followed  by  centre  activation  of  intended  movements  via  the  direct 
corticostriatopallidal route (From Nambu et al 2002).
1.1.2.3  Oscillatory activity as an information signal in the basal ganglia 
There  is  accumulating  evidence that oscillatory  activity within  cortical-basal  ganglia 
networks  serves  to  bind  functionally  connected  ensembles  of neurons  to  coordinate 
their  activity  both temporally  and  spatially.  These  models  have  obvious  advantages 
over simple wiring models of basal ganglia connectivity where interactions are either
29positive  or  negative,  since  they  can  incorporate  not  only  the  rate  but  patterns  of 
neuronal firing as an information signal.
In  the  resting  state,  most  studies  have  shown  basal  ganglia  neurons  fire  in  an 
independent and predominantly non-oscillatory manner (Bergman et al 1998, Raz et al
2000).  Correlation studies using dual microelectrodes have found very little correlation 
between pallidal  neurons  in the normal  monkey  at rest  (Bergman et al  1998).  More 
recently, studies using local field potential recording from multiple sites in the putamen 
of  awake,  performing  monkeys  have  demonstrated  that  significant  synchronous 
oscillations in the beta band occur across wide regions of the putamen (Courtemanche 
et  al  2003).  As  in  previous  studies  very  few putamenal  neurons  fired  rhythmically, 
however,  for  many  their  firing  was  phased-locked  to  the  LFP.  Furthermore  these 
synchronous oscillations were focally attenuated during saccades raising the possibility 
that such desynchronisations represent a mechanism for selective recruitment of task- 
related neuronal subpopulations.
Brown et al (2002) identified that amplitude of beta oscillations recorded from the GPi 
in patients with Parkinson's disease or dystonia during a hand movement task correlated 
with the eventual movement duration suggesting the strength of oscillations may carry 
some information signal, particularly with respect to the timing of movements (Brown 
et al 2002).  Similarly LFPs recorded from human STN during a go/no-go movement 
task  show  pre-movement  beta  desynchronisation,  the  latency  of  which  correlates 
strongly  with reaction time  and which  is  attenuated  in  the  no-go  trials  (Kuhn  et  al
2004). This suggests the level of oscillatory activity within basal ganglia nuclei might 
encode some parameters of movement preparation and execution.  LFP oscillations in 
the gamma band are absent in the untreated Parkinsonian state, but coupling of LFPs at 
these  frequencies  exists  between  GPi  and  STN,  and  these  structures  and  cortex,
30especially SMA after Parkinsonian subjects are treated with levodopa.  These changes 
occur  before  and  during  movement,  suggesting  that  in  the  presence  of  a  normal 
dopaminergic  drive  elements  within the  pallidum,  STN  and  cortex  form  a  dynamic 
functional  network  resonating  in  the  high  gamma  band  (Brown  2003).  Phase 
relationships indicate activity in GPi and STN leads the cortex in this frequency band 
suggesting that the normal basal ganglia may play a specific role in desynchronising 
low frequency idling cortical rhythms, thereby allowing temporal binding of distributed 
cortical elements into a functional ensemble in the gamma band.
The probable role of oscillations as an information signal in normal basal  ganglia is 
underscored  by  the  fact  that  diseases  such  as  Parkinson's  disease  and  dystonia  are 
associated  with  characteristic  patterns  of abnormal,  often  excessively  synchronised, 
oscillatory activity (Brown 2003, Gatev et al 2006).  The role of abnormal oscillatory 
activity  in  the  pathogenesis  of dystonia  is  further  discussed  in  the  Pathophysiology 
section 1.2.4.3.
1.2  Dystonia
1.2.1 Classification and clinical features
1.2.1.1 Clinical features
Dystonia is  an involuntary movement disorder,  characterised  by muscle  contractions 
resulting in spasms, twisting repetitive movements and abnormal postures (Fahn et al
1998).  Its  clinical  expression  is  diverse,  ranging  from  static  hypertonia  with  fixed 
postures to phasic spasms, tremor or myoclonic jerks, but some component of sustained 
contraction is a consistent feature. The contractions are not random, rather they usually 
exhibit  directional  preponderance  leading  to  a  particular  posture.  A  characteristic 
feature  is  cocontraction  of muscles  with  opposing  actions  across  a joint.  Sustained
31hypertonic  postures  may  eventually  lead  to  joint  contractures  and  orthopaedic 
deformity.  Another  important  general  feature  of  dystonia  is  its  modulation  of 
expression by action; dystonia is usually made worse by voluntary movement and some 
forms  of focal  dystonia only  occur during  specific tasks,  such  as  writing.  Particular 
actions  may  temporarily  alleviate  dystonia,  so  called  geste  antagoniste  or  sensory 
tricks,  examples  include  touching the  chin or back  of the  head to  lessen  spasmodic 
torticollis or walking backwards with improvement of gait in generalised dystonia. The 
fact that dystonia may be so intimately linked to specific actions reflects its status as a 
higher order movement disorder, which may selectively involve execution of specific 
motor programs.
1.2.1.2 Classification by distribution of involvement
Dystonia may involve part or all of the body,  allowing a system of classification by 
affected body region (Fahn et al 1998, Geyer & Bressman 2006). In focal dystonia, one 
discrete  body  region  is  affected  (e.g.  blepharospasm,  writers  cramp).  In  segmental 
dystonia, two or more adjacent body regions are affected (e.g. cervical and upper limb 
dystonia).  Multifocal  involves  two  or  more  non-contiguous  body  segments  (e.g. 
blepharospasm and upper limb).  Generalised dystonia must involve one or both legs, 
the trunk and at least one other body part. Hemidystonia involves just one side of the 
body and is frequently associated with a focal structural lesion in the contralateral basal 
ganglia or thalamus.
1.2.1.3 Classification by age of onset
Dystonia may  also be  classified on the basis of age of onset:  childhood  onset (0-12 
years),  adolescent  onset  (12-20  years)  and  adult  onset  (>20  years).  Alternative
32classifications have proposed division into early (<26 years) or late onset (>26 years) 
(Bressman 2004).  The important distinction in this classification is that childhood or 
adolescent onset imparts a much higher risk that the dystonia will spread to other body 
regions and become generalised.  Conversely adult onset dystonia is usually focal and 
while it may progress to segmental distribution, rarely spreads to become generalised 
(Marsden et al 1976, Greene et al 1995).
1.2.1.4  Classification by aetiology
Classification by aetiology has the advantage of conferring diagnostic and prognostic 
specificity,  but  because  dystonia  may  present  variably  even  within  aetiological 
categories, additional classification by distribution and age of onset remains important. 
The main division in the aetiological classification is between primary and secondary 
dystonia (Fahn et al  1998). In primary dystonia, also referred to as idiopathic torsion 
dystonia, the clinical features must be purely dystonia, which may include tremor, and 
the  brain  must  be  structurally  normal.  Secondary  dystonia  results  from  acquired 
structural  lesions  of the  brain  or  as  a  consequence  of drugs  (e.g.  tardive  dystonia). 
Further subgroups include dystonia-plus syndromes, in which features other than pure 
dystonia are present, but in other respects the picture is similar to primary dystonia in 
that  the  brain  is  structurally  normal  (eg.  myoclonic  dystonia  and  dopa-responsive 
dystonia).  Heredodegenerative  dystonia  comprises  disorders  which  result  in  brain 
degeneration,  often  with  clinical  features  additional  to  dystonia  such  as  spasticity, 
parkinsonism,  oculomotor abnormalities and include conditions  such as  pantothenate 
kinase associated neurodegeneration (PKAN) and Wilson's disease.  Developments in 
molecular genetics have greatly advanced the aetiological classification of dystonia and
33the  genes  responsible  for  various  forms  of  primary,  dystonia-plus  and 
heredodegenerative dystonia have now been identified (Nemeth 2002).
1.2.2  Aetiology and epidemiology
1.2.2.1  Primary dystonia
Early onset primary dystonia typically begins in middle to late childhood starting in the 
arm or leg and usually progresses to become generalised within 5 years. When familial, 
the usual pattern of inheritance is autosomal dominant with incomplete penetrance. The 
most  common  genetic  abnormality  identified  in  young  onset  primary  generalised 
dystonia is the DYT1 mutation, a GAG deletion of the Torsin A gene on chromosome 9 
(Ozelius et al  1997, Bressman et al 2000). The clinical spectrum of DYT1  dystonia is 
broad and ranges from profound disability in childhood to mildly affected adults and 
about 70% of individuals with the DYT1  mutation are asymptomatic.  Rarely,  DYT1 
may present as late onset dystonia (Edwards et al 2003a). The prevalence estimates of 
primary generalised dystonia range from 0.3/100,000 to 5/100,000 (Duffey et al  1998, 
Castelon-Konkiewitz et al 2002, Defazio et al  2004, Asgeirsson et al  2006).  In late 
onset primary dystonia, the DYT 7 locus has been identified in one family with mainly 
cervical  dystonia.  Other  loci  include  DYT6  (Almasy  et  al  1997)  and  DYT 13 
(Bentivoglio  et al  1997),  which both display mixed early or late  onset,  with mainly 
craniocervical and sometimes generalised dystonia. These latter entities describe only a 
few  families,  the  causative  genes  are  unknown  and  other  phenotypically  similar 
families have  been  found to  lack these  loci  (Jarman  et al  1999),  suggesting  genetic 
heterogeneity.
341.2.2.2  Secondary dystonia
Secondary dystonia can be defined as dystonia arising from an environmental insult to 
the brain such as trauma, infections, vascular lesions or drugs. Focal structural lesions 
of the basal  ganglia,  particularly the  globus pallidus  and putamen,  or thalamus  may 
result in contralateral focal or hemidystonia (Marsden et al  1985, Bhatia & Marsden 
1994,  Chuang et al 2002).  Among the secondary generalised dystonias,  those due to 
perinatal hypoxic ischaemic cerebral injury form a large group and may be associated 
with multifocal  cerebral  lesions  or more  selective  bilateral  involvement of the  basal 
ganglia  that  with  MRI  imaging  may  appear  as  increased  signal  in  the  putamen  or 
pallidum. Typically the onset of dystonia is delayed by a variable period up to many 
years after the occurrence of the structural brain lesion with longer delay if the lesion 
occurs in early childhood (Pettigrew et al  1985,  Scott & Jankovic  1996, Chuang et al
2002).  Secondary dystonia differs from primary dystonia in its clinical appearance in 
that it is more often present at rest, tends to be tonic or athetoid rather than jerky and is 
rarely  accompanied  by  a  sensory trick  (Svetel  et  al  2004).  Tardive  dystonia  occurs 
secondary  to  exposure  to  centrally  acting  dopamine  receptor  antagonists,  typically 
neuroleptic drugs used to treat psychiatric disorder (Burke et al  1982).  It may follow 
relatively short exposure to dopamine antagonists, the distribution is often axial with 
cervical involvement, and retrocollis and truncal hyperextension are frequently present. 
In some patients classical orobuccal tardive dyskinesias coexist with dystonia (Kang et 
al 1988).
The heredodegenerative dystonias, although not strictly secondary, since many are now 
recognised to be on a genetic basis, can be considered together since they often display 
distinctive  neurodegenerative  basal  ganglia  lesions,  and  have  significant  clinical 
overlap  with  the  secondary  dystonias.  Of  these  disorders,  pantothenate  kinase
35associated  neurodegeneration  (PKAN)  is  of relevance  to  the  present  work.  PKAN, 
formerly  known  as  Hallervorden-Spatz  syndrome,  is  a  rare  autosomal  recessive 
condition, which usually presents in childhood with progressive generalised dystonia, 
often  affecting  orobulbar  regions  and  subsequent  cognitive  impairment.  Later  onset 
milder forms of the disease are recognised (Thomas et al 2004, Hayflick et al 2003). 
The gene responsible is PANK2 on chromosome 20 and encodes pantothenate kinase 
(Taylor et al 1996, Zhou et al 2001), and multiple different causative mutations of this 
gene have been identified  (Hayflick  et al  2003).  The  characteristic  histopathological 
feature is deposition of iron in the globus pallidus and substantia nigra (Halliday 1995). 
T2  weighted  MRI  appears  as  bilateral  pallidal  hyperintensity  with  surrounding 
hypointensity, the so  called  "eye of the tiger", present in most patients with PANK2 
mutations (Hayflick et al 2003, Hartig et al 2006).
1.2.2.3  Dystonia-plus syndromes
This group of disorders  includes dopa-responsive dystonia (DYT  5),  the paroxysmal 
dystonias (DYT 8, 9,  10) and rapid onset dystonia-Parkinsonism (DYT 12). Myoclonus 
dystonia  (DYT  11)  usually  presents  in  early  childhood  with  myoclonic  jerks  and 
dystonia  involving  predominantly  the  upper  body,  the  symptoms  may  be  alcohol 
responsive  (Quinn  et  al  1996).  This  condition  is  often  familial  with  an  autosomal 
dominant pattern of inheritance with incomplete penetrance. Mutations of the epsilon 
sarcoglycan gene on chromosome 7 have been identified as the cause in most of the 
affected families (Zimprich et al 2001, Asmus et al 2002).
361.2.3  Therapy
1.2.3.1  Medical therapy
The medical treatment of dystonia can be divided into the following general categories: 
systemic  medications,  botulinum  toxin  injection  therapy,  intrathecal  baclofen  and 
physical therapies. In this section the pharmacological therapies will be reviewed with 
an emphasis on the treatment of generalised dystonia.
Anticholinergic medications are the most effective class of drug for primary dystonia, 
including  generalised  and  segmental  (Fahn  1983,  Burke  et  al  1986).  Secondary 
dystonia  responds  less  well  (Lang  1986).  In  some  patients,  an  initially  favourable 
response  is  not  sustained.  The  most  widely  used  drug  is  Trihexphenidyl,  and  large 
doses,  up  to  100  mg  per  day,  may  be  required,  which  is  usually  well  tolerated  in 
younger  patients  although  cognitive  side-effects  are  common  (Taylor  et  al  1991). 
Baclofen  is  beneficial  in  some  patients  with  generalised  and  segmental  dystonia 
(Greene and Fahn 1992). Intrathecal baclofen is useful in severe generalised dystonia, 
particularly where there is associated spasticity (Ford et al  1996, Albright et al 2001). 
Dopamine  replacement  therapies,  principally  Levodopa,  have  a  crucial  role  in  the 
diagnosis and treatment of dopa-responsive dystonia (DYT 5) and is effective in low 
doses  (Segawa  et  al  1976).  Levodopa  is  also  sometimes  beneficial  in  primary 
generalised  or  segmental  dystonia,  although  there  is  no  trial  data  to  support  this. 
Paradoxically dopamine antagonists or depleting agents are sometimes beneficial (Lang 
1988). Tetrabenazine is the most effective, particularly for tardive dystonia, and has the 
advantage  that it does  not  induce tardive  dyskinesia/dystonia  although  it may  cause 
Parkinsonism  or  depression  (Jankovic  1982,  Jankovic  1997).  Benzodiazepines  are 
modestly beneficial in some patients for both focal and generalised dystonias, although 
there are no studies to support their use.
37Botulinum toxin injections are the most effective treatment for locoregional dystonic 
syndromes, particularly cervical,  cranial,  laryngeal  and limb dystonia (Jankovic et al
2004). The majority of patients achieve long term improvement by repeated injections 
(Hsiung et al 2002). EMG guidance of injection can improve the efficacy of treatment 
in  some circumstances.  Neutralising  antibodies  have been described to  both BTX-A 
and B,  and may cause  secondary therapy failure  (Jankovic  et al  1995,  Berman et al
2005). For generalised dystonia, BTX is often a useful adjuvant treatment for particular 
regions such as the neck or larynx.
1.2.3.2 Functional neurosurgery
1.2.3.2.1  Ablative procedures
The advent of human stereotactic surgery with Spiegel and Wycis in  1947 paved the 
way for the development of functional neurosurgery for dystonia. The initial attempts 
to treat dystonia with functional neurosurgical intervention involved ablative lesions in 
the pallidum (Cooper 1956, Guiot & Brion 1952, Hassler 1960) and thalamus. Cooper 
achieved good results with unilateral and staged bilateral thalamotomy for generalised 
dystonia  in  about  a  quarter  of  his  large  series,  some  with  dramatic  sustained 
improvement (Cooper 1976). This experience popularised thalamotomy and it became 
the most widely performed operation for dystonia. Andrew et al (1983) reported results 
of thalamotomy  in  a  series  of 55  patients  with  dystonia;  the  benefit  in  generalised 
dystonia  was  less  than  that  reported  by  Cooper,  and  more  than  half  the  patients 
developed  dysarthria  when  thalamotomy  was  performed  bilaterally.  Secondary 
hemidystonia  responded  well  to  unilateral  thalamotomy,  with  a  low  risk  of speech 
complications  leading Andrew to  consider it a good indication.  Renewed  interest  in 
pallidotomy for dystonia occurred after the reintroduction of Leksell’s posteroventral
38pallidotomy for Parkinson's disease by Laitinen (Laitinen et al  1992). The observation 
of marked improvement of Levodopa-induced dyskinesias and dystonia in Parkinson's 
disease  patients  following  pallidotomy  (Laitinen  1992,  Lozano  1995)  led  to  some 
reports  of bilateral posteroventral  pallidotomy  for generalised  dystonia  (Iacono  et al 
1996, Lozano et al  1997, Ondo et al  1998, Lin et al  1999).  In these case reports and 
small series, favourable results were achieved in the majority of patients, particularly 
those  with  primary  dystonia,  with  lesser  improvement  in  patients  with  secondary 
dystonia (Lin et al  1999).  Combining the  larger  studies of Ondo  and Lin,  of the  23 
patients  with  generalised  dystonia  (19  secondary)  who  underwent  simultaneous 
bilateral  pallidotomy,  none  was  reported  to  have  dysarthria  as  a  consequence  of 
surgery. In fact, an overall improvement in speech was reported in these patients. From 
these  studies  bilateral  posteroventral  pallidotomy  appears  to  be  an  effective  and 
relatively  safe  treatment  for  generalised  dystonia  particularly  when  primary  in 
aetiology. However, pallidotomy is now rarely performed for dystonia,  and has been 
largely superseded by GPi DBS which is considered safer and more reversible than a 
permanent  lesion.  Thalamotomy  when  performed  bilaterally  is  associated  with 
excessive complications, particularly dysarthia, however unilateral thalamotomy may 
retain a role, including the successful treatment of focal musician’s dystonia (Taira et al 
2003).
1.2.3.2.2  Thalamic DBS
Since the 1950's, it had been observed that high frequency stimulation (>50Hz) of brain 
targets such as the motor thalamus could lead to suppression of tremor, similar to that 
achieved  by  a  thermal  lesion,  but  in  a  reversible  fashion  (Walker  1982,  Speelman
1991).  Thus  high  frequency  stimulation  became  an  important  tool  to  test  the
39effectiveness of brain targets prior to making a permanent lesion. These observations 
led to the use of chronic high frequency DBS for movement disorders and pain. Cooper 
et  al  (1982),  reported  results  of DBS  for  various  movement  disorders  including  8 
patients with dystonia treated with DBS targeting the ventrolateral thalamus unilaterally 
or  bilaterally;  the  best  response  was  in  the  patients  with  cervical  dystonia  but  the 
benefit was modest. Benabid and colleagues in Grenoble pioneered the practical use of 
chronic deep brain stimulation initially in the motor thalamus for tremor (Benabid et al 
1987,  1991), but also dystonia (Vercueil et al 2001). They reported 8 secondary and 4 
primary dystonia patients,  all but one generalised who underwent either unilateral or 
bilateral  DBS  targeting  the  Vim  nucleus  of the  thalamus.  In these  patients,  tremor, 
when  present,  improved  and  in  about  half,  the  patients’   global  functioning  scores 
improved,  and  in  the  7  patients  in  whom  motor  dystonia  scores  were  recorded,  4 
benefited by about 25%, the others showed no improvement.  In one of these patients 
with primary  generalised  dystonia who  failed to  respond  to  bilateral  thalamic  DBS, 
subsequent  bilateral  GPi  DBS  led  to  67%  improvement  in  motor  scores.  Similarly, 
Trottenberg et al (2001) reported a patient with tardive dystonia who failed to improve 
with bilateral Vim thalamic DBS but improved by 73% on BFM score with bilateral 
GPi DBS.  This contrasts with the report of Ghika et al (2002), who reported very good 
improvement  in  severe  secondary  generalised  dystonia following  bilateral  Voa DBS 
despite previous failed GPi DBS. There is limited experience with thalamic DBS for 
dystonia, but from the available studies it can be concluded that it might offer some 
therapeutic possibilities, but its precise role remains undefined.
401.2.3.2.3 STN DBS
STN DBS has been tried in a few patients with dystonia. The Grenoble group reported 
4  patients  with  generalised  dystonia,  3  with  PKAN,  and  1   late  onset  primary  who 
underwent bilateral  STN  DBS  (Detante  et al  2004a).  There  was no  improvement  in 
dystonia with STN DBS either with chronic stimulation or by comparison of the ON 
and OFF stimulation condition. The authors concluded that STN DBS is not useful for 
dystonia,  in  sharp  contrast  to  its  marked  benefits  for  OFF  period  dystonia  in 
Parkinson’s disease (Krack et al 1999).
1.2.3.2.4 GPi DBS
The growing acceptance of the pallidal target in dystonia and acceptance of DBS as an 
alternative to ablative lesions led Coubes in 1996 to first use GPi DBS in a young girl 
with  life-threatening  DYT1  negative  primary  generalised  dystonia,  with  marked 
improvement (Coubes  et al  1999).  Subsequently,  several  groups  reported  favourable 
results  with  bilateral  pallidal  DBS  for  generalised  dystonia  in  children  and  adults 
(Coubes et al 2000, Tronnier & Fogel 2000, Vercueil et al 2001, Bereznai et al 2002, 
Cif et al 2003, Katayama et al 2003, Yianni et al 2003, Krauss et al 2004, Krause et al 
2004,  Coubes  et  al  2004,  Starr  et  al  2004).  More  recently,  two  larger  prospective 
blinded studies have confirmed the beneficial effects found in small series for primary 
generalised  and  segmental  dystonia  (Vidailhet  et  al  2005,  Kupsch  et  al  2006).  A 
consistent feature among these studies is that improvement in dystonia after GPi DBS 
is not immediate but progressive over weeks to months which has led some authors to 
speculate that brain plasticity may underly the therapeutic effect (Bereznai et al 2002, 
Yianni et al 2003, Vidailhet et al 2005).  To date, however, physiological evidence for 
neural plasticity has been lacking. It should be noted that progressive improvement in
41dystonia was also noted after pallidotomy (Lozano et al  1997), suggesting that it may 
be more a property of dystonia than GPi DBS per se.
1.2.4  Pathophysiology of dystonia
The pathophysiology of dystonia is characterised by a range of abnormalities involving 
both  motor  and  sensory  systems.  These  abnormalities  have  been  identified  largely 
through  electrophysiological  and  imaging  studies  in  dystonia patients.  Owing  to  the 
technical challenges posed by performing these types of studies in patients with severe 
dystonia, much of the available information in this area has been gleaned from patients 
with focal dystonia who  are easier to  study.  Some  studies, however,  are available in 
generalised  dystonia,  which  show  a  similar  range  of abnormalities.  An  important 
theme which emerges in dystonia pathophysiology is that abnormalities may be found 
in parts of the nervous system subserving body regions unaffected by dystonia, or even 
in  non-manifesting  carriers  of  the  DYT1  mutation  (Edwards  et  al  2003b).  The 
recognition that the physiological hallmarks of dystonia may be present without overt 
clinical dystonia has led to the concept of endophenotypic abnormalities (Meunier et al
2001).  In other words, patients with dystonia express a pathophysiological  substrate, 
which may be genetic, and under appropriate environmental influence may lead to the 
development  of  clinical  dystonia.  This  general  model  can  be  further  adapted  to 
incorporate newer information concerning the role of plasticity.
1.2.4.1  The role of defective inhibition
The pathophysiology of dystonia is characterised by abnormally reduced excitability of 
inhibitory  connections  within  the  brain  and  spinal  cord.  The  finding  of  reduced 
inhibition  within  brainstem  blink  reflex  (Berardelli  et  al  1985)  and  spinal  H-reflex
42circuits (Nakashima et al 1989) were the first to be identified and provided some of the 
early  evidence  of organic  dysfunction  in  dystonia,  which  helped  establish  it  as  an 
organic  rather  than  psychological  condition.  Like  other  abnormalities,  defective 
inhibition may be dissociated from clinical symptoms (Chen R et al 1995, Deuschl et al
1992), and can be considered part of the dystonia endophenotype.
1.2.4.1.1  Motor cortex
In patients with focal dystonia, transcranial magnetic stimulation (TMS)  studies have 
shown  abnormally  reduced  short  latency  intracortical  inhibition  in the  motor  cortex 
(Ridding  et  al  1995).  Similar  reductions  in  intracortical  inhibition  have  been 
demonstrated  in  patients  with  segmental  and  generalised  forms  of dystonia  due  to 
DYT1 (Edwards et al 2003b). In addition to reductions of intracortical inhibition at rest, 
patients  with  focal  hand  dystonia  have  abnormally  reduced  motor  cortex  inhibition 
preceding  (Gilio  et al  2003)  and  during voluntary  movement  (Chen  R et  al  1997a), 
particularly during tasks requiring selective finger movement (Stinear & Byblow 2004, 
Biitefisch et al 2005). Another related abnormality found in patients with focal hand 
dystonia  is  abnormally  increased  recruitment  of cortical  motomeurons  with  action 
(Ikoma  et  al  1996).  Defective  inhibition,  at  the  level  of  the  motor  cortex,  could 
contribute to dystonia by interfering with normal motor selection and suppression of 
unwanted movements (Mink et al 1996, Hallet 2004).
1.2.4.1.2  Blink reflex disinhibition and involved circuits
The blink reflex excitability is abnormally increased in patients with cranial (Berardelli 
et  al  1985),  cervical  (Tolosa  et  al  1988),  segmental  and  generalised  dystonia 
(Nakashima et al  1990). Therefore disinhibition of brainstem blink reflex circuits is a
43general feature of dystonia, often in patients without blepharospasm (Nakashima et al 
1990). The blink reflex of orbicularis oculi in response to electrical stimulation of the 
supraorbital nerve has two components.  The early R1  response  is  seen unilateral to 
stimulation  and  is  mediated  by  an  oligosynaptic  pathway  involving  first  division 
trigeminal afferents relaying via intemeurons near the trigeminal sensory nucleus and 
then motomeurons of the facial nucleus. The later R2 response is bilateral, of longer 
duration  and  is  mediated  via  a  polysynaptic  pathway  involving  the  descending 
trigeminal  spinal  tract,  caudal  spinal  nucleus  and  medullary  reticular  formation  to 
project  bilaterally  to  facial  motomeurons  (Aramideh  et  al  2002).  The  human  blink 
reflex R2 component displays the property of paired pulse inhibition.  Excitability of 
these  circuits  is  usually  measured  by  delivering  paired  stimuli  and  examining  the 
degree  of inhibition  of the  second  R2   response  with respect to  the  first  (Kimura & 
Harada  1976). Paired pulse R2 inhibition is mediated by local inhibitory intemeurons 
and  reduced  in  animals  treated  with  systemic  GABA  antagonists,  suggesting  the 
inhibition is mainly GABAergic (Pellegrini & Evinger  1995). The local intemeuronal 
networks in turn receive descending modulation from basal ganglia and cortex (Esteban
1999).  Basal  ganglia  influence  on  the  blink  reflex  may  involve  GPi,  thalamus  and 
cortex, in turn projecting to the brainstem (Berardelli et al 1983). More recently, animal 
studies have shown that 6-hydroxydopamine lesions of the SNc result in blink reflex 
R2  disinhibition through  a nigro-collicular projection via the  nucleus  raphe  magnus 
(Basso  et al  1996,  Schicatano  et  al  1997).  The  anatomical  connections  permit  basal 
ganglia influence on brainstem blink reflex circuits via both major basal ganglia output 
channels,  the  GPi  or  SNr.  Therefore,  blink reflex  excitability provides  a  subcortical 
measure of changes in basal ganglia output of relevance to the study of dystonia and 
effects of GPi DBS.
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Figure 1.3.  (a) The normal human blink reflex showing R1 and R2 components. Note the R1 
response is unilateral to the stimulated side (*) whereas the R2 response is bilateral, (b) Shows 
the brainstem circuits mediating the R1 and R2 component. (From Aramideh et al 2002)
1.2.4.1.3  Abnormalities of spinal reciprocal inhibition and involved circuits 
At the spinal cord level, reduced reciprocal inhibition (RI) between forearm flexor and 
extensor muscles has been demonstrated in patients with focal and generalised dystonia 
(Nakashima  et  al  1989,  Panizza  et  al  1989,  1990).  It  is  unclear  whether  these 
abnormalities contribute to dystonia because abnormally reduced RI has been found in 
the asymptomatic contralateral arm in writer's cramp patients (Chen R et al  1995) and 
in  patients  with  spasmodic  torticollis  without  limb  dystonia  (Deuschl  et  al  1992). 
Botulinum toxin therapy has been shown to reverse reductions in reciprocal inhibition 
in patients with dystonia involving the arm (Priori et al  1995); however, this effect is 
unlikely to  be  due  to  relief of dystonia,  rather  an  effect  on  intrafusal  fibres  and  la
45afferent  feedback.  Spinal  reciprocal  inhibition  is  usually  measured  by  recording  H- 
reflex in the flexor carpi radialis with low intensity preceding stimuli delivered to the 
radial nerve. Three phases of reciprocal inhibition are identified. The first is maximal 
for ISI=0ms and is mediated by la afferents of the antagonist muscle spindles, which 
inhibit alpha motor neurons of the agonist via la inhibitory intemeurons in a disynaptic 
pathway (Day et al  1984). The second phase which is maximal with ISI  10-20 ms is 
mediated  by  presynaptic  inhibition  of  agonist  la  afferents  by  type  I  afferents  of 
antagonist muscles (Berardelli et al  1987). The third phase is observed with ISIs of 75 
to  500  milliseconds  and  is  physiologically  less  well  understood,  but  may  represent 
continued presynaptic inhibition (Berardelii et al  1987). The la inhibitory intemeurons, 
which are located in the  intermediate spinal grey matter are central to the  control  of 
reciprocal  inhibition  and  their  excitability  is  influenced  by  a  variety  of inputs.  This 
arrangement confers on spinal reciprocal inhibition circuits a degree of local autonomy 
but  their  behaviour  is  under  constant  descending  influence  of projections  from  the 
cortex  and basal  ganglia.  These  projections  include  the  reticulospinal,  mbrospinal, 
vestibulospinal  and  corticospinal  tracts,  which  modulate  excitability  of  both  la 
inhibitory  intemeurons  (Hultbom  1976)  and  intemeurons  involved  in  presynaptic  la 
inhibition (Baldisera et al  1981). Reduced reciprocal inhibition in dystonia is therefore 
likely to be a downstream effect of abnormal descending influence on spinal circuitry 
as a result of disordered basal ganglia output (Nakashima et al 1989).
46Figure 1.4.  (a) Shows the pathway for disynaptic reciprocal inhibition with la afferents of the 
agonist (in this case the flexor) project to the alpha motomeurons of the antagonist via the la 
inhibitory interneuron,  (b) Shows the pathway for presynaptic inhibition of the antagonist la 
inhibitory intemeurons by la spindle afferents of the agonist (in this case the extensor).
1.2.4.2  Sensory system abnormalities
Tactile  spatial  discrimination  is  reduced  in  patients  with  focal  hand  dystonia  (Bara- 
Jimenez et al 2000a).  These patients also exhibit abnormal temporal discrimination of 
tactile and visuo-tactile stimuli, which correlate with the severity of focal hand dystonia 
(Bara-Jimenez  2000b,  Fiorio  et  al  2003).  Again,  the  mechanistic  role  of  these 
abnormalities is unclear, since they may be detected in clinically unaffected body parts 
(Molloy  et  al  2003).  The  explanation  for  this  may  be  that  the  physiological 
abnormalities are more widespread than the clinical symptoms; disorganisation of the 
somatosensory  cortical  hand  representation  contralateral  to  the  clinically  unaffected 
side  has  been  demonstrated  in  patients  with  focal  hand  dystonia,  suggesting  that 
endophenotypic  abnormalities  exist  and  provide  the  substrate,  in  which,  under 
appropriate  environmental  influence,  dystonia  may  develop  (Meunier  et  al  2001). 
Interestingly, tactile spatial sensory discrimination is normal in patients with primary
47generalised dystonia (Molloy et al 2003).  However, other sensory abnormalities have 
been demonstrated in patients  with primary generalised dystonia including  abnormal 
summation  of  cortical  sensory  evoked  potentials  in  response  to  peripheral  nerve 
stimulation (Tinazzi et al 2000) and dedifferentiation of sensory receptive fields within 
the thalamus determined from microelectrode recording of patients undergoing surgery 
(Lenz et al 1999).
1.2.4.3  Basal ganglia neuronal and oscillatory activity
Studies  of pallidal  neuronal  activity  in  dystonia  patients  undergoing  microelectrode 
exploration during functional neurosurgery have demonstrated reduced firing rates and 
irregular  firing  patterns  when  compared  with  pallidal  neurons  of  patients  with 
Parkinson's disease (Lozano et al  1997, Lenz et al 1998, Vitek et al  1999, Sanghera et 
al  2003,  Starr  et  al  2005),  although  conflicting  results  have  also  been  reported 
(Hutchison et al 2003). Neuronal firing in the GPi and motor thalamus correlates with 
EMG activity recorded from dystonic limbs (Zhuang & Hallett 2004). Similarly, local 
field  potential  recordings  from  GPi  in  dystonia  patients  have  demonstrated  low 
frequency (4-10Hz)  oscillatory  activity  (Silberstein et al  2003,  Starr et al  2005), the 
amplitude of which correlates with dystonic  contractions  in the  EMG (Chen C  et al 
2006a)  and  which  is  synchronous  with  firing  of local  GPi  neurons  (Chen  C  et  al 
2006b). In cervical dystonia, application of a sensory trick with alleviation of dystonia, 
results in a corresponding reduction in low frequency oscillatory activity in the globus 
pallidus  and  cortex  (Tang  et  al  2007).  Taken  together,  these  observations  suggest 
abnormal neuronal firing patterns and excessive low frequency oscillations in GPi play 
an important role in the genesis of dystonia and may even be the driving signal for the 
expression of phasic dystonic contractions. The neuronal and oscillatory abnormalities
48are  consistent  with  a  model  of  dystonia  in  which  abnormal  basal  ganglia  output 
adversely affects cortical motor function.
1.2.4.4 Abnormalities of regional cerebral blood flow
Further evidence of cortical dysfunction in dystonia has come from PET studies which 
have  shown  overactivity  of  prefrontal  and  underactivity  of  primary  sensorimotor 
cortices  during  voluntary  movement  in  patients  with  primary  generalised  dystonia 
(Ceballos-Baumann  et  al  1995a),  whereas  in  secondary  hemidystonia  there  is 
overactivation of both prefrontal and primary sensorimotor cortices during movement 
(Ceballos-Baumann et al  1995b). These findings may be reconciled with TMS studies 
showing increased excitability of the motor cortex, as the mutual result of decreased 
thalamocortical  inhibition.  PET  studies have  also demonstrated  abnormal  patterns  of 
regional  cerebral  glucose  uptake  in  manifesting  and  non-manifesting  carriers  of the 
DYT  1   mutation,  with  bilateral  covarying  increases  in  the  putamen,  pallidum, 
supplementary  motor  area  and  cerebellar  hemispheres  (Eidelberg  et  al  1998), 
suggesting that endophenotypic abnormalities extend to regional cerebral metabolism. 
A  recent  fMRI  study  in  patients  with  writer's  cramp  showed  bilateral  increase  in 
activation in the striatum, internal globus pallidus and lateral thalamus during a tactile 
discrimination task (Peller et al 2006). These changes are interpreted as consistent with 
defective centre surround inhibition of sensorimotor cortical areas during a tactile task, 
as a result of defective basal ganglia function.
1.2.4.5 Abnormalities of neural plasticity
There are several lines of evidence to suggest that abnormal brain plasticity may play a 
role  in  the  pathophysiology  of  dystonia.  Abnormal  reorganisation  of  somatotopic
49domains in the sensorimotor cortex of monkeys has been observed following excessive 
hand  training  resulting  in  dystonia-like  involuntary  movements  (Byl  et  al  1996). 
Similarly  task  specific  focal  dystonia  may  develop  with  over-learned  tasks  such  as 
writing or playing musical instruments, and abnormal patterns of cortical reorganisation 
have been shown in these patients (Meunier et al 2001, Rosenkranz et al 2005).  More 
direct evidence for abnormal plasticity in dystonia has come from TMS studies using 
paired associative stimulation (PAS) repetitive TMS protocols to probe motor cortex 
plasticity.  Patients  with  writer’s  cramp  show  greater  potentiation  of motor  evoked 
potential  amplitude  (MEP)  following  PAS  than  healthy  subjects  (Quartarone  et  al
2003).  Similarly,  patients  with  focal  arm  dystonia  show  more  profound  changes  in 
regional  cerebral  blood  flow  (reflecting  synaptic  metabolic  activity)  following  1   Hz 
repetitive  TMS  to  the  premotor  cortex  (Siebner  et  al  2003).  Patients  with  sporadic 
cervical dystonia and DYT1  dystonia show more intense and longer-lasting inhibition 
of MEP amplitude following theta-burst repetitive TMS than healthy subjects or non­
manifesting carriers  of the  DYT1  gene  (Edwards  et al  2006).  Increased  plasticity in 
subcortical circuits has  also been demonstrated in dystonia patients.  Quartarone et al 
(2006a), using methodology devised by Mao and Evinger (2001) to  induce LTP-like 
plasticity  in  the  blink  reflex,  demonstrated  that  patients  with  blepharospasm  have 
increased  responsiveness  to  this  intervention  compared  with  healthy  subjects. 
Collectively, these results suggest short-term synaptic plasticity is increased in dystonia 
patients and could contribute to the development of dystonia by promoting maladaptive 
reorganisation within cortical and subcortical motor circuits (Quartarone et al 2006b).
501.2.4.6  Integrative model of dystonia pathophysiology
A  successful  model  for  dystonia  must  take  into  account  the  varied  physiological 
abnormalities which have been identified. Similarly, potential interaction between these 
abnormalities must also be considered, which might be synergistic. For example, loss 
of inhibition might promote excessive neural plasticity by failing to gate the strength of 
synaptic inputs, thereby  encouraging disorganisation of sensorimotor representations. 
Abnormal  oscillatory  activity  and  excessive  neuronal  synchrony  could  enhance 
aberrant  synaptic plasticity  within the  basal  ganglia  and cortex.  Such  an  interaction 
seems likely, given that neuronal oscillations may facilitate cortical plasticity (Buzsaki 
&  Draguhn  2004).  Excessive  synchrony  of neuronal  firing  within the  basal  ganglia 
thalamus  and  cortex  could  also  interfere  with  correct  spatiotemporal  processing  of 
sensory input and motor output required for normal voluntary movement.  Taking the 
varied abnormalities into account, the model which emerges is one in which there is an 
underlying  defect  of basal  ganglia function,  abnormal  excitability  of motor  circuits, 
misprocessing of sensory feedback and increased cortical synaptic plasticity, resulting 
in  abnormal  neural  reorganisation  and  ultimately  clinical  dystonia.  The  proposed 
sequence of changes are compatible with the typical clinical course of primary dystonia 
with onset in one body part and subsequent gradual  spread to  other body regions,  a 
time-course in keeping with progressive aberrant plasticity. Furthermore the model can 
accommodate the  observation  of subclinical  physiological  abnormalities,  since  these 
would represent partial evolution of the pathophysiological cascade but insufficient to 
manifest  clinical  dystonia.  An  important  question  is  whether  such  a model  can  be 
applied to all forms of dystonia. Most of the pathophysiological studies have been in 
patients with primary dystonia, particularly focal hand dystonia but also segmental and 
generalised dystonia, with few studies in secondary dystonia. Although these categories
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physiological  abnormalities that have been identified.  Therefore  the proposed  model 
mainly aims to describe primary dystonia, but may also be of relevance to secondary 
dystonia.
1.3  Objectives of the thesis
The development of GPi DBS has heralded an exciting development for the treatment 
of severe  dystonia.  The  progressive  improvement  noted  in  dystonia  after  GPi  DBS 
suggests brain plasticity is involved. Furthermore, physiological data suggests dystonia 
is a disorder in which abnormal synaptic plasticity and the emergence of dysfunctional 
reorganisation  of  the  sensorimotor  system  plays  an  important  role.  From  these 
observations, the hypothesis emerges that GPi DBS leads to brain reorganisation into a 
more  normal  physiological  pattern,  in  this  way  reversing  the  underlying  abnormal 
plasticity  characterising  the  dystonic  state.  This  hypothesis  leads  to  the  following 
predictions. Firstly, that physiological measures should change progressively after GPi 
DBS, reflecting brain reorganisation and secondly, that  GPi  DBS  should have  some 
effect on mechanisms  of brain plasticity  such as  LTP.  To  this  end,  the  longitudinal 
effects  of  GPi  DBS  on  blink  reflex  excitability  and  forearm  H-reflex  reciprocal 
inhibition were  studied  and  the  impact  of GPi  DBS  on  motor  cortex  plasticity  was 
assessed.  These physiological measures were compared with the therapeutic response 
of dystonic symptoms. To probe the connections between GPi and the extent to which 
DBS activates these pathways, cortical evoked potentials were recorded in response to 
GPi stimulation.  A secondary aim of this study was to assess the therapeutic efficacy 
of  GPi  DBS  for  dystonia  with  special  attention  to  the  time-course  and  factors 
influencing the magnitude of clinical improvement, in particular the effect of location
52of stimulation within the pallidum. The ultimate goal of this work was to find evidence 
of neural plasticity underlying the mechanism of action of GPi DBS for dystonia.
53Chapter 2. General Methods
2.1 Subjects
The work presented is this thesis is derived from a consecutive  series of 29 dystonia 
patients who were all studied clinically before and after deep brain stimulation surgery, 
a subgroup of which underwent physiological studies. The series included 27 patients 
with  generalised  dystonia,  the  aetiology  of which  was  as  follows:  20  primary  (10 
DYT1, 10 non-DYTl), 4 secondary, 2 PKAN,  1   tardive. Two patients with secondary 
hemidystonia  were  also  studied.  All  patients  were  included  in  clinical  evaluation 
studies.  The primary generalised dystonia patients, both DYT1  and non-DYTl, were 
recruited  for  the  electrophysiological  experimental  studies.  A  group  of  18  healthy 
volunteers, recruited mainly from within the Sobell Department, were also studied as 
control subjects in the electrophysiological experiments.
The description of subjects included in each study is outlined in the methods section for 
each  chapter.  All  subjects  gave  written  informed  consent  to  participate  in  the 
experiments  described  in  this  thesis,  and  the  studies  were  approved  by  the  Joint 
Research Committee of the National Hospital for Neurology and Neurosurgery and the 
Institute of Neurology.
2.2 Surgical technique
The surgical technique  described here was used in all the operated dystonia patients 
included in this thesis. The stereotactic electrode implantation is MRI guided and relies 
on  direct  targeting  without  the  use  of microelectrode  recording  (Hirabayashi  et  al 
2002).  The  surgery  is  carried  out  under  general  anaesthesia.  The  hair  is  shaved 
completely and the  Leksell  G frame (Elekta Instruments,  Sweden)  is  attached to  the
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canthus, and care is taken to eliminate antero-posterior or lateral tilting and rotation. 
Following transfer of the patient to the MRI table, the MRI adapter and fiducial box are 
fitted to the frame and checks are made, using a biaxial spirit level, that the frame is 
completely level, Figure 2.1.
Figure 2.1 Leksell G frame in position in dystonic patient with fiducial box attached  just prior 
to MRI scanning.  Note the biaxial spirit level to check the frame is completely level in  both 
planes.
After  fitting  of transmit-receive  head  coil,  the  level  of the  frame/fiducial  box  are 
rechecked before the patient enters the MRI.  Stereotactic MRI is then obtained using
1.5  Tesla MRI (General Electric, USA) with 2 mm contiguous axial and coronal images 
with proton density  sequences, which provide excellent visualisation of the pallidum 
allowing  resolution  of  boundaries  of  GPe,  GPi,  medial  medullary  lamina,  lateralmedullary  lamina  and  pallido-capsular  border  (Hirabayashi  et  al  2002),  Figure  2.2. 
Using these images, direct targeting of the posteroventral GPi is carried out using both 
manual and computer aided techniques (Stealth workstation, Framelink TM, Medtronic, 
Minneapolis USA). The patient is then transferred from the MRI suite to the operating 
theatre. The burr-holes are made bilaterally 2-2.5 cm lateral to the mideline at the level 
of the coronal suture using a pneumatic craniotome and 14 mm perforator. The dura is 
opened using bipolar diathermy.  The ring angle  (anteroposterior angle) was between 
70-80 degrees, the arc angle 85-95 degrees. A rigid  1.5 mm diameter radio-frequency 
electrode  with  an  uninsulated  tip  2  mm  in  length  (Elekta  Instruments,  Sweden)  is 
slowly inserted to the target to  create the tract  for the therapeutic  electrode.  During 
insertion of the radio-frequency electrode, tissue impedance is measured and displayed 
continuously  numerically  in  Ohms  and  as  an  auditory  analogue  tone  allowing 
differentiation of grey  and  white  matter  (Limonadi  et al  1999).  Typically  a drop  in 
impedance  is  encountered  as the  electrode  passes  from  white  matter  into  the  dorsal 
putamen or GPe, usually about  10 mm before the target point.  The quadripolar DBS 
electrode model 3389 (Medtronic Neurological Division, Minneapolis USA), with four 
platinum-iridium cylindrical surfaces  (1.27 mm diameter and 1.5 mm in length and 2 
mm  centre-to-centre  separation)  is  then  implanted  and  fixed  to  the  skull  using  the 
plastic  cap  or Navigus  electrode  fixation  system  (Medtronic  Neurological  Division, 
Minneapolis USA). In four patients operated early in the series, model 3387 electrodes 
were used (Medtronic Neurological Division, Minneapolis USA) with 3 mm centre-to- 
centre contact separation.
56Figure 2.2 From Hirabayashi et al 2002.  Proton density sequence MRI coronal (a) and axial 
(b) views, showing clear visualisation of  pallidal boundary:  laterally the putamen, medially the 
internal capsule and inferiorly on the coronal image the optic tract (dark) is visible.  Note the 
medial medullary lamina separating GPi and GPe is clearly visible.
2.2.1  Post-implantation imaging and confirmation of electrode position 
Immediately after bilateral electrode implantation and fixation, the stereotactic MRI is 
performed.  The  number  of image  slices  in the  immediate  post-implantation  MRI  is 
limited  to  ensure  the  specific  absorption  rate  (SAR)  is  kept  below  0.4  W/Kg  to 
minimise  the  risks  of electrode  or  tissue  heating  (Rezai  et  al  2004).  Once  correct 
electrode placement has been confirmed, the patient is returned to the operating theatre 
and  the  pulse  generator  implanted  (Kinetra  model  7428,  Medtronic  Neurological 
Division,  Minneapolis  USA),  usually  into  a  left  infraclavicular  subcutaneous  pocket 
and connected to the implanted electrodes. In some patients, for cosmetic reasons, the 
implanted pulse generator was implanted in the abdomen. By convention, the electrode
57for the  right hemibody  is  connected to  Channel  1   (contacts  0,  1,  2,  3)  and the  left 
hemibody to Channel 2 (contacts 4, 5, 6, 7).
In one patient, MRI could not be performed due the presence of a metal fragment in the 
thalamus  related to  previous  thalamotomy.  In this  patient  CT  was  used  with  2  mm 
contiguous slices and manual calculation of target coordinates were used. In addition 
intraoperative  high  frequency  stimulation,  with patient  anaesthetised  but non-muscle 
relaxed, to observe thresholds for capsular response was performed, and finally post­
implantation stereotactic CT to confirm electrode placement.
2.3  Clinical Evaluation
2.3.1 Study design: prospective longitudinal assessment
In all patients  clinical evaluations were performed before,  and  serially  after surgery. 
Evaluations were undertaken at the following time-points; pre-operatively, 2 weeks,  1  
month, 3 months, 6 months, 1  year and annually thereafter, the longest follow up being 
4 years. The clinical scoring was carried out by a single neurologist rater (ST).
2.3.2 Burke-Fahn-Marsden dystonia rating scale
The Burke-Fahn-Marsden dystonia rating scale (BFM) was used throughout this work 
(Burke  et  al  1985).  The  BFM  is  divided  into  two  parts,  the  movement  score  and 
disability subscales.  The BFM movement score ranges from 0 to 120 and is the sum of 
body region items for the eyes, face/mouth, speech/swallow, neck, arms, trunk and legs. 
The arms and legs are scored separately for right and left sides, the other regions carry 
a  single  score.  For  each  body  region,  the  score  is  derived  from  the  product  of a 
provoking factor (0-4) and severity factor (0-4) multiplied by a weighting factor where 
zero represents no dystonia.  The provoking factor ranges from dystonia present with
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severe=4. A severity factor of 4 corresponds to no useful grip of the hand or inability to 
walk. The weighting factor for eye, mouth and neck regions is 0.5 reflecting their lesser 
impact on disability, and 1.0 for remaining regions.
The  total  disability  score  ranges  from  0  to  30  and  is  the  sum  of scores  for  seven 
functional  items:  speech,  handwriting,  feeding,  swallowing,  hygiene,  dressing  and 
walking. All disability score items are rated (0-4) except walking which is (0-6). All 
patients were videotaped at the time  of scoring  according to  a standardised protocol 
described  by  Burke  et  al.  However,  all  BFM  data quoted  in this  work  pertains  to 
scoring made by live, direct examination of patients at the stated time-point.
The BFM has been validated and shown to have good inter-rater and retest reliability 
(Burke et al 1985). The BFM has been compared to the more detailed Unified Dystonia 
Rating Scale and the relatively simple Global Dystonia Rating Scale and was found to 
be equivalent in terms of intra and inter-rater reliability, with an ease of use in between 
the two other scales (Cornelia et al 2003). The BFM is the most widely used dystonia 
scale in studies of GPi DBS for dystonia (Cif et al 2003, Yianni et al 2003, Coubes et al 
2004, Vidailhet et al 2005, Kupsch et al 2006).
2.3.3  Selection and adjustment of stimulation parameters
The implanted pulse generator was switched on usually on the first postoperative day. 
The electrode contacts were  assessed individually with monopolar stimulation,  pulse 
width 60 ps,  130 Hz increasing progressively to 4 V to assess for any side effects or 
acute therapeutic effects. Stimulation was commenced using the most ventral contacts 
without side effects, starting with 1   V, 60 ps,  130 Hz with further increase by 0.5-IV 
per  day  until  a  clinical  benefit was  noted  or  an  arbitrary  level,  usually  3.5  V,  was
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then alternative  contacts were tried, usually the adjacent ventral  contact  singly or in 
combination. Different contacts were compared usually over a 24-hour period to assess 
their impact, most of this adjustment occurring with the patient in hospital in the early 
post-operative period.  Further adjustment of stimulation parameters was made where 
necessary at each subsequent follow-up visit. In most instances, this adjustment was an 
increase in voltage or pulse width or sometimes the addition of a second active adjacent 
contact  or  change  of  single  contact.  Clinical  scores  were  made  before  change  of 
stimulation  parameters  at  each  visit.  All  patients  received  continuous  GPi  DBS. 
Patients were provided with a personal therapy controller, allowing some adjustment of 
voltage within set limits.
2.4 Neurophysiological recordings
As described in the  Introduction,  abnormalities  of inhibition at brainstem  and  spinal 
level are well documented in generalised dystonia. Furthermore, these abnormalities are 
measured by blink reflex R2 inhibition and forearm H-reflex reciprocal inhibition using 
surface EMG and are practicable to perform in patients with generalised dystonia,  as 
evidenced by existing studies in this patient group (Nakashima et al 1990, Panizza et al 
1990).  In  addition,  abnormalities  of brainstem  blink  and  spinal  H-reflex  reciprocal 
inhibition  in  dystonia  are  thought  to  reflect  abnormal  descending  modulation  from 
cortex and basal ganglia, and therefore provide an indirect means of examining changes 
in activity in these regions. For these reasons, blink reflex R2 inhibition and forearm H- 
reflex  reciprocal  inhibition  were  selected  for  longitudinal  study  in  patients  with 
generalised dystonia after GPi DBS.
602.4.1 Surface EMG recordings
All  EMG  recordings  were  made  using  1   cm  Ag/Ag  chloride  disc  electrodes  and 
conductive gel after preparation of the skin with isopropyl alcohol. The active electrode 
was placed over the muscle belly and the reference at a distal nearby site. To further 
reduce the impedance, particularly for the blink reflex recordings,  a sterile  21-gauge 
hypodermic  needle  was  introduced  through  the  disc  electrode  to  touch,  without 
breaking, the skin.
2.4.1.1 Amplification and filtering
The EMG signals were amplified and analogue band pass filtered using Digitimer D360 
amplifiers  (Digitimer  Ltd,  Welwyn  Garden  City,  Herts.  UK)  analogue  to  digital 
converted using a  1401  AD converter (Cambridge Electronic Design Ltd Cambridge, 
UK)  sample  rate  of  5  KHz  and  recorded  on  computer  using  Signal  software 
(Cambridge Electronic Design Ltd Cambridge, UK).  For blink reflex recordings band 
pass filtering was 53 Hz to 3 kHz, whilst for all other experiments 3 Hz to 2-3 kHz was 
used.
2.4.1.2 Artifact elimination
EMG  artifact,  mainly  in  the  form  of 50  Hz  mains  interference  was  minimised  by 
adequate skin preparation to reduce impedance  and positioning of amplifier box and 
recording wires. The 50 Hz notch filter was rarely used. To minimise the presence of 
involuntary dystonic EMG activity in the resting recordings, the least affected arm was 
studied.  Unrelaxed trials with any ongoing  EMG activity were  rejected  on-line.  GPi 
DBS produced 130 Hz artifact in the blink reflex recordings but not the H-reflex, owing 
to the greater distance from the source and lower amplification gain. To eliminate DBS
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at the beginning of the experimental session from monopolar to bipolar stimulation at 
30% higher voltage.
2.4.2 Blink reflex
Surface  EMG  recordings  were  made  bilaterally  from  the  orbicularis  oculi  muscles. 
Electrical  stimulation was  applied to the  supraorbital nerve  in the  supraorbital  notch 
with  a  bipolar  stimulating  electrode  and  constant  current  generator  (Digitimer  Ltd, 
Welwyn Garden City, Herts. UK). All stimuli were 0.2 ms duration with intensity 3-4 
times sensory threshold (8-14 mA). The blink reflex in response to paired stimulation 
was  assessed  at  interstimulus  intervals  of 500  ms  and  1000  ms.  The  500  ms  was 
included because a previous study found it to be the interval which most discriminated 
between dystonia patients and control subjects (Nakashima et al 1990), and 1000 ms to 
provide a comparator interval with a lesser degree of inhibition. The interval between 
trials was varied randomly between  10 and 20 seconds to minimise habituation of the 
blink response. Thirty trials at each ISI were performed in a randomised order in three 
blocks for both right and left sided supraorbital nerve stimulation.
2.4.3 Forearm H-reflex reciprocal inhibition
EMG  recordings  were  made  from  flexor  carpi  radialis  and  extensor  digitorum 
communis.  Electrical  stimulation was applied to  the median nerve  in the  antecubital 
fossa  and  radial  nerve  above  the  elbow,  using  two  constant  current  generators 
(Digitimer Ltd, Welwyn Garden City, Herts. UK).  Stimuli to median nerve were 500 
ms.  Longer  stimulus  duration  500-1000  ms  preferentially  excites  afferent  la  spindle 
fibres which assists in elicitation of the H-reflex. The intensity was adjusted to produce
62the maximum H-reflex, without an M wave.  Radial nerve  stimuli  were  also  500  ms 
duration at an intensity to produce an EMG response of 0.1-0.5  mV.  The H-reflex in 
response to preceding radial nerve conditioning stimuli was assessed at 8 interstimulus 
intervals (ISI) of — 1, 0,  1,  10, 20, 30, 100 and 200 ms. Stimuli were delivered every 5 
seconds.  Sixty  trials  at  each  ISI  and  120  unconditioned  trials  were  performed  in  a 
randomised order in three blocks of 100 stimuli.
2.4.4. EEG for evoked potential (EP)
2.4.4.1 Origin of EEG signal and EP
The EEG  signal  recorded  at the  scalp  is the  electrical  activity  corresponding  to  the 
postsynaptic  dendritic  potentials of populations  of neurons  near the  cortical  surface. 
The  postsynaptic  potentials  time-vary  between  excitatory  and  inhibitory,  the 
synchronised activity of many neurons contribute to the oscillatory activity recorded as 
scalp EEG.  In general EPs represent time-locked synchronised activity of a group of 
cortical neurons in response to a stimulus. The EP following a single stimulus is often 
invisible, embedded within the background EEG. By averaging in the time domain the 
EEG  following  many  stimuli,  the  EP,  which  is  relatively  constant  in  position  and 
waveform is reinforced while the backgound EEG cancels out. The main quantification 
of the resulting EP is by its latency, amplitude and cortical topography.
2.4.4.2 Montage, amplification and filtering
The EEG was recorded using the Neuroscan EEG system (Compumedics Ltd, El Paso, 
Texas USA). A modified  10-20 montage was used with 60 Ag/AgCl electrodes fitted 
with  an  elastic  cap  and  chin-strap.  The  scalp  surface  was  prepared  with  isopropyl 
alcohol, gentle abrasion and conductive gel to reduce electrode impedance to <1 kOhm.
63Recordings  were  referenced  to  linked  ears.  EEG  signals  were  amplified,  band  pass 
filtered 0.05-200 Hz and analogue to digital converted at a sample rate of 2500 Hz.
2.4.4.3  Triggering and elimination of DBS artifacts
EEG  during  therapeutic  monopolar  GPi  DBS  is  affected  by  extreme  artifact  which 
precludes any meaningful recording. Therefore GPi DBS was changed to bipolar for all 
recordings and the frequency reduced to 10 Hz, amplitude 3.5-4 V and pulse width 60- 
90  ps.  For  triggering,  surface  electrodes  were  attached  to  the  forehead  and  nuchal 
region  and  the  signal  amplified  using  a  Digitimer  360  amplifier  (Digitimer  Ltd, 
Welwyn  Garden  City,  Herts.  UK)  and  the  output  fed  into  a  Schmidt  trigger  and 
displayed  on  an  oscilloscope.  This  setup  allowed  the  10  Hz  DBS  artifact  to  be 
continuously  displayed,  the  Schmidt  trigger  was  adjusted  during  the  experiment  to 
ensure  a  consistent  10  Hz  triggering  signal  which  was  fed  into  the  Neuroscan  and 
recorded as a triggering channel in the EEG. Recordings lasting 90-120 seconds were 
made during stimulation at each bipolar pair of the quadripolar electrode on both sides 
consecutively, with the other electrode set to zero amplitude.
2.4.5  Transcranial magnetic stimulation (TMS)
2.4.5.1  Mechanisms and principles of TMS
TMS  exploits  the  property  of a  time-varying  magnetic  field  to  induce  current  in  a 
conductor to excite the cortex. It was first demonstrated by Barker (Barker et al  1985) 
and  has  become  a  widely  used  tool  for  non-invasive  cortical  stimulation  in  awake 
human subjects. It replaced electrical cortical stimulation, having the major advantage 
that it is not painful. The basic principle involves the capacitative discharge of a large 
transient current into a wound hand-held coil, which results in a powerful time-varying
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to the coil. Coils exist in single and double configurations, the latter, so called figure- 
of-eight coils are the most widely used because the magnetic  flux is  delivered more 
focally beneath the intersection of the coils (Cohen & Cuffin  1991).  The TMS pulse 
induces currents in the cortex which flow parallel to the surface of the brain and excites 
cortical  neurons.  The  relative  focality  of TMS  allows  fairly  selective  stimulation  of 
homotopic motor cortical areas for individual muscles; usually intrinsic hand muscles 
are tested. The basic arrangement for TMS is shown in Figure 2.3
2.4.5.2  Origin of the motor evoked potential (MEP)
A  single  TMS  pulse  applied to  the  motor  cortex  excites  a pool  of pyramidal  cells, 
resulting in a descending volley of action potentials and an MEP recordable with EMG 
in the corresponding muscle. TMS applied to the motor cortex may activate pyramidal 
neurons transsynaptically producing indirect I-waves, or at higher intensities can excite 
the  pyramidal  cell  axons  directly  producing  D-waves.  Because  of the  intervening 
synapses, I-waves are of longer latency than the D-waves and depending on the number 
of synapses II, 12 or 13 waves may be observed at progressively longer latencies (Terao 
& Ugawa 2002).  Coil  orientation in the anteroposterior axis favours  elicitation of II 
waves  over  D  waves.  For  the  TMS  experiment  described  in  this  thesis  the  MEPs 
measured were for the most part elicited by II waves.
65Figure 2.3 General set-up for TMS of the motor cortex using a figure-of-eight coil
2.4.5.3  Methods of experimentally inducing plasticity using TMS 
Plasticity refers to the capacity for dynamic adaptation of the nervous  system and is 
thought to be largely mediated by alterations in synaptic efficiency. Studies using brain 
slice preparations have shown that particular types of conditioning stimulation can give 
rise to sustained increases or decreases in synaptic efficiency. Long term potentiation 
(LTP)  describes  a  sustained  increase  in  the  amplitude  of  excitatory  postsynaptic 
potentials  (for  a  given  presynaptic  input  stimulus)  and  is  usually  produced 
experimentally  by  high  frequency  stimulation  of presynaptic  neurons.  This  process 
involves calcium  influx  into  the  cell,  activation  and  increased  expression  of AMPA 
glutamate  receptors  and  a resulting  decrease  in  the  cell  resting  potential  membrane 
potential,  making  it  more  excitable.  In  synapses  that  exhibit  NMDA  receptor- 
dependent  LTP,  sufficient  depolarization unblocks  NMDA  receptors,  which  permits 
calcium influx  into  the cell,  when bound by  glutamate.  NMDA receptors,  at resting 
membrane  potentials  are  blocked  by  a  magnesium  ion  that  prevents  the  entry  of
66calcium  into  the  postsynaptic  cell,  however  after  depolarization  by  summation  of 
EPSPs, the magnesium blockade is reversed, allowing calcium influx which facilitates 
and  maintains  LTP.  Conversely,  long-term  depression  (LTD)  refers  to  sustained 
decreases in synaptic efficiency and is usually produced by low frequency stimulation 
of the  presynaptic  neurons,  and  is  associated  with  an  increased  resting  membrane 
potential.  LTD  may  also  be  dependent  on  activity  of NMDA  and  metabotrophic 
glutamate  receptors.  The  formation  of  LTP  or  LTD  is  influenced  not  only  by 
presynaptic  inputs but also activity in the postsynaptic  cell, particularly its timing in 
relation to these inputs,  so called associative plasticity.  In general when presynaptic 
input  is  coincident  or just  before  firing  of the  postsynaptic  cell,  LTP  is  favoured, 
whereas reversal of this temporal order favours LTD.
TMS  methods  modelled  on  the  observations  made  in  slice  preparations  have  been 
developed to experimentally induce plasticity in humans. A variety of protocols using 
repetitive TMS (rTMS), which simulate the repetitive input stimuli used in vitro, have 
been  developed.  Motor  cortex  conditioning  with  low  frequency  rTMS  around  1   Hz 
results in sustained decreases in motor cortex excitability lasting  15-30 minutes (Chen 
R et al 1997b, Touge et al 2001). Motor cortex conditioning at higher frequency rTMS, 
around 5-25 Hz, results in sustained increases in motor cortex excitability (Peinemann 
et al 2004, Khedr et al 2007). Recently some new methods for inducing plasticity with 
TMS have been developed. Thickbroom and colleagues (Thickbroom et al 2005) found 
that conditioning with low frequency (0.2 Hz) paired suprathreshold stimulation with 
an interstimulus interval equal to the inter-I wave latency, resulted in marked sustained 
increase in motor cortex excitability. Pulsatile 50 Hz rTMS, so-called theta burst is a 
highly efficient means of inducing sustained decreases and increases in motor cortex 
excitability (Huang et al 2005).
672.4.5.3.1  Paired associative stimulation (PAS)
Stefan  and  colleagues  (Stefan  et  al  2000)  first demonstrated  motor  cortex  plasticity 
using  PAS  with  TMS.  The  technique  uses  paired  stimulation  of motor  cortex  and 
median nerve with the median nerve stimulus preceding the TMS pulse by 25 ms. This 
order allows time for the median afferent volley to reach the sensorimotor cortex and 
arrive synchronously with the motor cortex stimulus.  Stefan used 90 pairs of stimuli 
delivered at 0.05 Hz, with the median nerve intensity of 300 % of perceptual threshold 
and the TMS  intensity adjusted to produce a  1   mV resting MEP in abductor pollicis 
brevis (APB).  In healthy subjects this conditioning resulted in sustained increases in 
motor cortex excitability, as evidenced by the size of the resting MEP, lasting up to  1  
hour. The plasticity effect was topographically restricted to APB and not accompanied 
by changes in spinal excitability,  suggesting its origin to be the motor cortex.  Stefan 
subsequently showed the facilitatory effect of PAS 25 is blocked by NMDA antagonist, 
suggesting  that  it  may  be  mediated  by  LTP-like  mechanisms  (Stefan  et  al  2002). 
Further  evidence  supporting  this  notion  has  come  from  experiments  in  which  the 
temporal  order  of inputs  was  reversed.  Conditioning  with  the  median  pulse  10  ms 
before the motor cortex  TMS pulse,  so that its arrives after pyramidal  neurons have 
fired, results  in a sustained  decrease  in motor cortex  excitability,  which  can also  be 
blocked pharmacologically (Wolters et al 2003). These observations suggest PAS can 
produce  both  LTP  and  LTD  like  effects,  depending  on  the  temporal  order  of 
stimulation, analogous to effects seen in slice preparations. It has also been shown that 
higher frequencies of paired stimulation including 0.25 Hz (Ziemann et al 2004) and 5 
Hz (Quartarone  et al  2006c)  are  also  effective  in producing  sustained  facilitation  of 
motor cortex excitability, and have the practical advantage of taking less time. In the 
TMS experiment described in this thesis, a method of PAS identical to that of Stefan et
68al (2000) was used, with the exception that 200 paired stimuli were delivered at a rate 
of 0.25 Hz.
2.5  Analysis
2.5.1 Clinical scores and percentage improvement
The BFM Movement and Disability subscales were analysed separately throughout. For 
correlation of clinical effects with physiological changes, only the Movement subscale 
was  used.  Percentage  improvement  in  both  Movement  and  Disability  subscales  was 
calculated as follows:
(pre-operative score -  post-operative score) X 100 / pre-operative score.
This  method  of deriving  percentage  improvement  has  been  widely  used  in  clinical 
studies using rating  scales, including  studies  of GPi DBS  for dystonia (Coubes et al 
2004, Vidailhet et al 2005).
2.5.2 Quantification of EMG signals
EMG  data  were  analysed  off-line  using  custom-written  software  (Nucursor  2001, 
Sobell Department, ION, London UK). For blink reflex data, the raw blink recordings 
were DC corrected, rectified and averaged. The onset latency and duration of R1  and 
R2 responses were determined by manual cursor marking of the beginning and end of 
responses.  The  area  ratio  of the  conditioned  R2  component  to  the  unconditioned 
response was calculated. The area of the conditioned R2 was calculated over the same 
duration as the unconditioned response. For the H-reflex the onset and termination of 
the response was marked manually with cursors and the peak-to peak amplitude of each 
H-reflex  was  measured  using  an  automated  function  (Nucursor  2001,  Sobell 
Department, ION, London UK). Reciprocal inhibition at each ISI was calculated as the
69ratio of the conditioned to the unconditioned response. The same method was used to 
measure the peak-to-peak amplitude of TMS evoked MEPs.
2.5.3 EEG analysis and derivation of evoked potentials
EEG data was analysed using Neuroscan software (Compumedics Ltd, El Paso, Texas 
USA).  The continuous EEG recordings  for each contact pair and  side were  epoched 
from -10 ms to 100 ms in relation to the 10 Hz triggering marker of DBS artifact. The 
epoched  files  were  then  averaged  and  the  average  trace  baseline  corrected  for  the 
prestimulus interval. The EP was derived from the average of 1000-1200 sweeps. The 
EP was analysed initially qualitatively by examining all the averaged EEGs to identify 
waveforms following the DBS stimulus. Waveforms identified qualitatively were then 
analysed  quantitatively  by  manual  marking  of the  onset  and  peak  latency  and  the 
amplitude calculated and these data were used for the numerical statistical analysis. The 
EP  was  compared  from  contact  pairs  located  in  GPi  or  GPe.  The  identification  of 
position of contact in relation to pallidal anatomy was made using Stealth workstation 
(Framelink TM, Medtronic, Minneapolis USA). Grand averages were also derived for 
contact pairs in GPi or GPe.
2.5.4 Statistics
All  statistics  were  performed  using  SPSS  for  Windows  version  11.5  (SPSS  Inc., 
Chicago, Illinois USA). Data are expressed as means and standard error of the mean 
unless  otherwise  stated.  For  analysis  of clinical  and  physiological  time-course  data, 
SPSS curve estimation function was used which allows the data to be modelled against 
several  functions  (linear,  exponential,  logarithmic  etc)  and  computes  the  non-linear 
regression coefficients  in that function,  which describe the  line of best  fit.  Repeated
70measures analysis of variance (ANOVA) was used to  identify  significant changes  in 
clinical or physiological data before and after surgery at one or more time point. One­
way  ANOVA  was  used  where  appropriate  to  compare  data  from  healthy  control 
subjects and patients.  The nature of significant effects identified using ANOVA was 
explored using two-tailed paired or unpaired t-tests, depending on the comparison. For 
analysis  of  electrode  contact  location  data,  K-means  cluster  was  used  to  identify 
statistically  significantly  segregated  groups  within  continuous  distributed  data.  Chi- 
square  tests  were  used  to  identify  differences  in  the  frequency  of superior  clinical 
outcomes  between  different  spatial  clusters  of electrode  contacts.  Correlations  were 
performed using the  Pearson correlation coefficient or the  Spearman Rho coefficient 
where  appropriate.  For  all  statistics  a  probability  (p)  value  <0.05  was  considered 
significant. The precise factors and terms used within these statistical tests are given in 
detail in the Methods section for each Chapter.
71Chapter 3. Therapeutic effects of GPi DBS in dystonia *
3.1  Summary
In this  Chapter the therapeutic  response of dystonia to  deep  brain  stimulation  in 29 
patients who underwent bilateral (n=27) or unilateral GPi DBS (n=2) is presented. The 
series  included 27  patients with generalised dystonia, the  aetiology of which was as 
follows: 20 primary (10 DYT1, 10 non-DYTl), 4 secondary, 2 PKAN,  1   tardive. Two 
patients with secondary hemidystonia were also studied. Patients were studied using the 
BFM score with a prospective single rater design, with assessments made before and at 
intervals of 0.5,  1,  3, 6,  12, 24 and 36 months after surgery.  In twenty patients with 
primary generalised dystonia (10 DYT1  positive,  14 female, mean age 41  years ±16, 
mean duration of symptoms 24 years ±  14) at 6 months follow up,  BFM movement 
score  improved  by  an  average  of  68%  ±  18  and  disability  score  by  55%  ±  23 
(p<0.00001).  Longer  follow-up  confirmed  these  improvements  in  BFM  movement 
score to be stable: at 12 months 68% ± 20 (n=16), 2 years 71  % ± 21  (n=16), 3 years 
65% ± 25  (n=10).  Improvement in dystonia was progressive.  In the 20 patients with 
primary generalised dystonia BFM movement score improved by 47% ±21 at 2 weeks, 
and 55% ±  19  at  1   month.  Regression analysis  confirmed  a progressive  time  course 
independent of changes in DBS electrical parameters. The time course of improvement 
in BFM movement score was closely modelled by a logarithmic function.  Univariate 
analysis  of variance  identified  the  presence  of the  DYT1  mutation  and  orthopaedic 
deformity to be significant positive and negative predictors  of outcome,  but age  and 
symptom duration were  not predictive.  The four patients  with secondary  generalised 
dystonia were more severely affected at baseline and improved significantly less, at  1  
year movement score 21% ± 6.8, disability score 10% ± 6%, but still benefited in terms
72of comfort and ease of management. In comparison, the patient with secondary tardive 
dystonia improved by 48% and the two patients with PKAN dystonia by 48% and 12% 
at 1  year.  Two patients with secondary hemidystonia due to contralateral basal ganglia 
lesions  both  failed  to  improve  with  unilateral  GPi  DBS.  No  major  complications 
occurred.  Failure  of the  DBS  system, due to  breakage  or device  failure,  occurred  in 
three patients. Reversible, stimulation related side effects included dysarthria, akinesia 
and tremor. The present results confirm bilateral GPi DBS to be a safe and effective 
treatment for various forms of dystonia, particularly primary generalised. The presence 
of the DYT1 mutation is a favourable marker for response to DBS. The poorer response 
in those with orthopaedic deformity argues for earlier surgery before such deformities 
occur.  The progressive time  course of improvement  in primary  generalised dystonia 
although the result of GPi DBS, is not a by-product of serial adjustments in stimulation 
parameters.  Instead  it  is  likely to  reflect  neural  plasticity  underlying the  therapeutic 
response.
*  Preliminary  results  of this  work were presented in poster form  at  the  Movement 
Disorders Society Meeting, New Orleans,  USA March 2005
733.2 Introduction
The  most  significant  advance  in  the  functional  neurosurgical  approaches  to  the 
treatment of severe,  medically refractory dystonia has been the  development of GPi 
DBS (Coubes et al  1999, Coubes et al 2000, Tronnier et al 2000, Vercueil et al 2001, 
Bereznai et al 2002, Cif et al 2003, Katayama et al 2003, Yianni et al 2003, Krause et al 
2004,  Coubes  et  al  2004,  Starr  et  al  2004,  2005).  More  recently,  two  prospective 
blinded studies have confirmed the efficacy of GPi DBS for adult primary generalised 
and segmental dystonia (Vidailhet et al 2005, Kupsch et al 2006). Despite this progress, 
little is known about factors which might predict better outcome in primary generalised 
dystonia. The DYT1 mutation has been considered a favourable prognostic marker, but 
statistical evidence for this has been lacking. An important feature of GPi DBS effect in 
dystonia is that improvement is not immediate but progressive over weeks to months, 
which has been attributed to neuroplasticity mechanisms (Bereznai et al 2002, Yianni et 
al 2003, Vidailhet et al 2005).  The present study sought to carefully assess the clinical 
consequences  of  GPi  DBS  in  dystonia  patients,  with  special  emphasis  on  the 
timecourse  of improvement,  in  an  effort  to  better  understand  this  phenomenon  and 
critically examine the possible role of neuroplasticity. In addition the study sought to 
identify  factors  predictive  for  improvement  after  GPi  DBS  in  primary  generalised 
dystonia, and compare with the efficacy in secondary forms of dystonia.
3.3 Methods
3.3.1  Patients and surgery
A  consecutive  series  of  29  dystonia  patients  undergoing  GPi  DBS  were  studied 
prospectively. The patients comprised 20 with primary generalised dystonia (10 DYT1
74positive,  14 female, mean age 41  years ±  16, mean duration of symptoms 24 years ± 
14), 4 with secondary generalised dystonia (mean age 26 years ± 6, disease duration 21 
±  5  years),  2  patients  with  PKAN  dystonia,  1   patient  with  tardive  dystonia  and  2 
patients with secondary hemidystonia. Two patients with primary generalised dystonia 
had undergone previous unilateral thalamotomy more than 20 years earlier. All patients 
underwent  bilateral  GPi  DBS  except  the  two  patients  with  hemidystonia  who  were 
implanted unilaterally.  Surgery was carried out in all cases under general anaesthesia 
using the Leksell G frame, with direct targeting of the posteroventral GPi as seen on 
contiguous  2  mm  thick  stereotactic  proton  density  MRI  images.  GPi  DBS  was 
delivered with monopolar stimulation of one or two adjacent contacts on each electrode 
with a constant frequency of 130 Hz, with amplitude (Volts) and pulse width (psec) 
adjusted  to  maximise  clinical  benefit.  Further  details  of  surgical  technique  and 
adjustment of stimulation parameters are provided in the General Methods.
3.3.2  Clinical evaluation
Clinical evaluation was performed using the BFM scale.  Scoring was performed by a 
single rater (ST) before and at intervals of 0.5, 1, 3, 6, 12, 24, 36 months after surgery. 
Scoring was carried out at the beginning of each follow-up visit before interrogation or 
adjustment of stimulation parameters. Medications for dystonia were kept constant after 
surgery for a minimum of 6 months and in most patients for the first year, in order to 
eliminate any confounding effects on the therapeutic time course.  Details of the BFM 
score are provided in the General Methods
753.3.3  Statistical analysis
Repeated measures ANOVA was used to identify significant effects of TIME on serial 
measures such as BFM scores and electrical stimulation parameters. Paired two-tailed t 
tests were  then used to  identify  significant differences  in measures  at different time 
points. One-way ANOVA or unpaired two-tailed t tests were used to compare means 
between groups.  The time course of changes in BFM was modelled using non-linear 
regression curve estimation to determine the best fitting function. To examine the effect 
of TIME on BFM scores and take into account the possible effects of serial adjustments 
in  stimulation,  a  random-effects  maximum  likelihood  regression  was  used,  which 
unlike  GLM  repeated  measures  ANOVA,  is  able  to  accommodate  time-varying 
covariates  (stimulation  parameter).  Univariate  ANOVA  was  used  to  identify 
independent  predictive  factors  of improvement.  All  statistics  were  performed  using 
SPSS  11.5, except the random-effects maximum likelihood regression, where STATA 
10.0 was used.
3.4  Results
3.4.1 Primary generalised dystonia
3.4.1.1 Time-course of improvement
The  time-course  of  improvement  in  BFM  movement  score  after  GPi  DBS  was 
progressive with the majority of the improvement occurring in the first 2-4 weeks and a 
further, more gradual improvement thereafter (Fig 3.1). The grand average time-course 
was best described by a logarithmic function: BMF score = 19.1  + (-2.91) x log [TIME 
(months)], p=0.0001. The time-course in each patient was also significantly logarithmic
76(Table 3.1). The BFM score decreased significantly between consecutive time points up 
to 3 months, the improvement then plateauing around 6 months (Table 3.2).
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Figure 3.1 Time course of BFM movement score following GPi DBS in 16 patients with 1 year 
follow up. Error bars show ± 1 SEM
11Patient Constant B P value
1 4.2 ± 0.8 -2.2 ± 0.2 0.001
2 32.3 ± 2.4 -3.2 ±0.8 0.015
3 12.4 ± 1.1 -2.4 ± 0.4 0.002
4 4.8 ± 1.2 -2.0 ± 0.4 0.007
5 9.0 ± 1.4 -5.4 ± 0.5 0.00001
6 24.8 ± 1.3 -2.1 ±0.4 0.006
7 23.8 ±3.4 -4.5 ± 1.1 0.014
8 10.0 ±0.7 -2.3 ± 0.2 0.001
9 6.7 ±0.8 -2.4 ±2.7 0.001
10 37.2 ± 0.6 -2.2 ± 0.2 0.00001
11 11.6 ±1.5 -1.5 ±0.5 0.033
12 30.6 ± 1.2 -6.2 ± 0.4 0.00001
13 18.2 ±0.7 -1.5 ±0.2 0.003
14 27.2 ± 3.2 -3.3 ± 1.0 0.032
15 38.9 ±3.0 -3.6 ± 1.0 0.02
16 13.7 ±0.8 -1.7 ±0.3 0.003
Table  3.1  Logarithmic  regression  coefficients  ±   SEM for time  course  of improvement  in  16 
patients over time points 0,  0.5,  1,  3,  6 and 12 months. Patients 1-8 are DYT 1+.  Changes in 
BFM score  are  described  by  the  equation:  BFM movement  score  =   Constant  +
[TIME], where TIME is in months. Note that for all patients logarithmic regression of the time 
course was significant.
Interval n Change in BFM 
( Mean ± SEM)
% improvement at end of 
interval from baseline 
(Mean ± SEM)
P value
pre - 0.5 month 20 17.4 ±2.0 46.8 ±4.8 p< 0.00001
0.5 -1 month 20 3.3 ±1.1 55.5 ±4.3 p = 0.007
1-3 months 20 4.3 ± 1.2 64.8 ±4.3 p = 0.002
3-6 months 20 1.6± 1.0 68.3 ±4.0 p = 0.113
6-12 months 16 -0.66 ± 0.76 68.6 ±4.9 p = 0.401
12-24 months 16 0.28 ±0.61 70.5 ± 5.3 p = 0.653
24 - 36 months 10 -1.15 ±0.50 65.5 ±8.0 p = 0.037
78Table 3.2 Changes in BFM movement score in primary generalised dystonia after GPi DBS. 
Note changes are the difference (pre-post) over the stated interval, positive numbers represent 
a decrease  in score.  P  values  are for paired two-tailed t tests  of the  change  in  mean BFM 
scores.
Repeated measures ANOVA of the BFM movement scores with a main factor of TIME 
(5 levels: pre, 0.5, 1, 3, 6 months) showed a significant effect of TIME [F(4,76)= 67.4, 
p<0.00001].  Since serial adjustments of stimulation were made at each time point the 
significance  of these  changes was  examined.  Repeated  measures  analysis with main 
factor TIME (4 levels: 0.5, 1, 3, 6 months) was then performed on the serial stimulation 
parameters of amplitude (mean for both sides units volts) pulse width (mean of both 
sides, units microseconds) and their numerical product (amplitude x pulse width). The 
product term was included because it describes the area of each delivered pulse and a 
better approximation of delivered current than either term alone. This analysis revealed 
a  significant  effect  of TIME  for  amplitude  [F(3,57)=  12.8,  p<0.0001],  pulse  width 
[F(3,57)= 7.2, p<0.0001] and amplitude x pulse width [F (3,57)= 17.1, p<0.0001]. Post 
hoc t-tests comparing data at 0.5  months  with later time points  showed a significant 
progressive increase in amplitude (3.1  V ± 0.15 to 3.69 V ± 0.10, p < 0.0001), pulse 
width (60.8 ps ± 0.8 to 74.3 ps ± 3.8, p = 0.003) and their product (189.3 Vps ± 9.3 to 
275.8  Vps  ±  17.8,  p  <  0.0001),  {0.5  vs  6  months,  mean  values  ±  SEM}.  The 
recognition of concurrent significant progressive increases in stimulation intensity over 
the time course of interest raised the possibility that increases in stimulation parameters 
might account for progressive improvement observed in BFM scores. To address this 
question,  random-effects  maximum  likelihood  regression  of BFM  score  with  main 
factor of TIME (4  levels:  0.5,  1,  3  and 6 months) was performed with covariates of
79amplitude, pulse width and amplitude x pulse width in separate analyses. There was an 
effect of TIME (z= -4.98, p < 0.0001) independent of amplitude (z= -0.12, p=0.905) or 
pulse width (z=  1.13, p=0.260). There was also an independent effect of TIME (z= - 
5.06, p <0.0001) controlling for amplitude x pulse width (z= 0.81, p=0.417).
3.4.1.2  Distribution of improvement by body region
The regional improvement in dystonia was evaluated by analysis of BFM movement 
scale subscores for each body region (Figure 3.3). For this analysis, 6 month follow up 
data in 20 patients was used. The 6 month time point was chosen since this maximised 
the number of subjects and time-course analysis showed stabilisation of BFM scores by 
6 months.
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Figure  3.2.  Mean  BFM movement  scale  subscores  before  and  6  months  after  GPi  in  20 
patients,  n - number of  patients with dystonia involving the particular body region. Note eyes,
80mouth and neck are scored out of 8,  the remaining items are out of 16.  Error bars show ± 1 
SEM,  *p<0.05,  **p< 0.001,  ***p<0.0001.
The  percentage  improvement  in  each  body  region  was  compared  using  univariate 
ANOVA, the presence of the DYT1 mutation and orthopaedic deformity were included 
as between subjects factors. There was no main effect of body region [F(8,l 16)=1.19, 
p=0.31], but significant main effects of DYT1  [F(l,l 16)=9.2, p=0.003] and orthopaedic 
deformity [F(l,l 16)=7.0, p=0.009]. A characteristic pattern of dystonia was observed in 
four patients (all female, 3 DYT1, mean age 33 years) with mobile axial flexor spasms 
of the trunk and hips triggered by walking. These features resolved rapidly (within 2 
weeks) after GPi DBS, the average overall improvement in BFM movement score in 
these patients at 6 months was 94% (range 87-98%).
3.4.1.3  Changes in functional status
Patients  experienced  significant  improvement  in  BFM  disability  score  following 
surgery. The mean disability scores at 6 months improved by 55% ± 23  (p<0.00001). 
After  6  months  significant  improvement  occurred  in  all  functional  domains  except 
speech (p=0.08).
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Figure  3.3.  Mean BFM disability scale subscores before and 6 months after GPi DBS in 20 
patients, n= number of  patients with dystonia involving the particular activity. Note walking is 
scored out of 6,  the remaining items are scored out of 4. Error bars show  ±   1 SEM,  * p< 0.05,
**p< 0.001,  ***p<0.0001.
The time-course of improvement of functional scores was progressive. An observation 
made during follow-up of these patients was that improvement in handwriting usually 
occurred after several months, whereas walking tended to improve soon after surgery 
(Figure 3.4a). To further analyse these differences, the time-course of handwriting and 
walking was compared in  14 patients with follow up of 24 months, all of whom had 
involvement of both handwriting and walking on the disability subscales (Figure 3.4b). 
The walking subscale data were normalised to a maximum score of 4 (instead of 6) to 
match the writing subscore. Repeated measures ANOVA with main factors of TIME (6 
levels:  pre-op,  1,  3,  6,  12,  24  months)  and FUNCTION  (2  levels:  writing,  walking) 
revealed main effects  of TIME  [F(5,65)=13.1,  pO.OOOl],  FUNCTION  [F(l,13)=5.4,
82p=0.037]  and  TIME*FUNCTION  interaction  [F(5,65)=9.6,  pO.OOOl].  Paired  t  tests 
showed that  significant  decreases  in  disability  score  occurred  for writing  between  1  
month  and  12  months  (p=0.008)  and  1   month  and  24  months  (0.019)  but  not  for 
walking (p=0.435 and p=0.98 respectively).
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Figure 3.4 (a) Time-course of mean percentage improvement in disability subscales for writing 
and walking in the entire cohort at all time points (n=20 up to 6 months, n=16 up to 24 months
83and n=10 at 36 months). Note that walking improves more steeply initially than writing 
whereas writing reaches its maximum improvement later,  (b) Time course of mean normalised 
BFM disability subscores for writing and walking in 14 patients at all time points. Note writing 
decreases significantly beyond 1 month whereas for walking no further significant change 
occurs. Error bars show ±  1 SEM.
3.4.1.4  Predictive factors for improvement
To evaluate the effects of certain factors on outcome in primary generalised dystonia, 
the percentage improvement of BFM movement score at 6 months was analysed in 20 
patients. Univariate ANOVA was used with between subjects factors of DYT1 positive 
and  orthopaedic  deformity  and  covariates  of  age,  symptom  duration  and  baseline 
severity  (preoperative  BFM  movement  score).  This  revealed  independent  effects  of 
DYT1  positive  [F(l,13)=7.7,  p=0.016]  and  orthopaedic  deformity  [F(l,19)=8.8, 
p=0.011]. There was a trend to an effect of symptom duration [F(l,19)=3.1, p=0.102], 
while  age  (p=0.63)  and  baseline  severity  (p=0.94)  were  clearly  non-significant.  Six 
patients had orthopaedic deformity,  3  were DYT1  positive.  The deformities involved 
spine (usually scoliosis) in 5 patients, and limb joint deformity (equinovarus foot) in 2 
patients.  Post-hoc  comparison  of  groups,  using  one-way  ANOVA,  confirmed 
significantly better outcome in DYT1  positive patients compared to those lacking the 
DYT1  mutation:  77.0% ±  16.6 (Mean ± SD) vs 59.8% ±15.1  [F(l,19)=5.9, p=0.026]. 
Similarly those with orthopaedic deformity had significantly worse outcome compared 
to those without: 53.6% ± 13.6 vs 74.7 ± 15.7 [F(l,19)=8.14, p=0.011].
843.4.2  Secondary generalised dystonia
Four  patients  with  secondary  generalised  dystonia  were  studied  before  and  after 
bilateral GPi DBS (mean ± SD: age 25.5 years ± 6.1, disease duration 21.3 ± 4.8 years). 
These patients had one or more of the following features supporting the diagnosis of 
secondary  dystonia:  structural  brain  lesions  or  atrophy,  history  of perinatal  cerebral 
insult, motor developmental delay, prominent/early orobulbar involvement, additional 
neurological  features  (cognitive  impairment,  pyramidal,  cerebellar  signs, 
hemiatrophy/dysmorphism,  or  previous  epilepsy).  In  one  patient  there  was  a  clear 
history of perinatal  septic-anoxic  encephalopathy with  secondary pallidal  atrophy on 
MRI (Fig 3.5a). Another patient had mild developmental delay and childhood onset of 
a progressive  dystonic  syndrome  with cerebellar features  and  associated  striatal  and 
cerebellar atrophy (Fig 3.5b). In all 4 patients, investigations had excluded alternative 
aetiologies  including  DYT1,  Wilson's  disease,  acanthocytosis,  PKAN,  white  cell 
enzyme and mitochondrial disorders.  All four patients were clinically quite  similar at 
the  time  of  surgery;  all  had  severe  generalised  dystonia  with  marked  orobulbar 
involvement and were non-ambulant.  All were almost anarthric with eating, chewing 
and swallowing difficulty and required soft food, two had PEG feeding tubes. Episodes 
of  severe  generalised  spasms  causing  pain  occurred  in  3  patients,  and  all  had 
orthopaedic deformities in the trunk and/or limbs.
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Figure 3.5 Proton density MR1 showing (a) pallidal atrophy in a patient with severe secondary 
generalised  dystonia  due  to  perinatal  septic-cmoxic  encephalopathy,  (b)  Striatal  atrophy 
particularly affecting caudate in another patient with severe secondary generalised dystonia.
The mean BFM movement score pre-operatively was 93.5 ±  13.9, and disability score
27.3  ±  1.5 out of a possible 120 and 30 respectively. Six months after surgery the BFM 
movement  score had  decreased to  76.8 ±  13.9  an  18.1% ± 6.8  improvement  and  by 
twelve months to 73.4 ± 7.7, a 21.0% ± 6.8 improvement (p=0.02, paired two tailed t 
test). This effect remained stable at 2 years post-op average improvement was 22.9 % ± 
6.9  (n=3).  Improvement  in  secondary  dystonia  was  also  progressive  but  less 
dramatically than in primary dystonia, since absolute improvements were smaller (Fig 
3.7).  To  compare  the  relative  efficacy  of GPi  DBS  in  primary  versus  secondary 
generalised dystonia, taking into account differences in baseline severity, a univariate 
ANOVA  was  performed  of percentage  improvement  in  BFM  movement  score  at  6 
months,  with  between  subjects  factors  of  aetiology  (primary  vs  secondary)  and 
presence of orthopaedic deformity, and covariates of age, disease duration, and baseline 
severity (Pre-op BFM movement score). This showed independent effects of aetiology
86[F(l,23)=7.3, p=0.015] and orthopaedic deformity [F(l,23)=5.5, p=0.031] and no effect 
of  baseline  severity  (p=0.55).  One  way  ANOVA  confirmed  significantly  lower 
percentage improvement at 6 months in secondary compared with primary generalised 
dystonia (18.1% vs 68.6%, [F(l,23)=30.0, p<0.00001].
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Figure  3.6  Time-course  of changes  in  BFM movement  score  in  4 patients  with  secondary 
generalised dystonia. Data points show means, error bars ± 1 SEM.
The disability scores improved modestly after surgery; at 12 months 24.3 ± 2.5 an 8.9% 
±  6  improvement.  This  translated  into  modest  gains  in  writing,  feeding,  eating  and 
hygiene,  but  speech  and  ambulation  were  in  general  not  improved.  In  one  patient 
dystonic tongue protrusion improved significantly.  More importantly, and not captured 
in the BFM scale, patients and their carers reported improvements in posture, ease of 
handling for assisted care, pain and episodes of severe exacerbation of dystonic spasms. 
These improvements translated into noticeable benefits for patients in terms of comfort 
and ease of management.
873.4.3 Secondary hemidystonia
The  efficacy  of  unilateral  GPi  DBS  was  studied  in  two  patients  with  secondary 
hemidystonia were  studied.  The  first patient was a 36 year old female with infantile 
onset right hemidystonia, which worsened in adulthood, affecting the arm more than 
the leg.  Brain MRI demonstrated a lesion in the left posterior putamen and GPe, the 
likely aetiology being placental haemorrhage  in late pregnancy.  Pre-operatively this 
patient was  maintained  on high  doses  of Trihexphenidyl  and  Baclofen  with modest 
benefit.  The  second  patient  was  a  21  year  old  male,  with  infantile  onset  dystonia 
affecting the left leg, with flexion at the hip and knee and equinovarus posture of the 
foot,  hemiatrophy  of the  left  leg  and  chronic  secondary  dislocation  of the  hip.  The 
dystonia was refractory to Trihexphenidyl, Levodopa and Tetrabenazine, and modestly 
improved with Clonazepam and botulinum toxin injections. The brain MRI showed a 
very small lesion in the posterior-most tip of the  left  GPi.  In neither patient did the 
lesion directly encroach on the target area in the ipsilateral posteroventral  GPi.  Both 
patients showed some modest improvement in dystonic posture in the first few months 
after the surgery, however these improvements were not sustained. The pre-operative 
BFM movement scores were  18  and  16,  and these  were  unchanged  12  months  after 
surgery. The BFM disability scores (8 and 3  respectively) were also unchanged at  12 
months. Neither patient has been able to reduce medications nor discontinue botulinum 
toxin injections.
3.4.4 Pantothenate kinase associated neurodegeneration (PKAN)
Two patients  with  PKAN  generalised  dystonia underwent  bilateral  GPi  DBS  (Table 
3.2). Patient  1   had a relatively mild presentation of PKAN with generalised dystonia
88worse in the upper limbs and oromandibular regions, amimia, dysarthric pallilalia and 
drooling, gait freezing and normal intellect. Patient 2 was more severely affected, with 
severe generalised dystonia, inability to walk, marked opisthotonic spasms, anarthria, 
tongue protrusion, dysphagia requiring PEG feeding and laryngeal dystonia requiring a 
tracheostomy.
Patient age
gender
age of 
onset (yr)
PANK2
mutation
MRI  "eye 
of the tiger"
Medications
(mg/day)
BFM Movement 
pre/12m   %A
BFM disability 
pre/12m   %A
1 35 /M 12 yes yes B aclofen  60 4 2 /2 2 48 1 4 /1 2   14
2 3 5 /M 11 yes yes B aclofen  100 
T rihexyphenidyl  15 
L ev o d o p a  500 
D iazep am   15
88 / 77.5 12 2 9 /2 9   0
Table  3.2  Clinical  data  cmd  outcome  after  GPi  DBS  in  two  PKAN generalised  dystonia 
patients.
Both patients improved after surgery. In patient one, the oromandibular and upper limb 
dystonia  improved  such  that  he  could  dispense  with  the  stick  he  chewed  against 
constantly, and feed himself without difficulty. The gait freezing did not improve, and 
could be made worse with higher stimulation current.  Patient 2 improved modestly in 
terms of the  BFM movement  score,  a  12%  improvement at  12  months,  without any 
corresponding change in disability score. The most improved aspects were curvature of 
the trunk at rest, tongue protrusion and reduction in severe spasms. A few months after 
surgery it was possible to remove the tracheostomy.
893.4.5 Tardive dystonia
The patient with tardive dystonia operated was a 39 year old male with severe mobile 
retrocollis and truncal hyperextension, with moderate orofacial and limb dystonia of 2 
years  duration  on  the  background  of learning  disability,  anxiety  disorder  and  prior 
neuroleptic exposure. The patient was known to have a chromosomal abnormality with 
18p  deletion,  brain  MRI  was  normal.  Although  the  18p  deletion  is  associated  with 
dystonia  (Awaad  et  al  1999)  the  aetiology  was  deemed  more  likely  to  be  tardive, 
because of the relatively  short history,  and characteristic  axial extensor spasms.  The 
patient had failed to  respond to  Tetrabenazine or high dose  Trihexphenidyl  and was 
under treatment with Trihexphenidyl  6 mg/day and Diazepam 30  mg/day.  Following 
bilateral GPi DBS, there was an early dramatic improvement in the dystonia. The BFM 
movement  score  decreased  from  87  preoperatively  to  25  at  0.5  months,  a  71% 
improvement,  which was maintained  up to  3  months.  Thereafter some recurrence of 
dystonia occurred particularly in the neck and upper limbs, and at 12 months the BFM 
score  was  45  (48%  improvement).  The  disability  score  at  12  months  had  improved 
from 19 to 15,a21% improvement.
3.4.6 Changes in medical therapy after GPi DBS
Reduction in oral medications after GPi DBS was effected in the most of the primary 
generalised dystonia patients and the patient with tardive dystonia, but not in the other 
patients, owing to the lesser degree of improvement after GPi DBS. Medications were 
deliberately not reduced for the first 6-12 months, and thereafter slowly reduced. Four 
of 6 patients were able to reduce Trihexphenidyl from a mean of 36 mg to  11  mg per 
day after 30 months.  In one of these patients,  Sulpiride 600 mg per day was stopped
90after 18 months.  The doses of Levodopa, Baclofen and Diazepam were approximately 
halved  within  2  years  in  3  patients.  Of  the  7  patients  receiving  botulinum  toxin 
injections before surgery, 3  were able to discontinue injections completely,  and three 
were  able  to  stop  injections  for  limb  or  trunk.  The  four  patients  who  continued 
botulinum toxin, all received injections for residual cervical dystonia.
3.4.7  Stimulation related side effects in primary generalised dystonia
3.4.7.1 Dysarthria
Dysarthria occurred in 4 patients with primary generalised dystonia, 2 with DYT1. In 
each case it developed gradually after adjustment and was reported in follow-up, and in 
3 was associated with a feeling of stiffness or tension in the upper lip.  The dysarthia 
was  subtle  on  direct  examination,  but  in  all  patients  brief cessation  of stimulation 
resulted  in  noticeable  immediate  improvement  in  speech  quality  and  relief of oral 
tension.  The  symptoms  were  permanently  relieved  by  adjustment  of  stimulation 
parameters: in one a reduction of voltage and the other three, deactivation of a ventral 
contact and use of the adjacent dorsal contacts singly on both (n=2) or one (n=l) side.
3.4.7.2 Orofacial dyskinesia
In  one  patient  with  DYT1  primary  generalised  dystonia,  orofacial-oromandibular 
involuntary  movement  developed  de-novo  a  few  weeks  after  change  of  electrode 
contacts from the most ventral contacts (0, 4 both located in GPi) to the adjacent dorsal 
contacts (1, 5 both located in GPi/MML). This change was mandated because of loss of 
effect on the ventral  contacts (following a fall) that was later identified to be due to 
partial  cable  fracture.  The  movements  subsided  acutely  with  reinstatement  of the
91previous  settings  at  the  expense  of  worsening  of  lower  limb  dystonia,  and  were 
permanently relieved when the cable was repaired, allowing the ventral-most contacts 
to  be  reinstated  for  chronic  stimulation.  A  second  patient  with  non-DYTl  primary 
generalised  dystonia  experienced  worsening  of pre-existing  orofacial  dystonia,  from 
intermittent pursing  of the  lips to  forceful  grimacing  of the  whole  face  under  acute 
stimulation with contact 3  (located in left GPe) alone and contact 5  alone (located in 
GPi/MML) at 4.5 V, 60 psec,  130 Hz. After two weeks of stimulation with contacts 2 
and  6,  3.5  V,  60  psec,  130  Hz,  improvement  in  orofacial  dystonia  occurred  (BFM 
mouth item score decreased from pre-op 3 to 1). However, the movements temporarily 
worsened after contacts  1   and 5  were additionally activated (BFM mouth item score 
4.5).  Therefore  GPi DBS  in this patient resulted in both temporary exacerbation and 
eventual improvement of orofacial dystonia/dyskinesia, that appeared to depend of the 
level of stimulation applied.
3.4.7.3  Akinesia
In 2 patients, one DYT  1, progressive akinetic  symptoms developed  1   and 2 months 
after starting stimulation. Both patients complained of difficulty arising from sitting and 
turning in bed, slowness of gait, smaller steps, gait ignition difficulties and stiffness in 
the legs. There was also some slowing of foot taps, however, arm swing was preserved 
and there was no rigidity, amimia or dysarthria. In both patients, these features occurred 
with stimulation of the most ventral contacts, which were providing effective relief of 
dystonia.  The  symptoms  were  reversible  by  changing  to  more  dorsal  contacts,  with 
improvement noted within hours of adjustment.
923.4.7.4  Tremor
In six patients upper extremity tremor was noted following GPi  DBS  (Table 3.3).  In 
three  of these  patients  some  tremor was  present  before,  but to  a  lesser  degree.  The 
character of the tremor was dystonic,  present during posture  and action.  The tremor 
appeared within days of commencing stimulation, and in some patients was sufficient 
to  make  eating  and  drinking  more  difficult  than  before  surgery.  The  tremor  was  a 
transient phenomenon and in all patients resolved within 1-3 months.
Patient DYT1 Onset (d) Site Pre-existing
tremor
Type Severity Duration (wk)
1 + 3 Right UE + postural and action Moderate 8
2 - 6 UE,  R » L + postural and action Moderate 8
3 + 4 UE,  R>L - postural and action Mild 12
4 - 2 LeftUE - postural and action Very mild 0.5
5 + 13 Left UE - postural and action Moderate 4
6 - 4 UE,  R=L + postural and action Moderate 3
Table 3.3 Tremor in six patients following GPi DBS.
3.4.8  Stimulation parameters and DBS battery life
The average stimulation parameters for the primary generalised dystonia patients at 6, 
12, 24 and 36 months are shown in Table 3.4. There was no significant difference at 6 
months in the mean voltage or pulse width for DYT1 vs non-DYTl  (3.6 ± 0.4 V vs 3.8 
± 0.5 V p = 0.47, 68 ±  13  psec vs 81  ±  19  psec, p= 0.08)  In the entire cohort,  five 
patients required replacement of Kinetra after an average duration of 33  ±  8 months. 
The depletion of the Kinetra was linear with respect to time (Figure 3.8).
93Time after surgery 6 months 12
months
24
months
36
months
n (patients) 20 16 16 10
Amplitude (V) 3.7 ±0.5 3.4 ± 0.9 3.6 ± 0.6 3.7 ±0.9
Pulse width (psec) 74 ± 17 116 ± 100 89 ±48 73 ± 17
Single monopolar (n, sides) 27 20 22 14
Double monopolar (n, sides) 13 12 10 6
contacts 0,1  and 4,5 in use (n, 
sides)
35 28 29 19
Table  3.4  Stimulation parameters  in  20 patients  with primary  generalised dystonia  at  six 
months and later time points.  Values are means  ±  SD. Note increase of  pulse width and SD at 
12  months,  with  corresponding  decrease  in  voltage.  This  was  the  result  of 3  sides  being 
stimulated with pulse width of450 psec,  in an effort to improve residual dystonia.  This strategy 
did not produce  added benefit  and parameters  were  later  reverted to  shorter pulse  width, 
higher voltage. Note also that almost all patients were stimulated on either the most or second 
most ventral contact singly or in combination.
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Figure  3.7  Kinetra  implanted pulse  generator  voltage  over  time  in  patients  with primary 
generalised dystonia. Points show means, error bars ± 1 SD. Sample size for means as follows, 
3 m; n— 3, 6 m; n=10,  12 m; n=12, 24 m; n=15, 36 m; n=9.
943.4.8  Complications and adverse events
There  were  no  serious  adverse  events,  in  particular  no  intracranial  haematoma  or 
infection of the implanted system. There were three hardware-related complications. In 
one patient, the connecting cable partially fractured near the attachment to IPG due to a 
fall. This resulted in dystonia recurrence which was remediable,  in the short term by 
changing to more dorsal contacts until the cable was replaced. In one patient the IPG 
failed abruptly  resulting  in recurrence  of dystonia,  38  months  post-implant but well 
before depletion of the IPG. The IPG was one of a faulty batch with a manufacturing 
defect of the bond wire linking battery with neurostimulator assembly inside the IPG, 
and was replaced with a new unit. Another patient experienced gradual worsening of 
dystonia following  IPG  replacement with unusually high  electrode  impedances.  Test 
stimulation  at  high  currents  (4V,  90  psec,  contacts  0  and  4)  evoked  no  side  effect, 
suggesting a broken circuit, however when the left arm was elevated, sudden capsular 
side  effects  (right  facial  muscle  contractions)  occurred,  suggesting  an  intermittent 
connection.  Fluoroscopy  of  the  implanted  system  revealed  no  cable  fracture.  At 
surgery, loosening of the screws fixing the cable to the IPG was found resulting in a 
loose connection, which was corrected.
3.5  Discussion
3.5.1  Time-course of improvement and neural plasticity
The present results  show that the time-course  of improvement  is progressive,  as has 
been observed previously (Yianni et al 2003, Krauss et al 2004, Vidailhet et al 2005). A 
novel  aspect  of the  present  findings  is  that  the  time  course  follows  a  logarithmic 
distribution. This was true not only of the group average but also of individual patients,
95each with their own log function coefficients. A previous study looking at time course 
of improvement  in  dystonia  after  DBS  suggested  a  linear  distribution  with  patient- 
specific  slopes  (Yianni  et al  2003).  Examination of individual patient data from this 
study  reveals  a  similar  pattern  to  the  present  study,  with  most  of the  improvement 
achieved within the first 3 months, and then some further progressive benefit. Unlike 
the present  study,  the  earliest time  point was  3  months,  which omits the  early time 
course, and may explain the differing interpretation of a linear effect. The logarithmic 
time-course  demonstrated  in the present  study suggests that neuroplasticity underlies 
GPi DBS effect. A logarithmic time-course has also been observed in recovery of upper 
limb  motor  strength  following  stroke,  a  setting  in  which  adaptive  neuroplasticity  is 
believed to play an important role (Goodwin et al 2003, Koyama et al 2005).
An interesting feature of functional improvement after GPi DBS (as reflected in BFM 
disability  subscales)  was  that  different  time  courses  occurred  for  handwriting  and 
walking.  Improvement  in  handwriting  was  slower,  but  eventually  exceeded  that  of 
walking.  This result is  also  compatible with the notion of plasticity underlying DBS 
effect.  Walking is a semi-automated motor activity whereas writing is highly learned 
and more demanding of the sensorimotor cortex. Therefore functional reorganisation of 
representations for hierarchically more complex tasks might be expected to take longer 
than for more automated activity such as walking.
It has been previously reported that mobile  dystonia tends to  improve  more  quickly 
than tonic postures after GPi DBS (Vercueil et al 2002, Krauss et al 2002). Moreover, it 
has  been  suggested  that  patients  with  mainly  mobile  dystonia  may  respond  better 
overall (Vidailhet et al 2005). Limitations of the BFM scale in delineating mobile and 
tonic aspects of dystonia precludes any firm quantitative judgement on this important 
point  in  the  present  series.  However,  based  on  clinical  observation  the  same  basic
96pattern of response  occurred,  well  illustrated by rapid and excellent improvement in 
axial flexor spasms during walking in four patients.
3.5.2  Efficacy of GPi DBS depends on aetiology of dystonia
In the  present  study,  among  patients  with  generalised  dystonia,  secondary  aetiology 
was a strong predictor of poorer response, even after adjustment for baseline severity of 
dystonia.  This  suggests  that  secondary  generalised  dystonia  is  inherently  less 
responsive to GPi DBS and that the poorer response is not an indirect consequence of it 
being more severe. These results agree with previous reports of poorer response to GPi 
DBS in secondary than primary generalised dystonia (Cif et al 2003, Starr et al 2004, 
Eltahawy et al  2004).  Although improvement in  secondary  generalised dystonia was 
modest, the changes were both clinically relevant and statistically significant, in terms 
of comfort and ease of management of these severely disabled patients.  The level  of 
improvement  in  PKAN  was  intermediate  between  secondary  and  primary  and  the 
response in these two patients was poorer than that reported previously (Umemura et al 
2004,  Castelnau  et  al  2005).  PKAN  patients  also  display  basal  ganglia  lesions, 
suggesting that structural lesions of the basal ganglia may negate the effectiveness of 
GPi DBS.  This  certainly  appears to  be true  in patients with secondary hemidystonia 
related to unilateral structural basal ganglia lesions in whom no improvement occurred 
with GPi DBS. The converse also appears true,  in that tardive dystonia, which lacks 
basal  ganglia  lesions  responded  more  favourably  than  other  forms  of  secondary 
dystonia, a result in agreement with previous reports (Trottenberg et al 2001, Starr et al 
2004). Because primary generalised dystonia enjoys a superior response to  GPi DBS 
than secondary, patients considered for GPi DBS, particularly those lacking the DYT1 
mutation, should be fully investigated for secondary causes of dystonia, with particular
97attention  to  brain  MRI.  For  symptom  palliation  in  secondary  generalised  dystonia 
bilateral GPi DBS appears a reasonable therapeutic option, however the present results 
do not support its use for secondary hemidystonia due to focal basal ganglia lesions.
3.5.3  Predictive  factors  for  improvement  in  primary  generalised  dystonia  and 
implications for patient selection
The striking difference between the response of primary and secondary dystonia stands 
as a major distinction in therapeutic  effectiveness of GPi  DBS  for different types of 
dystonia. Within primary dystonia, some factors were also identified which influenced 
outcome. The presence of the DYT1 mutation was an independent positive predictor of 
outcome after GPi DBS.  Several  studies have noted that patients with DYT1  tend to 
respond well (Coubes et al 2000, Krause et al 2004,  Starr et al 2004) although recent 
larger  series  have  shown  no  significant  outcome  difference  (Vidailhet  et  al  2005, 
Kupsch  et  al  2006).  There  are  several  possible  reasons  why  DYT1  dystonia  might 
respond more efficiently to GPi DBS. The first possibility is that DYT1 dystonia differs 
pathophysiologically, allowing GPi DBS to work more efficiently. Against this view, 
the  range  of physiological  abnormalities  in  DYT1  patients  is  very  similar  to  those 
lacking DYT1,  including defective inhibition at cortical and brainstem levels and the 
tendency to excessive motor cortical plasticity (Edwards et al 2003b, 2006, Huang et al 
2006). An alternative explanation relates to the fact that the identification of the DYT1 
mutation confirms the diagnosis of primary dystonia with certainty. In patients lacking 
the  DYT1  mutation,  even  those  fulfilling  clinical  criteria  for  primary  generalised 
dystonia, there remains the possibility of an unrecognised secondary aetiology, which 
will confer a poorer response to  GPi  DBS.  Therefore  it may not be that the DYT1 
mutation  has  any  special  biological  significance  for  GPi  DBS  effect,  but  rather  it
98guarantees  a  homogenous  study population  of primary dystonia.  The present results 
indicate that the DYT1 mutation is a favourable prognostic indicator and emphasise the 
need  for  genetic  testing  in  all  young  onset  primary  generalised  dystonia  patients, 
particularly those considered for GPi DBS.
In the present  study, orthopaedic deformity predicted a poorer response to GPi DBS. 
Joint or  spine  deformity  itself does  not  attract  a  score  in the  BFM  movement  scale 
unless accompanied by  active muscle  contractions  or involuntary movements,  which 
are assessed  by  observation and palpation of muscles.  So the  mere presence  of the 
deformity  does  not explain the poorer  scores.  Instead  a more  complex  physiological 
relationship  between orthopaedic  deformity  and dystonia may  exist where peripheral 
injury  to  joints  alters  function  in  skeletomuscular  afferents  perpetuating  a 
pathophysiological component of the dystonia.  Whatever the mechanism, orthopaedic 
deformity appears to confer a poorer response to GPi DBS. A related result was a trend 
for longer duration of symptoms to predict a poorer outcome (p=0.102 in the univariate 
analysis).  Taken together, these results suggest that patients with primary generalised 
dystonia should be operated early, once medication refractory disability has occurred, 
but well before the development of fixed orthopaedic deformity.
3.5.4  Stimulation related side effects: reversibility and mechanisms
The dysarthria observed in the present series following GPi DBS may relate to spread 
of current to adjacent capsule and activation of corticobulbar fibres. In support of this, 
the  symptoms  were  rapidly  reversible  with  switching  stimulation  off and  in  some 
patients  tension  or  stiffness  was  described  around  the  mouth,  suggestive  of 
corticobulbar activation. The delayed onset of dysarthria following adjustment of DBS
99parameters argues somewhat against direct capsular effects which tend to be immediate 
once the threshold is reached. A possible explanation is that tissue impedance falls over 
time, so that the delivered current increases, even with constant electrical parameters. 
The origin of the akinesia observed in two patients, so named because of the slowness 
of movement, is uncertain. However, the two main possibilities are extrapyramidal due 
to modification of basal ganglia output, or corticospinal due to spread of current to the 
adjacent  internal  capsule.  There  has  been  another  report  of reversible  Parkinsonism 
with bradykinesia, rigidity and gait freezing,  in a dystonic patient following bilateral 
GPi DBS also associated with stimulation of ventral contacts and relived by switching 
to more dorsal contacts (Watson et al 2006).  In the present patients and the previous 
report,  akinesia  occurred  with  stimulation  of ventral  contacts  and  was  relieved  by 
changing to  more  dorsal  contacts.  These  observations  agree  with those  made  during 
pallidal  for  stimulation  Parkinson's  disease  where  akinesia  could  be  elicited  with 
ventral GPi stimulation and dyskinesia with dorsal GPe stimulation (Bejjani et al 1997, 
Krack et  al  1998)  and  support  an  underlying  extrapyramidal  mechanism.  Similarly, 
chorea induced by GPe stimulation in a dystonic patient has been reported (Mouton et 
al  2006)  which parallels  the  present  observation  of orofacial  dyskinesia  when  more 
dorsal contacts  were  activated which were  in the  GPi/MML boundary  and  closer to 
GPe.  In  the  present  series,  temporary  upper  extremity  tremor  occurred  soon  after 
commencement  of stimulation  in  some  patients.  This  may  relate  to  a  shift  in  the 
balance of dystonic  symptoms affecting the  limb.  Improvement of tonic dystonia by 
relaxing the limbs may have allowed phasic dystonia during action to be more obvious, 
resulting in occurrence or worsening of tremor.
1003.5.5  DBS parameter selection: are high currents necessary in dystonia?
A  number  of studies  have  found  that  dystonia  patients  with  GPi  DBS  require  high 
stimulation currents (Coubes at al 2000, 2004, Starr et al 2004, Krauss et al 2004). The 
present  results  challenge  this  notion  in  that  the  average  parameters  in  the  primary 
dystonics were  lower than many of those published  in  other series.  There  are  a few 
possible  explanations  for  this  discrepancy.  Firstly,  the  present  series  comprised  10 
DYT1  patients who respond well to GPi DBS and showed a trend for requiring lower 
electrical stimulation parameters (pulse width, p=0.08), therefore escalation of current 
to combat residual symptoms might be less needed in this group. However, other series 
have also included DYT1  patients  so this is unlikely to be the  sole explanation.  The 
approach  to  adjustment  of  stimulation  parameters  may  also  be  important.  Several 
groups use longer pulse widths and higher amplitudes, ranging from 150-450 psec and 
1.5-10V (Kumar et al  1999b, Yianni et al 2003, Coubes et al 2004,  Starr et al 2004) 
whereas  in  the  present  series  shorter pulse  widths  have  been  used.  In  the  study  of 
Vidailhet  et  al  (2005)  in  a  comparable  sample  of 22  primary  generalised  dystonia 
patients with bilateral GPi DBS, the average parameters at 12 months were pulse width 
139 ± 130 psec, amplitude 3.7 ± 1.0 V and frequency 134 ± 18 Hz, the main difference 
being the longer pulse width.  The present results would suggest that lower electrical 
stimulation parameters, particularly pulse width, may be equally efficacious, with the 
added advantage of energy conservation and prolongation of IPG life.  Another issue in 
the  adjustment  of stimulation  parameters  in  dystonia  relates  to  the  time  course  of 
improvement. Because the therapeutic response in dystonia is delayed, there may be a 
temptation  to  increase  the  stimulation  current  rather  than  wait  for  improvement  to 
develop at a given setting. In the present study a relatively low initial current was used, 
and  increased  incrementally  at  later  follow-ups,  particularly  in  patients  in  whom
101improvement  appeared  to  have  plateaued.  It  is  of relevance  that  serial  increases  in 
stimulation  current  made  during  follow  up  did  not  dictate  the  time  course  of 
improvement,  which  brings  into  question the  need  for  increasing  the  current  during 
follow up. This also tends to imply that the bulk of GPi DBS effect is achieved with the 
initial current and provision of sufficient time for the dystonia to respond.
3.5.6  Study limitations
A limitation of the present study is that the same single rater (ST) performing the BFM 
scoring was also responsible for the adjustment of stimulation parameters, and therefore 
unblinded. This could have potentially introduced bias in the scoring of patients. There 
are a few reasons which argue  against this point playing a major role in the present 
results.  Firstly,  adjustments  of  stimulation  parameters  do  not  lead  to  immediate 
improvement in dystonia, therefore the clinical effect corresponds to adjustment made 
weeks or months before. Therefore it would be difficult for a rater to mentally associate 
an adjustment with a corresponding  clinical  effect.  Also patients were  scored before 
any adjustment was  made  or interrogation of stimulation parameters.  Secondly there 
were no  a priori  groups in this study,  such as a "real" vs.  "sham"  stimulation, where 
explicit  knowledge  grouping  might  influence  the  rater’s  judgement  as  to  what  to 
expect.
Another limitation of the present study relates to the BFM scale.  Although this scale 
has  good  intra  and  inter-rater  reliability  for  the  overall  burden  of dystonia,  it  has 
limitations with regard to dystonia evaluation in the setting of GPi DBS therapy. Firstly 
it  does  not  readily  distinguish  between  mobile  and  tonic  forms  of dystonia.  Such  a 
distinction would be potentially very useful  since mobile aspects of dystonia tend to
102respond  more  quickly  and  fully  to  GPi  DBS  than  tonic  elements;  however  this 
observation, although bom out in the present study remains unsubstantiated in terms of 
quantitative measurement.  Another limitation of the BFM scale is that it is relatively 
insensitive  to  small  improvements  in  the  motor  score  and  unable  to  capture  certain 
functional improvement in the functional score, perhaps giving a falsely low impression 
of  improvement.  This  is  particularly  true  in  severely  affected  patients  with  near 
maximal  scores,  where the scale may be  "saturated"  and subject to ceiling effects.  It 
should be pointed out that these limitations do not pose a direct threat to the validity of 
the  present  results,  but  rather  highlight  the  need  for  the  development  of additional 
rating tools  or forms  of quantitative  assessment to  tackle  some  of these  outstanding 
questions.  Future  studies using longitudinal  quantitative kinematic  analysis would be 
helpful to resolve this question.
3.6  Conclusions
GPi DBS  is a safe  and effective treatment for several types of dystonia,  particularly 
primary  generalised,  and  confers  significant  and  sustained  therapeutic  benefit. 
Although  all  primary  generalised  patients  may  respond  well,  those  with  the  DYT1 
mutation  enjoy  a  greater  benefit.  Conversely,  the  presence  of  fixed  orthopaedic 
deformities  reduces  the  effectiveness  of  GPi  DBS.  This  makes  a  strong  case  to 
undertake surgery earlier, before orthopaedic deformity has occurred. The time course 
of improvement in dystonia after GPi DBS is progressive and logarithmic and points to 
neural plasticity underlying GPi DBS effect.
103Chapter 4.  The effect of electrode  contact location  on  clinical 
efficacy of GPi DBS in primary generalised dystonia
4.1  Summary
This study sought to determine the effect of electrode contact location on efficacy of 
bilateral  globus  pallidus  intemus  (GPi)  deep  brain  stimulation  (DBS)  for  primary 
generalised dystonia (PGD). A consecutive series of 15 patients with PGD (10 female, 
mean age 42 years, 7 DYT1) who underwent bilateral GPi DBS, were assessed using 
the  BFM  dystonia  scale  before,  and  6  months  after  surgery.  The  position  of the 
stimulated  electrode  contact(s)  was  determined  from  the  post-operative  stereotactic 
MRI.  Contralateral  limb  and  total  axial  BFM  sub-scores  were  compared  with  the 
location of the stimulated contact(s) within GPi. The mean total BFM score decreased 
from  38.9  preoperatively  to  11.9  at  6  months,  a  69.5%  improvement  (p<0.00001). 
Cluster analysis of the stimulated contact coordinates identified two groups, distributed 
along  an  anterodorsal  to  posteroventral  axis.  Clinical  improvement  was  greater  for 
posteroventral than  anterodorsal  stimulation  for the  arm  (86% vs  52% p  <0.05)  and 
trunk (96% vs 65%, p<0.05) and inversely correlated with the y coordinate. For the leg, 
posteroventral and anterodorsal stimulation were of equivalent efficacy. Overall clinical 
improvement was maximal with posteroventral stimulation (89% vs 67%, p<0.05) and 
inversely correlated with y (A-P)  coordinate (r=-0.62, p<0.05).  GPi DBS  is effective 
for  PGD  but  the  outcome  is  dependent  on  contact  location.  Posteroventral  GPi 
stimulation provided the best overall  effect  and was  superior for the  arm  and trunk. 
These results may be explained by the functional anatomy of GPi and its outflow tracts.
1044.2  Introduction
Primary  generalised  dystonia  (PGD)  is  a  movement  disorder  characterised  by 
involuntary muscle contractions, causing abnormal postures and spasms (Fahn  1998). 
The failure of medical treatment has led to renewed interest in functional neurosurgical 
approaches  to  its  treatment.  Earlier  positive  reports  of ablative  pallidal  surgery  in 
dystonia (Cooper 1956) and the subsequent observations of improvement of dystonia in 
Parkinson's disease with posteroventral pallidotomy and DBS led to the first attempts to 
treat dystonia using  globus  pallidus  intemus  (GPi)  deep brain  stimulation  (DBS)  by 
Coubes in 1996 (Coubes et al  1999). Since then GPi DBS has emerged as an effective 
treatment for PGD (Coubes at al 2004, Vidailhet et al 2005). Despite this progress and 
the more widespread acceptance of the technique there is still debate about the optimal 
target within the GPi to achieve the best effect in dystonia.  Most surgeons target the 
posteroventral  portion  of the  GPi,  the  classical  target  for pallidotomy  developed  by 
Leksell and Laitinen (Laitinen et al 1992). However to date, there has been little data to 
support the superiority of this target in dystonia, or to indicte whether within this region 
there may be an optimal zone to achieve the best effect.
The  aim  of the  present  study  was  to  explore  the  relationship  between  the  precise 
location  of  the  therapeutically  stimulated  electrode  contact  and  the  magnitude  of 
clinical benefit in a consecutive series of patients with PGD who all underwent bilateral 
GPi DBS. The aim of this analysis was to determine if within GPi there is any regional 
stratification of the efficacy of stimulation for dystonia.
1054.3  Methods
4.3.1  Subjects
We studied a consecutive series of 15 patients with PGD. The clinical characteristics of 
the patients  are  summarised  in  Table  4.1.  Patient  8  had  a previous  thalamotomy  23 
years before, The study was approved by the Joint Research Committee of the National 
Hospital for Neurology and Neurosurgery and the Institute of Neurology.
Patient Gender Age
(years)
Disease
duration
(years)
DYT1
gene
status
Site of 
onset
Worst
affected
areas
BFM score 
pre-op/ 6 
months (0- 
120)
Medications DBS parameters
1 F 18 9 + R h an d Trunk 
R  lim bs
48/1 T rihexphenidyl R:  4,5-,  3.9v,  6 0 p se c ,  130  Hz 
L:  0,1-,  3.9v,  6 0 n se c ,  130  Hz
2 M 24 16 ■ R  h an d N eck,  trunk 
R  lim bs
7 3 /1 5 C lo n azep am R:  4,5-,  3.9 v,  9 0 p se c ,  130  Hz 
L:  0,1-,  3.8 v,  9 0 p se c ,  130  Hz
3 M 47 37 + L leg N eck,  trunk 
L sid e
52122 D iazep am
T e tra b e n a z in e
R:  4-,  3.5v,  9 0 p se c ,  130  H z 
L:  0,1-,  3.3v,  6 0 n se c ,  130  Hz
4 F 23 12 - R  leg Trunk 
R  leg
5 3 /32 N one R:  5-,  4.0v,  6 0 n se c ,  130  Hz 
L:  1-,  4.2v,  6 0 p se c ,  130  Hz
5 F 52 36 + L arm L lim bs 29/7 N one R:  4-,  3.0v,  6 0 p se c ,  130  Hz 
L:  0-,  3.0v,  6 0 p se c ,  130  Hz
6 F 16 7 + R  leg R  lim bs 
T runk
20/1 L -dopa
T rihexphenidyl
R:  4-,  2.9v,  6 0 p se c ,  130  Hz 
L:  0-,  2.9v,  6 0 p se c ,  130  Hz
7 F 63 4 - T runk Trunk 
Both  leg s
23/3 L -dopa
T rihexphenidyl
R:  6-,  4.6v,  9 0 p se c ,  130  Hz 
L:  2-,  4.6v,  9 0 n se c ,  130  Hz
8 F 54 43 - R h a n d L  lim bs 24/9 N one R:  4-,  3.7v,  6 0 p s e c ,  130  Hz 
L:  1-,  3.7v,  6 0 p s e c ,  130  Hz
9 F 36 25 + L foot Trunk 
L lim bs
21/1 T rihexphenidyl R:  4-,  4.6v,  90p.sec,  130  Hz 
L:  0-,  4.2v,  9 0 p se c ,  130  Hz
10 M 62 43 N eck N eck,  trunk 
L arm
2 8 /1 5 T rihexphenidyl
B aclofen
C lo n a z ep a m
R:  6  -,  3.7v,  9 0 p se c ,  130  Hz 
L:  1-,  3.7v,  9 0 p s e c ,  130  Hz
11 F 22 15 + L foot Trunk 
B oth  leg s
51/11 T rihexphenidyl
B aclofen
R:  4-,  3.6v,  6 0 p s e c ,  130  Hz 
L:  0-,  3.6v,  6 0 p s e c ,  130  Hz
12 F 64 50 - R h an d Trunk 
R  lim bs
4 6 /1 3 N one R:  5,6-,  3.5v,  6 0 (isec,  130  Hz 
L:  1,2-,  3.5v,  6 0 p se c ,  130  Hz
13 M 62 7 - L leg N eck,  L leg 
R arm
6 4 /3 0 N one R:  4,5-,  3.5v,  6 0 p se c ,  130  Hz 
L:  1,2-,  3.5v,  6 0 p se c ,  130  Hz
14 M 47 26 - N eck N eck 
R arm
2 5 /1 2 N one R:  4,5-,  3.5v,  9 0 p se c ,  130  Hz 
L:  0,1-,  3.5v,  9 0 p se c ,  130  Hz
15 F 42 30 + R foot R arm ,  leg 2 7 /6 N one R.  5-,  3.5v,  60^isec,  130  Hz 
L:  1-,  3.5v,  6 0 p se c ,  130  Hz
Table 4.1 Clinical patient data.
1064.3.2. Surgical procedures and stimulation parameters
All  patients  underwent  bilateral  implantation  of  electrodes  into  GPi  and  chronic 
stimulation using surgical technique outlined in the General Methods. The quadripolar 
DBS electrode model 3389, with four platinum-iridium cylindrical surfaces  (1.27 mm 
diameter  and  1.5  mm  in  length  and  2  mm  centre-to-centre  separation)  and  Kinetra 
model 7428 implanted pulse generator (Medtronic Neurological Division, Minneapolis 
USA) were used in all except four patients where model 3387 (3 mm centre-to-centre 
separation)  electrodes  were  used.  Confirmation  of electrode  placement  in  GPi  was 
obtained in all patients with immediate post-implantation stereotactic MRI. All patients 
received monopolar stimulation with one or two adjacent active contacts. Stimulation 
parameters were individualised in each patient and chosen for the best clinical effect 
and  the  least  side  effects.  Eight  patients  were  stimulated  at  ventral  contacts;  in  7 
patients  (12  sides)  the  most  ventral  contacts  (0  and  4)  were  not  used  for  chronic 
stimulation.  The  reasons  for  not  using  the  most  ventral  contacts  were  capsular 
(corticospinal)  response,  with  tension  in  the  contralateral  face  or  arm  or  dysarthria 
(patients  8,10,15),  dizziness (patient 4), better clinical  effect of more dorsal  contacts 
(patient 7), and not tried for chronic stimulation from the outset (patients  12 and  13). 
The stimulation parameters in each patient at 6 months are shown in Table 4.1.
4.3.3  Clinical evaluation
Clinical  assessment  was  performed  using  the  Burke-Fahn-Marsden  scale  (BFM). 
Patients  were  assessed  pre-operatively  and  6  months  after  surgery.  Right  and  left 
hemibody scores were derived from the BFM Movement scores for the arm and leg. 
The BFM Movement scores for axial items (eyes, mouth, speech, neck, trunk), which
107are  unpaired  data,  were  analysed  separately on a whole  patient  basis  rather than by 
sides.
4.3.4 MRI analysis and determination of electrode contact position
MRI images were analysed using the Stealth workstation (Framelink TM, Medtronic, 
Minneapolis USA).  The investigator determining contact location was blinded to the 
clinical scores of the patients. Electrode contacts were identified on the post-operative 
stereotactic MRI. The centre of the electrode contact was determined as the centre of its 
artifact  visible  on  the  MRI  image.  Electrode  contact  position  with  respect  to  mid- 
commissural  point,  atlas-defined  target  and  the  visible  anatomical  target  was 
determined. The visible target was spatially normalised to atlas target of x = 21 mm, y 
= 2 mm, z = - 5 mm in relation to mid-commissural point. The Cartesian coordinates of 
the  active  contact  after  this  transposition  were  then  derived.  This  transposition 
normalised for anatomical variation between and within patients.  Where two adjacent 
contacts were stimulated, (11 sides), the geometric mean of the two stimulated contacts 
was used.  In addition to quantitative localisation of the stimulated electrode contacts, 
their position in relation to anatomical boundaries of the GPi visible on MRI images 
was determined.  Using the  same MRI  analysis  methods,  the targeting  error for each 
electrode was determined as the distance between the intended target and the electrode 
position.
4.3.5 Statistical analysis
Clinical and contact location data were cross tabulated so that total hemibody, arm and 
leg scores were paired with the coordinates of the contralateral active electrode contact 
(30  sides).  Total  scores  and  axial  sub  scores  were  paired  with  the  mean  x,  y,  z
108coordinates of active contacts of both electrodes (15 patients), to enable the data to be 
treated on a whole patient basis rather than by sides.  Cluster analysis (K-means cluster) 
was  used  to  identify  subgroups  of electrode  contacts  within  geographically  distinct 
domains. Differences between groups were determined using Chi square and two-tailed 
unpaired  t-tests.  Repeated  measures  ANOVA  was  used  to  explore  the  effects  of 
coordinate and DYT1  status on clinical outcome.  Correlations were performed using 
the Pearson correlation coefficient.  A p value less than 0.05 was considered significant. 
All statistics were performed using SSPS for Windows version 11.5.
4.4  Results
4.4.1  Clinical Outcome
Dystonia  improved  in  all  patients  after  surgery.  The  mean  BFM  Movement  score 
decreased  from  38.9  preoperatively  to  11.9  at  6  months,  a  69.5%  improvement 
(p<0.00001). The BFM disability score improved from 9.0 to 4.1, a 58% improvement 
(p<0.00001).  The  mean  percentage  improvement  in  hemibody  scores  was  67.8% 
(p<0.0001).  There  was  no  significant  difference  in  outcome  between  arm  and  leg 
(63.8% vs 72.9% p=NS) or right and left body sides (67.5% vs 68.0% p=NS). Patients 
with DYT1  showed significantly greater improvement in total movement score (82.5% 
vs 61.5% p<0.05), hemibody score (81.8% vs 55.4 %, p<0.01) but not axial (89.4% vs 
63.9% p=NS) or disability score (69.5% vs 50.9%, p=NS). Improvement in hemibody 
score  was  non-significantly  greater for  3387  than  3389  electrodes  (79.0%  vs  63.6% 
p=NS). The clinical outcome results are summarised in Figure 4.1. Of note, there were 
2 patients (patients 5 and 8), who developed delayed onset akinesia with gait slowing, 
and difficulty arising from sitting and turning in bed.  In both patients, these akinetic
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features  occurred  with  stimulation  of ventral  contacts  and  improved by  changing to 
more dorsal contacts.
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110Figure 4.1. Mean BFM movement scores for whole body, hemibody (arm,  leg) and axial (eyes, 
mouth,  speech/swallow,  neck and trunk)  before and 6 months after bilateral GPi DBS.  Error 
bars ±1 SEM. All decreases in BFM significant atp<0.05 level.
4.4.2  Electrode contact location
Table 4.2 shows the electrode contact position in relation to pallidal anatomy, for each 
patient side.
Patient Left side Right side
Contact 0 Contact 1 Contact 2 Contact 3 Contact 4 Contact 5 Contact 6 Contact 7
1 GPi* GPi/MML* GPe GPe / LML GPi * GPi/MML* GPe GPe/LML
2 GPi* GPi* GPe GPe/LML GPi * G Pi/M M L* GPe LML/PT
3 GPi* GPi* GPi/MML Gpe GPi * GPi/MML GPe GPe
4 GPi GPi/MML* MML/GPe GPe/LML GPi GPi/MML* GPe GPe
5 GPi* GPi/MML GPe Gpe GPi * GPi/MML GPe GPe/ LML
6 GPi* Gpi GPi Gpi GPi* GPi/MML MML/GPi GPe
7 GPi Gpi GPi * GPi/MML GPi GPi GPi * GPi/MML
8 GPi GPi * GPi/MML Gpe GPi * GPi/MML GPe LML/PT
9 GPi* Gpi GPi GPi/ MML GPi * MML/GPe GPe GPe/ LML
10 GPi GPi / MML * MML/GPe Gpe IC/GPi GPi G Pi/M M L* MML
11 GPi* GPi/MML MML Gpe GPi * GPi /MML MML MML/GPe
12 GPi GPi/MML* GPe* Gpe GPi GPi* GPi/MML* GPe
13 GPi GPi* GPi/MML* LML/PT GPi* GPi/MML* MML/GPe GPe
14 GPi* GPi/MML* MML MML/GPe GPi* GPe* GPe/LML LML/PT
15 GPi GPi* GPi/MML Gpe GPi GPi/MML* GPe/LML GPe
Table  4.2.  Legend:  Abbreviations;  GPi=globus  pallidus  intemus,  GPe=globus  pallidus 
externus,  MML= medial medullary lamina (separates GPi and GPe),  LML ^lateral medullary 
lamina (separates GPe andputamen), PT=putamen, IC=internal capsule.  * denotes stimulated 
contact.
IllThe MRI of patient 1   is shown in Figure 2. For the entire cohort, the mean coordinates 
of the stimulated contact were x = 20.8 mm (18.3-22.4) y = 3.2 mm (1.2-5.1) and z = - 
0.76 mm (-5.3-2.2). Electrode contacts on the left brain side were more medial than on 
the right (20.2 mm vs 21.4 mm p<0.001), but for Y and Z coordinates there was no 
significant difference between right and left sides. The mean Euclidean targeting error 
for all  the electrodes was  0.9  mm ±  SD  0.5,  and not significantly different between 
right and left sides.  Since the targeting error was acceptably small and equal on both 
sides, the likely explanation of the left electrode being more medial is that the GPi is 
anatomically more medial on the left than the right, as has been shown in a previous 
study (Hirabayashi et al 2002).
Figure 4.2.  Immediate post-implantation axial and coronal MRI images of patient 1  showing 
quadripolar 3387 electrodes located bilaterally in the GPi.
Cluster analysis of the stimulated contact coordinates identified two  spatially distinct 
groups with the following geometric centres; cluster one (10 sides) x = 20.8 mm, y -
2.2  mm, z = -3.1 mm, and cluster two (20 sides) x = 20.8 mm, y = 3.6 mm, z = 0.4 mm. 
Clustering  was  influenced  by  the  y  (F=22.4,  p<0.0001)  and  z  (F=  64.8,  p<0.0001)
112coordinates but not x (F=0.02, p=0.89), reflecting less variation in x. Cluster  1   is the 
most posteroventral, cluster 2 is more anterodorsal.  When plotted in the Y-Z plane the 
electrode  contacts  lie  along  a  line  reflecting  the  electrode  trajectory  and  are 
significantly correlated (r=0.748, p<0.001), Figure 4.3a.
4.4.3  Effect of electrode contact location on clinical outcome
The  mean  percentage  improvement  in  BFM  movement  scores  for  the  contralateral 
hemibody, arm and leg for clusters 1  and 2 are shown in Figure 4.3b. The improvement 
in hemibody score was greater in cluster 1  than in cluster 2 (79.5% vs 61.9%), but this 
did  not  reach  significance  (p=0.071).  Analysis  of arm  and  leg  sub-scores  revealed 
significantly  greater  improvement  in  cluster  1   than cluster  2  for the  arm  (86.3%  vs 
51.9%, p=0.008) but not the  leg (72.6% vs  73% p=NS).  The number of sides with 
superior outcome  defined  as  >80%  improvement  in  hemibody  BFM  score  was  also 
determined for each cluster. The >80% level of improvement was chosen because it had 
been used as the cutoff in a previous study of GPi DBS for dystonia using the BFM 
scale  (Vayssiere  et  al  2004).  Overall,  there  were  16  (of  30)  sides  with  superior 
outcome, which occurred more frequently in cluster 1  (8/10) than cluster 2 (8/20), (Chi- 
square= 4.29, p<0.05). The number of DYT1  sides did not differ significantly between 
clusters 1   (6/10) and 2 (8/20) (Chi-square=1.07, p=NS). To further investigate if DYT1 
status  could  account  for  the  observed  superior  outcome  for  the  arm  in  cluster  1, 
repeated measures ANOVA on the arm sub-scores was performed, with main factor of 
TIME (before and after surgery), between subjects factor of DYT1  and covariates of y 
and z coordinate. The x coordinate was omitted from the ANOVA because x did not 
contribute to electrode contact clustering. There was a significant main effect of TIME
113[F(l,26)~  11.3,  p<0.005],  TIME*Y  interaction  [F(l,26)=4.6,  p<0.05],  but  no 
TIME*DYT1 interaction [F(l,26)=0.29, p=0.596].
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Figure 4.3.  (a) Plot of Y and Z coordinate of the stimulated contact for 30 sides showing a 
linear distribution and the membership of spatial clusters.  The  origin  of the plot is the  mid­
point of the AC-PC line. Note cluster 1 is posteroventral and cluster 2 anterodorsal.  (b) Mean
114percentage improvement in BFM movement score for hemibody,  arm and leg in clusters 1 and 
2. For arm scores, improvement was significantly greater in cluster 1 than 2 (*p=0.008). Error 
bars ±1 SEM.
There  was  a  significant  inverse  correlation  between  y  coordinate  and  percentage 
improvement in hemibody BFM score (r= -0.42, p=0.022), arm (r=-0.43, p=0.019), but 
not leg (r=-0.14, p=NS). The same inverse correlation with y coordinate was observed 
for total axial scores(r=-0.57, p=0.025), Figure 4.4.
Cluster analysis was applied to the averaged x, y, z coordinates in each patient.  This 
identified  two  spatially  distinct  groups,  a  posteroventral  cluster  (4  patients;  centre 
x=20.7  mm,  y=2.05  mm,  z=-3.23  mm)  and  more  anterodorsal  cluster  (11  patients; 
centre x=20.86 mm,  y=3.55  mm, z=0.14 mm).  The percentage improvement in axial 
BFM movement score  was greater in the posteroventral than the anterodorsal cluster 
(91% vs 70.3%) and  for the trunk sub  score this difference  was  significant (96% vs 
65%,  p<0.05).  Similarly,  for the  whole  body  BFM  movement  score,  the  percentage 
improvement was greater in the posteroventral than the anterodorsal cluster (88.7% vs 
67.2%, p=0.02) and correlated with y coordinate (r=-0.62, p=0.013).
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Figure 4.4.  (a)  Correlation between percentage change  in  hemibody BFM score,  and the  Y 
coordinate of the stimulated contact in 30 sides  (r- -0.42, p=0.022)  (b)  Correlation between 
percentage change in axial BFM score, and the average Y coordinate right and left sides in 15 
patients (r=-0.57, p=0.025).
1164.5  Discussion
In  the  present  study  the  main  finding  is  that  superior  improvement  of dystonia  is 
associated with chronic high frequency stimulation in the most posteroventral part of 
GPi.  The  y  (A-P)  axis  position  of the  electrode contact  significantly  influenced  the 
efficacy of GPi DBS; the more posterior electrode contacts were therapeutically more 
effective.
4.5.1 Elimination of confounding effects due to DYT1
The degree  of improvement  in patients  with primary  generalised  dystonia following 
bilateral GPi DBS was similar to that previously reported (Coubes et al 2004, Vidailhet 
et al 2005). In contrast to these studies, we did observe a significantly better outcome in 
patients with DYT1. The superior outcome in DYT1  could act as a confounding factor 
however this is unlikely for the following reasons. Firstly, DYT1  sides were not over­
represented  in  the  posteroventral  electrode  contact  cluster  and  secondly,  ANOVA 
showed no effect of DYT1 status and a clear effect of y coordinate on outcome.
4.5.2 Anatomical reasons for superiority of posteroventral stimulation
The  initial  cluster  analysis  identified  an  anterodorsal-posteroventral  gradient  of 
electrode contact effectiveness, with better outcomes occurring more frequently in the 
posteroventral location. The subsequent finding of an exclusive correlation between the 
y coordinate  and contralateral  clinical  outcome  suggests y to  be  the more  important 
predictor than z of electrode contact effectiveness.
The explanation for the present findings  may relate to pallidal  anatomy.  Anatomical 
and physiological studies in primates have shown the sensorimotor territory of the GPi 
is  ventral  and  posterior  (Iansek  et  al  1980,  Parent  et  al  1995),  the  somatotopic
117arrangement such that the face and arm are posterior and ventral and the leg central and 
more dorsal (Delong et al 1985). The pallidal anatomy supports the finding of superior 
efficacy  of  posteroventral  stimulation  since  this  is  the  sensorimotor  area  and 
modification of these circuits might be expected to alter the expression of dystonia. 
Another relevant anatomical consideration is that the major routes of pallidal outflow, 
the ansa lenticularis and lenticular fasciculus overlap in the posteroventral GPi (Patil et 
al  1998),  making  both  routes  of pallidal  outflow  accessible  to  intervention  in  this 
region.  It  should be  mentioned that although the  findings have  concentrated on  GPi 
which was the targeted and stimulated structure, a contributory role of GPe, which lies 
in intimate relation to GPi, cannot be excluded.  Congruent with the present targeting 
results,  groups  using  microelectrode  recording  during  pallidal  DBS  for  dystonia 
identify an optimal target area in the posteroventrolateral GPi close to the border with 
GPe (Starr et al 2005). At the very least, the present data confirm the superiority of the 
posteroventral pallidal target, which includes GPi but may also additionally include a 
contribution of effect from adjacent GPe.
4.5.3  Evidence for pallidal somatotopy
In the present study it was found that posteroventral stimulation was best for the arm 
and overall, while for the leg anterodorsal stimulation was of equivalent efficacy. These 
findings agree with the somatotopic arrangement of GPi derived from primate studies, 
in that the  arm  is  more  posteroventral,  and  the  leg  area  extends  more  dorsally  and 
centrally (DeLong et al 1985). Furthermore, the present results agree with another study 
of GPi DBS contact location in PGD in which superior improvement for the leg was 
associated  with  electrode  contact  placement  more  centrally  within  GPi,  whereas 
posterior contact location was more efficient for the arm (Vayssiere et al 2004).
1184.5.4 Clinical observation of pallidal interventions and relevance
Clinical  observations  also  provide  support  for  the  importance  of the  posteroventral 
pallidum  as  an  area  for  modification  of motor  symptoms.  Leksell  observed that the 
beneficial effects of pallidotomy improved as the lesions were made in a more posterior 
location  (Svenlinson  et  al  1960),  which  led  to  the  successful  re-introduction  of 
posteroventral  pallidotomy  for  PD  (Laitinen  et  al  1992).  In  patients  with  PD, 
stimulation in the posteroventral  GPi alleviates rigidity and abolishes dyskinesia, but 
may worsen akinesia, while stimulation of dorsal contacts improves akinesia (Bejjani et 
al 1997, Krack et al 1998), suggesting functional segregation of effects. The volume of 
lesions in the posteroventral but not anterodorsal part of GPi correlates with the relief 
of dyskinesias in patients with Parkinson's disease (Kishore et al 2000). In addition, two 
patients in the present study developed akinesia with posteroventral stimulation, which 
resolved  when  more  dorsal  contacts  were  used.  Taken  together  these  observations 
suggest  that  intervention  in  the  posteroventral  GPi  is  more  “antikinetic”  than  in 
anterodorsal areas, and is consistent with the present finding of optimal suppression of 
involuntary dystonic movements with stimulation in this region.
4.5.5 Study limitations
A limitation of the present study was that it was not randomised or fully blinded which 
may have allowed bias to be introduced. Another potential limitation was our relatively 
small sample size of 15 patients; however, this was offset by evaluating each electrode 
and body side separately which doubled the number of observations.
Another  important  question  is  why  the  most  ventral  contacts  were  not  used  in  all 
patients.  In most patients the most ventral  contacts were used,  in some patients  side 
effects  limited  their  use,  and  in  one  patient  (patient  7)  more  dorsal  contacts  were
119clinically superior to initial trials of more ventral contacts. However, in patient 7, the 
stimulated  contacts  were  0.7mm  and  0.45  mm  below  AC-PC,  therefore  the  good 
outcome in this patient was still associated with relatively more posteroventral rather 
than anterodorsal stimulation.
4.6  Conclusions
The present results confirm the superiority of the posteroventral GPi target for effective 
relief of dystonia with DBS. The accepted atlas target coordinates correspond well with 
the most effective contact location in this series.  The present data would suggest that 
particular attention should be paid to  targeting  in the  antero-posterior axis to  ensure 
sufficiently  posterior  placement  of the  electrode.  Based  on  the  present  findings,  it 
would  seem  reasonable  that  in  patients  with  GPi  DBS  for  dystonia,  the  lowermost 
contacts  of  the  quadripolar  electrode,  without  side  effects,  be  tried  for  chronic 
stimulation first, since these, with conventional orientation of electrode trajectory, will 
be  the  most  posteroventral.  The  identification  of  an  anterodorsal  to  posteroventral 
gradient  of  contact  efficacy  may  be  explained  by  the  functional  organisation  and 
anatomy of GPi and its outflow tracts.
120Chapter 5. Changes in forearm reciprocal inhibition following 
GPi DBS for dystonia
5.1  Summary
Dystonia  is  characterised  by  involuntary  muscle  contractions,  and  a  consistent 
pathophysiological feature is reduced inhibition at various levels of the nervous system, 
which  may  be  detected  in  clinically  unaffected  body  parts.  Chronic  deep  brain 
stimulation (DBS) of the  globus pallidus intemus  (GPi) has  emerged as an effective 
treatment for primary generalised dystonia (PGD),  although its mechanism of action 
and  impact  on  inhibitory  abnormalities  in  dystonia are  unknown.  The  present  study 
examined spinal excitability in patients with PGD before and after GPi DBS to explore 
the relationship between spinal disinhibition and dystonic symptoms and to probe the 
physiological basis for progressive improvement observed in dystonia after GPi DBS. 
Forearm  H-reflex  reciprocal  inhibition  (RI)  was  recorded  and  clinical  evaluation 
performed using the Burke-Fahn-Marsden dystonia rating scale in 8 patients with PGD 
before and at intervals of 1,  3  and 6 months after bilateral GPi DBS. Following GPi 
DBS, there was a significant progressive increase in the first and second phases of RI, 
which correlated with the clinical improvement in dystonia.  The time course of both 
clinical  improvement  and  increases  in RI  followed  a  logarithmic  distribution.  These 
results  demonstrate  that  GPi  DBS  progressively  restores  spinal  inhibition  in  PGD 
closely paralleling improvement in dystonic symptoms. The present results support the 
conclusion  that  GPi  DBS  for  primary  generalised  dystonia  results  in  functional 
reorganisation  of the  nervous  system,  which  includes  a  long-term  increase  in  spinal 
inhibition.
1215.2  Introduction
The  pathophysiology  of  dystonia  is  characterised  by  an  abnormal  reduction  of 
inhibition  within  the  brain  and  spinal  cord.  Defective  inhibition  may  contribute  to 
dystonia  by  interfering  with  normal  motor  selection  and  suppression  of unwanted 
movements.  In patients with focal dystonia, transcranial magnetic  stimulation (TMS) 
studies  have  shown  abnormally  reduced  short  latency  intracortical  inhibition  in  the 
motor cortex (Ridding et al 1995) and increased excitability of the motor cortex during 
voluntary  muscle  contraction  (Ikoma  et  al  1996).  The  blink  reflex  is  abnormally 
disinhibited in patients with cranial dystonia (Berardelli et al  1985) and segmental and 
generalised  dystonia  (Nakashima  et  al  1990).  At  the  spinal  cord  level,  reduced 
reciprocal inhibition (RI) of forearm H-reflexes has been demonstrated in patients with 
focal and generalised dystonia (Nakashima et al  1989, Panizza et al  1989,  1990). It is 
unclear  whether  these  abnormalities  directly  contribute  to  dystonic  cocontraction  of 
limb  muscles  since  abnormally  reduced  RI  has  been  found  in  the  asymptomatic, 
contralateral  arm in writer’s cramp patients (Chen R et al  1995) and in patients with 
spasmodic torticollis without limb dystonia (Deuschl et al  1992).  Chronic deep brain 
stimulation (DBS)  of the  globus pallidus  intemus  (GPi) has  emerged  as an effective 
treatment  for  PGD  (Coubes  et  al  2004,  Vidailhet  2005),  however  the  physiological 
mechanisms  of improvement  remain  unclear.  In  contrast  to  Parkinson’s  disease,  the 
improvement following DBS is not immediate but progressive over weeks to months, 
and brain plasticity mechanisms have been implicated, although physiological evidence 
has been lacking (Bereznai et al 2002,  Yianni et al 2003,  Vidailhet et al 2005).  It is 
unknown whether RI  changes after GPi  DBS  for PGD.  Previous work has identified 
that  physiological  abnormalities  in  dystonia  are  frequently  present  in  clinically 
unaffected body parts and may be considered an endophenotype, which under certain
122conditions manifests  in dystonia (Meunier et al 2001).  The aim of the present study 
was to determine  if spinal  disinhibition in dystonia patients would  change  after GPi 
DBS,  or  whether  abnormalities  might  persist  even  after  clinical  improvement  had 
occurred, in the same way that decreased RJ can be observed in clinically unaffected 
limbs in writer’s cramp (Chen R et al  1995).  To this end we studied forearm H-reflex 
RI in patients with PGD before and at intervals after GPi DBS.
5.3  Methods
5.3.1  Subjects
Eight patients with PGD (5 female, mean age 50 years range 24-64, three DYT1+) were 
enrolled in the study. The patient characteristics are shown in Table 5.1. Patients 3 and 
5  underwent  unilateral  thalamotomy  29  and  23  years  ago.  Medications  for dystonia 
were  not  altered  during  the  period  of the  study.  All  patients  gave  written  informed 
consent.  The  study  was  approved  by  the  Joint  Research  Committee  of the National 
Hospital for Neurology and Neurosurgery and the Institute of Neurology.
123Patient Gender Age
(years)
Disease
duration
(years)
DYT 1 gene 
status
BFM score 
pre-op  (0- 
120)
Medications DBS parameters
1 M 47 37 + 52 Diazepam
Tetrabenazine
Rt: 4*. 3.5v, 90psec, 130 Hz 
Lt: 0,1-, 3.3v, 60psec, 130 Hz
2 M 24 16 73 Clonazepam Rt: 4,5-, 3.9v, 90psec, 130 Hz 
Lt: 0,1-, 3.8v, 90psec, 130 Hz
3 F 53 43 + 40.5 Diazepam Rt: 5-, 2.9v, 90psec, 130 Hz 
Lt: 1-, 3.7v, 90psec, 130 Hz
4 F 63 4 23 L-dopa
T rihexphenidyl
Rt: 6-, 4.6v, 90psec, 130 Hz 
Lt: 2-, 4.6v, 90psec,  130 Hz
5 F 54 43 ■ 24 None Rt: 4-, 3.7v, 60psec,  130 Hz 
Lt: 1-, 3.7v, 60psec, 130 Hz
6 F 36 25 + 20.5 T  rihexphenidyl Rt: 4-, 4.6v, 90psec, 130 Hz 
Lt: 0-, 4.2v, 90psec,  130 Hz
7 F 64 50 ■ 46 None Rt: 6-, 3.5v, 60psec, 130 Hz 
Lt: 2-, 3.5v, 60psec, 130 Hz
8 M 62 7 64 None Rt: 4,5-, 3.5v, 60psec, 130 Hz 
Lt:  1,2-, 3.5v, 60psec, 130 Hz
Table 5.1 Clinical patient data.
5.3.2  Surgical procedures, stimulation parameters and clinical assessment 
All  patients  underwent  bilateral  implantation  of  electrodes  into  GPi  and  chronic 
stimulation.  The  surgery  and  adjustment  of stimulation  parameters  was  performed  a 
described in the General methods. The macroelectrode model 3389 and Kinetra model 
7428 implanted pulse generator (Medtronic Neurological  Division, Minneapolis USA) 
were used in  all  patients  except  in  one  where  model  3387  electrodes  were  used.  In 
patient  3,  MRI  could  not  be  performed  due  to  the  presence  of a  metal  fragment 
deposited in the target area during the previous thalamotomy. In this patient, targeting 
was performed using stereotactic computerised tomography (CT), atlas coordinates and
124intraoperative  stimulation  to  evaluate  proximity  to  capsular  fibres.  Confirmation  of 
electrode  placement  in  GPi  was  obtained  in  all  patients  with  immediate  post 
implantation stereotactic  MRI,  except in one patient in whom immediate  stereotactic 
CT  was  performed.  Clinical  assessment  was  performed  using  the  Burke-Fahn- 
Mardsen scale (BFM).
5.3.3  Forearm FI-reflex reciprocal inhibition recordings
EMG  recordings  were  made  from  flexor  carpi  radialis  and  extensor  digitorum 
communis  using  Ag-Ag  surface  electrodes.  The  EMG  signals  were  amplified,  using 
D360 amplifiers (Digitimer,  Welwyn UK), band pass filtered 3-2000 Hz, analogue to 
digital  converted  using  a  1401  AD  converter (CED,  Cambridge) at a sample rate of 
5000Hz and collected on computer.  Electrical  stimulation was applied to the median 
nerve  in the  antecubital  fossa  and  radial  nerve  above  the  elbow using two  constant 
current generators (Digitimer, Welwyn UK). All stimuli were 500 ms with an intensity 
at the median nerve to produce the maximum H-reflex without an M wave, and at the 
radial nerve to produce an EMG response of 0.1-0.5 mV. The H-reflex in response to 
radial nerve conditioning stimuli was assessed at 8 interstimulus intervals (ISI) of— 1, 0, 
1,  10, 20, 30,  100 and 200 ms.  Stimuli were delivered every 5 seconds. Sixty trials at 
each ISI and  120 unconditioned trials were performed in a randomised order in three 
blocks of 100 stimuli. RI was recorded in the clinically least dystonic arm to minimise 
EMG activity at rest.  Trials with excessive EMG artefact were rejected on line.  GPi 
DBS was not altered during the experimental session. Data were analysed off-line using 
custom-written software  (Nucursor 2001).  RI was calculated as the ratio of the mean 
peak-to-peak H-reflex amplitude at each ISI to the unconditioned response.
1255.3.4 Statistical analysis
The  average  RI  at  each  ISI  was  calculated  for  each  patient.  Repeated  measures 
ANOVA was used to assess changes in RI over time with main factors of TIME (pre­
op, 1, 3 and 6 months) and INTERVAL (-1, 0, 1, 10, 20, 30 ms). The third phase of RI 
(ISI 100 and 200 ms) was excluded from the ANOVA, because the first (ISI=0 ms) and 
second  (ISI=10-20  ms) phases  of RI  are physiologically better understood  and  have 
been  shown  previously  to  be  abnormal  in  dystonia.  Post-hoc  t  tests  were  used  to 
explore  the  nature  of  significant  interactions  found  in  the  ANOVA.  Correlation 
between  RI  and  BFM  score  were  calculated  by  pairing  the  BFM  score  with  the 
corresponding value of RI at each time point (pre-op,  1, 3 and 6 months) and applying 
the  Pearson  correlation.  The  time-course  of RI  and  BFM  were  explored using  non­
linear regression curve estimation function. For clinical correlations, ISI=0 ms for the 
first and ISI=10 ms for the second phase of RI were used. All statistics were performed 
using SPSS for Windows version 11.5.  A P value <0.05 was considered significant.
5.4 Results
5.4.1  Longitudinal effects of GPi DBS on reciprocal inhibition
The  RI  curves  at  each  ISI  at baseline,  1,  3  and  6  months  are  shown  in Figure  5.1. 
Repeated measures ANOVA with main factors of TIME (1-4) and INTERVAL (1-6) 
showed  a  significant  effect  of  TIME  [F(3,21)=6.14,  p<0.05],  INTERVAL 
[F(5,35)=30.03,  p<0.005]  and  TIME-INTERVAL  interaction  [F(15,105)=7.45, 
p<0.05]. Post hoc paired t tests revealed a significant decrease in H-reflex ratio for ISI= 
0 ms from 0.81 to 0.63 at 1   month (p<0.001) and progressive decrease by 6 months to 
0.58.  For ISI =10 and 20 ms there was a significant decrease in H-reflex ratio at 3 and 
6  months  (p<0.05).  There  was  no  significant  change  in  the  amplitude  of  the
126unconditioned H-reflex after GPi DBS, at one month (2.64 mV vs 2.19 mV, p=0.412) 
or later time points.
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Figure 5.1. Grand average of H-reflex ratio before and after GPi DBS.
5.4.2  Correlation of physiological changes and clinical improvement
There was a significant correlation between the BFM score and the H-reflex ratio for
the first (r=0.39, p<0.05) and second (r=0.59 p<0.0001) phases of RI
(Figure 5.2).
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005.4.3  Time-course modelling of changes in RI and clinical state
To investigate the time-course of changes in RI and clinical score, a curve estimation 
analysis was carried out in SPSS, which determined the function which best described 
the data. This revealed that changes in the second phase of RI (ISI=10 and 20 ms) and 
improvement in BFM score both followed a logarithmic distribution (Figure 5.3).
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Figure 5.3.  Time course of change in the second phase of RI (ISI 10 and 20 ms) and clinical 
improvement.  Data points  show  means  and  errors  bars  of ±   1  SEM.  All  curves follow  a 
logarithmic distribution; BFM =20.5  - 2.47 * logTIME, p=0.01; RI[ISI 10 ms]=0.67 - 0.017 * 
logTIME, p=0.02;  RIflSI 20 ms]=0.64 -  0.22  * logTIME, p=0.01.  A  line  is superimposed at 
0.6, which represents a normal level of RI  for the second phase in our laboratory (Huang et al 
2004).
1295.5  Discussion
The main finding in the present study was a progressive increase in RI in the first and 
second  phases  following  GPi  DBS,  which  correlated  with  clinical  improvement  in 
dystonia.  Furthermore,  changes  in  both  the  first  and  second  phases  of RI  and  the 
clinical symptoms followed a logarithmic time-course. Here it will be argued that GPi 
DBS reverses physiological abnormality in dystonia in a manner suggestive of long­
term neural reorganisation.
5.5.1  Mechanisms for alteration of spinal excitability by GPi DBS 
The first phase of RI, which is maximal with ISI=0 ms is mediated by la afferents of 
the antagonist muscle spindles which inhibit alpha motor neurons of the agonist via la 
inhibitory intemeurons  in a disynaptic  pathway  (Day  et  al  1984).  The  second  phase 
which is maximal with ISI 10-20 ms is mediated by presynaptic inhibition of agonist la 
afferents by type I afferents of antagonist muscles (Berardelli et al 1987). In the present 
study we observed abnormally decreased RI in both the first and second phase.  Other 
studies in patients with focal dystonia have shown reductions both the first and second 
(Panizza et al  1989, Chen et al  1995), or just the second phase of RI (Nakashima et al 
1989, Deuschl et al 1992). Our finding of additional impairment in the first phase of RI 
may be because the patients  we  studied with generalised dystonia are more  severely 
affected than those with focal dystonia.  This view is supported by the only previous 
study of RI in patients with generalised dystonia, which also found reductions in both 
the first and  second phases of RI  (Panizza et al  1990).  Since dystonia is primarily a 
disorder of basal ganglia rather than spinal cord function, the observed reductions in RI 
are likely due to an abnormality of descending control of spinal intemeurons as a result 
of basal ganglia dysfunction (Nakashima et al 1989). The basal ganglia have extensive
130connections  with  pathways  which  project  to  the  spinal  cord,  including  the 
reticulospinal,  rubrospinal,  vestibulospinal  and  corticospinal  tracts,  which  may 
modulate  la  inhibitory  intemeurons  (Hultbom  1976)  and  intemeurons  involved  in 
presynaptic  la inhibition (Baldiserra et al  1981).  The  GPi  is  one  of the main output 
nodes of the basal  ganglia with extensive inhibitory projections to the thalamus (and 
thence  cortex),  superior  colliculus  and  pedunculopontine  nucleus.  These  output 
structures might be expected to undergo major modifications of activity after GPi DBS 
which  would  in  turn  modify  descending  output  to  the  spinal  cord.  Relatively  few 
studies to date have examined the physiological consequences of pallidal stimulation in 
dystonia.  A  recent  PET  study  in  patients  with  PGD  found  that  during  voluntary 
movement, GPi DBS reverses abnormal overactivity in premotor cortex and thalamus 
(Detante  et  al  2004b).  The  excitability  of the  motor  cortex  to  transcranial  magnetic 
stimulation is decreased after cessation of GPi DBS in dystonic patients, these changes 
were reversible within minutes of switching the stimulator back ON (Kuhn et al 2003). 
Taken  together  these  observations  indicate  that  GPi  DBS  induces  physiological 
alterations in brain regions distant from the site of stimulation, in areas known to show 
physiological  abnormalities  in  dystonia,  and  which  are  known  to  contribute  to  the 
descending tracts responsible for control of RI.  A recent study found increases in the 
first and third phases  of forearm  RI to  normal  levels  when tested  immediately  after 
application of 1   Hz repetitive TMS to the premotor area  in DYT1  dystonia patients 
(Huang et al 2004). This confirms that intervention which alters activity in the cortex, 
such as GPi DBS, may modulate descending control of spinal RI in dystonia patients. 
The present observation that basal  ganglia DBS  can alter spinal reflex activity is not 
unprecedented.  A  recent  study  found  that  autogenic  inhibition,  which  is  mainly 
mediated by  lb  afferents  from  Golgi  tendon organs  of the  agonist,  was  increased to
131normal levels in patients with Parkinson's disease during STN stimulation (Potter et al
2004).  These observations  support the notion that DBS  within the basal  ganglia can 
influence spinal inhibitory circuits, as we have found in dystonia.
5.5.2  Normalisation of spinal excitability after GPi DBS and relevance to clinical effect 
of GPi DBS
In the present study progressive reductions in RI occurred following GPi DBS to reach 
levels equal to those  seen in healthy  subjects previously  recorded  in  our laboratory. 
This result confirms that the first and second phases of RI are abnormally reduced in 
primary generalised dystonia as described previously (Panizza et al 1990). Furthermore, 
normalisation of these abnormalities suggests GPi DBS reverses the pathophysiology of 
dystonia  with  respect  to  spinal  disinhibition.  Since  the  observed  changes  in  RI 
correlated well with clinical effects, it is tempting to attribute clinical improvement in 
dystonia after GPi DBS  to normalisation of RI.  However,  there are major caveats to 
such  an  interpretation.  Firstly,  RI  may  be  dissociated  from  clinical  symptoms  and 
secondly, spinal disinhibition is one of many factors implicated in the pathophysiology 
of  dystonia,  and  as  such  its  reversal  is  unlikely  to  be  the  sole  determinant  of 
improvement  in dystonia.  The  more  likely explanation  for the  present results  is  that 
changes in RI occurred as part of more widespread changes within the nervous system 
at  supraspinal  levels  after  GPi  DBS.  These  changes  could  account  for  both  clinical 
improvement and changes in RI, by modification of descending influence on the spinal 
cord,  and  would  explain  the  close  correlation  between  the  two  variables.  This 
interpretation does not preclude a contributory mechanistic role for reversal of spinal 
disinhibition in GPi DBS effect, but argues against this being the main determinant.
1325.5.3 Time-course of effects and evidence for neural plasticity
In the present study, progressive improvement in dystonia after GPi DBS was observed, 
as has been found previously (Yianni et al 2003, Vidailhet et al 2005). Furthermore, the 
time-course of both clinical improvement and increases in the second phase of RI were 
logarithmic. Because GPi DBS does not directly stimulate the spinal cord, the effect of 
GPi DBS  on RI  must be  accounted  for by changes  in descending drive to  la spinal 
inhibitory  intemeurons.  These  changes  in  descending  drive  would  in  turn  equate  to 
progressive modification in the basal ganglia and cortical output to the brainstem and 
spinal  cord.  Furthermore,  the  observed  progressive  time  course  of  changes  in  RI 
suggests that GPi DBS induces a gradual plastic modification within the brain. The site 
of reorganisation  after  GPi  DBS  could  include  both  cortical  and  subcortical  levels. 
Involvement  of the  cortex  in  such  reorganisation  seems  likely,  since  the  cortex  is 
recognised to  form  abnormal  sensorimotor representations  in dystonia which may be 
modified in a plastic  fashion  (Byl  et al  1996,  Meunier et al 2001,  Rozenkranz et al
2005).  There are parallels between the observations in the present study and the time- 
course  of  improvement  after  stroke,  a  setting  in  which  adaptive  neuroplasticity  is 
believed to play an important role. Recovery of upper extremity muscle strength after 
stroke  also  follows  a  logarithmic  time  course  (Goodwin  et  al  2003),  allowing 
logarithmic modelling to be used to predict stroke recovery (Koyama et al 2005).
5.5.4 Experimental limitations
An alternative explanation of our results might be that the reductions in RI are simply 
the result of decreased dystonic contractions in the limb being tested. This explanation 
is unlikely because decreased RI may be observed in clinically unaffected limbs (Chen 
R et al  1995),  so that improvement in dystonia would not guarantee normalisation of
133RI.  In addition, trials with EMG artefact were rejected,  and there  was no  significant 
change  in  unconditioned  H-reflex  amplitude  after  GPi  DBS,  suggesting  that 
potentiation  of the  H-reflex  by  muscle  contraction  did  not  play  a  major role  in  the 
results. A potential limitation in the present study was that a healthy control group were 
not specifically studied.  The rationale for this was that changes  from baseline in the 
dystonia  group  were  the  primary  point  of interest  and  could  be  studied  accurately 
without a healthy control  group because of the  longitudinal  study design.  However, 
comparison  of the  present  study  group  with  data  from  healthy  subjects  previously 
recorded  in  our  laboratory  using  the  same  methodology  was  possible,  and  showed 
normalisation of RI following GPi DBS.
5.5  Conclusions
The finding that RI also changes progressively in parallel with clinical improvement of 
dystonia suggests that changes at the spinal level reflect plastic adaptation occurring at 
higher levels. Restoration of RI is unlikely to be the major mechanism of action of GPi 
DBS, since impaired RI alone is insufficient to result in dystonic symptoms, but rather 
a  marker  for  collective  changes  at  supraspinal  levels.  The  results  support  the 
conclusion  that  GPi  DBS  for  dystonia  results  in  functional  reorganisation  of  the 
nervous system, which includes a long term increase in spinal inhibition.
134Chapter 6.  Changes in blink reflex excitability after GPi DBS 
for dystonia
6.1  Summary
A pathophysiological feature of dystonia is reduced inhibition at various levels of the 
nervous system,  which  may  be  detected  in clinically  unaffected body  parts.  Chronic 
deep brain stimulation (DBS) of the globus pallidus intemus (GPi) has emerged as an 
effective treatment for primary generalised dystonia (PGD), although its mechanism of 
action and impact on inhibitory  abnormalities  in dystonia are unknown.  The present 
study sought to determine the effect of GPi DBS on brainstem excitability in patients 
with primary generalised dystonia. The blink reflex from orbicularis oculi in response 
to paired electrical stimulation of the supraorbital nerve was measured at interstimulus 
intervals  of 500  ms  and  1000  ms  in  10  patients  with  primary  generalised  dystonia 
before and at intervals of 1, 3 and 6 months after bilateral GPi DBS, and in 10 healthy 
subjects. Patients were clinically evaluated using the BFM dystonia rating scale. Pre- 
operatively,  the  degree  of  R2  inhibition  was  significantly  decreased  in  patients 
compared with control subjects and progressively increased after GPi DBS. Changes in 
R2 inhibition correlated with changes in BFM score. The results indicate that GPi DBS 
partially restores a normal pattern of brainstem blink reflex inhibition in parallel with 
its beneficial effects on dystonic symptoms. These effects are interpreted as the result 
of  progressive  modification  of  basal  ganglia  and  cortical  function  by  GPi  DBS, 
reflected  at  the  brainstem  level.  The  results  suggest  that  GPi  DBS  for  primary 
generalised dystonia results in functional reorganisation of the nervous system, which 
includes a long-term increase in brainstem inhibition.
1356.2  Introduction
Dystonia is characterised by involuntary muscle contractions, which result in spasms 
and  abnormal  postures  (Fahn  1998).  Chronic  deep  brain  stimulation  of the  globus 
pallidus intemus (GPi) has emerged as an effective treatment for primary generalised 
dystonia  (PGD)  (Coubes  et  al  2004,  Vidailhet  et  al  2005)  but  the  physiological 
mechanisms of improvement remain unclear.  The improvement in dystonia after GPi 
DBS  is  progressive  over  months  (Yianni  et  al  2003,  Vidailhet  et  al  2005),  which 
suggests that DBS may act by inducing gradual plastic changes within the brain. The 
pathophysiology  of  dystonia  is  characterised  by  abnormally  reduced  inhibition  at 
cortical, brainstem and spinal levels. Transcranial magnetic stimulation (TMS) studies 
in patients  with  focal  hand  dystonia  have  shown  abnormally  reduced  short  latency 
intracortical inhibition of the motor cortex (Ridding et al  1995, Edwards et al 2003b). 
At the spinal cord level, reduced reciprocal inhibition of forearm H-reflexes has been 
demonstrated in patients with focal  and generalised dystonia (Nakashima et al  1990, 
Panizza  et  al  1989,  Panizza  et  al  1990).  Similarly,  the  blink  reflex  is  abnormally 
disinhibited  in  patients  with  cranial,  (Berardelli  et  al  1985,  Tolosa  et  al  1988), 
segmental  and  generalised  dystonia  (Nakashima  et  al  1990).  Disinhibition  may 
physiologically  contribute  to  dystonia  by  reducing  the  extent  to  which  unwanted 
movements can be suppressed. Nevertheless, disinhibition in dystonia may be detected 
in clinically unaffected body parts, for example impaired RI in the unaffected arm in 
patients with focal hand dystonia (Chen et al  1995), and blink reflex disinhibition is 
present in dystonia patients without blepharospasm (Nakashima et al 1990).
The  blink  reflex  of  orbicularis  oculi  in  response  to  electrical  stimulation  of  the 
supraorbital nerve has  two  components.  The early RI  response  is seen unilateral to 
stimulation  and  is  mediated  by  an  oligosynaptic  pathway  involving  first  division
136trigeminal afferents, relaying via intemeurons near the trigeminal sensory nucleus and 
then motomeurons of the facial nucleus.  The later R2 response is bilateral, of longer 
duration  and  is  mediated  via  a  polysynaptic  pathway  involving  the  descending 
trigeminal  spinal  tract,  caudal  spinal  nucleus  and  medullary  reticular  formation  to 
project  bilaterally  to  facial  motomeurons  (Arimedeh  et  al  2002).  Blink  reflex 
excitability  is  under  local  control  of inhibitory  intemeurons,  which  in  turn  receive 
descending modulation from basal ganglia and cortex (Esteban et al 1999). With paired 
supraorbital nerve stimulation, the second R2 response is normally inhibited compared 
to the first, the degree of inhibition being more intense with shorter ISIs and recovering 
with longer ISIs (Kimura et al  1976). The recovery cycle of the ratio of the second to 
the  first  R2  response  thus  provides  a  measure  of  inhibition  within  brainstem 
intemeuronal  networks  and  also  their  inputs  from  basal  ganglia  and  cortex.  Since 
disinhibition may be an important physiological mechanism in dystonia and dissociated 
from clinical involvement, the aim of the present study was to determine if inhibitory 
abnormalities would improve or persist after treatment with GPi DBS.  Moreover the 
present  study  sought  to  identify  the  relationship  bewteen  changes  in  blink  reflex 
excitability and clinical state to determine if they might represent a marker for neural 
reorganisation  which  has  been  postulated  to  underly  the  progressive  effects  of GPi 
DBS.  To this end the blink reflex in patients with PGD before and at intervals after 
GPi DBS was studied.
6.3  Methods
6.3.1  Subjects
Ten patients  with  generalised  PGD  (6  female,  mean  age  52  years  range  24-64,  four 
DYT1+) and  10 healthy  control  subjects  (5  female,  mean age 40 years range, 29-60
137years)  were  studied.  The  patient  characteristics  are  shown  in  Table  1.  One  patient 
(patient 2) had mild blepharospasm as part of the generalised dystonia. Patients 3 and 5 
had undergone  unilateral  thalamotomy  29  and  23  years  previously.  Medications  for 
dystonia were  not  altered  during  the  period  of the  study.  All  patients  gave  written 
informed consent.  The  study was  approved  by the  Joint Research  Committee  of the 
National Hospital for Neurology and Neurosurgery and the Institute of Neurology
6.3.2 Surgical procedures, stimulation parameters and clinical assessment
All  patients  underwent  bilateral  implantation  of  electrodes  into  GPi  and  chronic 
stimulation.  The  surgery and adjustment of stimulation parameters was performed as 
described in the General Methods. Clinical assessment was performed using the Burke- 
Fahn-Mardsen scale (BFM).
6.3.3 Blink reflex recordings
Surface  EMG  recordings  were  made  bilaterally  from  the  orbicularis  oculi  muscles 
using  Ag-Ag  surface  electrodes.  The  EMG  signals  were  amplified  using  D360 
amplifiers  (Digitimer,  Welwyn  UK),  band  pass  filtered  (53-3000  Hz),  analogue  to 
digital converted using  a  1401  AD  converter  (CED,  Cambridge)  at a sample rate of 
5000Hz, and collected on computer.
138Patient Gender Age
(years)
Disease
duration
(years)
DYT 1 gene 
status
BFM score (0- 
120)  pre-op/6 
months
Medications DBS parameters at 6 months
1 M 47 37 + 52/22 Diazepam
Tetrabenazine
Rt: 4-, 3.5v, 90psec, 130 Hz 
Lt: 0,1-, 3.3v, 60psec, 130 Hz
2 M 24 16 73/15 Clonazepam Rt: 4,5-, 3.9v, 90psec, 130 Hz 
Lt: 0,1-, 3.8v, 90psec, 130 Hz
3 F 53 43 + 41  / 22 Diazepam Rt: 5-, 2.9v, 90psec, 130 Hz 
Lt:  1-, 3.7v, 90psec, 130 Hz
4 F 63 4 23/3 L-dopa
Trihexphenidyl
Rt: 6-, 4.6v, 90psec, 130 Hz 
Lt: 2-, 4.6v, 90psec, 130 Hz
5 F 54 43
'
24/9 none Rt: 4-, 3.7v, 60psec, 130 Hz 
Lt:  1-, 3.7v, 60psec, 130 Hz
6 F 36 25 + 21  / 1 Trihexphenidyl Rt: 4-, 4.6v, 90psec, 130 Hz 
Lt: 0-, 4.2v, 90psec, 130 Hz
7 F 64 50 46/13 none Rt: 6-, 3.5v, 60psec, 130 Hz 
Lt: 2-, 3.5v, 60psec, 130 Hz
8 M 62 7 “ 64/30 none Rt: 4,5-, 3.5v, 60psec, 130 Hz 
Lt: 1,2-, 3.5v, 60psec, 130 Hz
9 F 52 36 + 29/7 none Rt: 4-, 3.0v, 60psec,  130 Hz 
Lt: 0-, 3.0v, 60psec, 130 Hz
10 M 62 43 28/15 Trihexphenidyl
Baclofen
Clonazepam
Rt: 6-, 3.7v, 90|isec, 130 Hz 
Lt:  1-, 3.7v, 90psec, 130 Hz
Table 6.1 Clinical patient data
Electrical stimulation was  applied to  the  supraorbital nerve  in the  supraorbital notch 
with a bipolar stimulating electrode and constant current generator (Digitimer, Welwyn 
UK). All stimuli were 0.2 ms duration with intensity 3-4 times sensory threshold (8-14 
mA). The blink reflex in response to paired stimulation was assessed at interstimulus 
intervals of 500 and 1000 ms. The interval between stimulations was varied randomly 
between  10  and  20  seconds  to  minimise  habituation.  Thirty  trials  at  each  ISI  were 
performed  in  a  randomised  order  in  three  blocks  for  both  right  and  left  sided
139supraorbital nerve  stimulation.  Trials  with  excessive  EMG  artefact were  rejected  on 
line.  GPi  DBS  was  changed  from  monopolar  to  bipolar  stimulation  at  30%  higher 
voltage at the beginning of the experimental session in order to eliminate DBS-induced 
artefacts.  Data were analysed off-line, using custom-written software (Nucursor 2001). 
The raw blink recordings were DC corrected, rectified and averaged. The onset latency 
and duration of RI and R2 responses were determined by manual cursor marking of the 
beginning and end of responses. The area ratio of the conditioned R2 component to the 
unconditioned response was calculated. The area of the conditioned R2 was calculated 
over the same duration as the unconditioned response.
6.3.4 Statistical analysis
The ipsilateral R2 ratio for ISI 500 andlOOO ms was calculated for right and left sides in 
each subject.  The  sides  were treated  separately  in the  statistical  analysis.  Data from 
patients and control  subjects were  compared  using one-way  ANOVA.  To  assess for 
significant changes in R2 ratio over time in patients, repeated measures ANOVA was 
performed with main factors  of TIME  (pre-op,  1,  3  and  6 months)  and INTERVAL 
(500  and  1000  ms).  Post-hoc  t  tests  were  used  to  explore  the  nature  of significant 
interactions found in the ANOVA.  Correlation coefficients were calculated using the 
Pearson correlation or the Spearman correlation for clinical outcome data. All statistics 
were  performed  using  SPSS  for  Windows  version  11.5.  A  P  value  <0.05  was 
considered significant.
6.4 Results
There was a significant improvement in dystonia in all patients following surgery. The 
mean BFM Movement  score decreased from 40  (+/-  5.8  SEM) pre-operatively to  14
140(+/- 2.9 SEM) at 6 months, a 66% improvement, (paired t-test, p<0.001, data shown in 
Table 1).
6.4.1  Longitudinal effects of GPi DBS on blink reflex R2 inhibition 
The average R2 ratio for 500 and 1000 ms at baseline in patients and controls and 1, 3 
and  6  months  in  patients  is  shown  in  Figure  6.1.  One-way  ANOVA  showed  a 
significant  difference  between  patients  and  controls  at  baseline  and  for  ISI  500  ms 
(F=15.8 p<0.0001) and 1000 ms (F=16.3, p<0.0001). This difference between controls 
and patients remained significant at 1, 3 and 6 months, but the statistical strength of the 
difference became weaker. Repeated measures ANOVA in the patient group with main 
factors  of TIME  (1-4)  and  INTERVAL  (1-2)  showed  a  significant  effect  of TIME 
[F(3,57)= 7.16, p=0.015] and INTERVAL [F(l,19)=63.0 p<0.0001], but no significant 
TIME-INTERVAL interaction [F(3,57)=2.49, p>0.05]. Post-hoc paired t tests revealed 
a significant decrease in R2 ratio for ISI=500 ms from 0.63 pre-op to 0.50 at 6 months 
(p=0.043).  For ISI =1000 ms there was a significant decrease in R2 ratio from 0.80 to 
0.67 at 3 months (p=0.011) and 0.66 at 6 months (p=0.019).
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Figure 6.1. Grand average R2 ratio for ISI 500 and 1000 ms in control subjects and patients at 
all time-points with Y error bars of + /-  1 SEM.  In patients the R2 ratio decreases significantly 
over time after GPi DBS but remains greater than control subjects at all time points.
6.4.2 Effects on latency and amplitude of RI and R2 response
For patients, the latency of the unconditioned RI  (mean ± SEM,  11.02 ms ± 0.19 ms) 
and R2 (32.24 ms ± 0.71  ms) response did not alter after GPi DBS. The duration and 
amplitude of RI  and R2 response (RI:  10.4 ms ± 0.46 ms,  134 pV ± 56 pV, R2: 63.3 
ms ± 3.42 ms, 122 pV ± 23 pV) were also unchanged after GPi DBS.
6.4.3 Effect of baseline R2 inhibition on changes after GPi DBS
To identify whether the degree of R2 disinhibition at baseline influenced the extent to 
which it changed after GPi DBS, patients were identified in whom the average baseline 
R2 ratio at ISI= 500 ms was more than two standard deviations above the control level
142(i.e.  greater  than  0.61).  The  500  ms  ISI  was  chosen  because  previous  work  has 
suggested this  to  be  the  most  discriminating  between  dystonia  patients  and  healthy 
controls (Nakashima et al  1990). There were 4 patients in this category of "abnormal" 
ISI = 500 ms R2 at baseline (patients 2, 6, 8 and 9). The averaged rectified blink reflex 
recording for patient 9 is shown in Figure 6.2.
(a)
R 2
(b)
1  m V
5 0 0   m s
Figure 6.2. Mean rectified ipsilateral blink reflex recordings in patient 9 for right supraorbital 
nerve stimulation ISI=500 ms.  (a) pre-op recording, RI and R2 components of the blink reflex 
are marked  for the unconditioned response (b) 6 months post GPi DBS recording. Note that the 
conditioned R2 response is smaller 6 months after GPi DBS.
Repeated measures ANOVA with main factors of TIME (1-4), INTERVAL (1-2) and 
GROUP  (Normal  vs  Abnormal)  showed  significant  effects  of TIME  [F(3,24)=13.5
143p=0.006],  INTERVAL  [F(l,8)=37.3,  P<0.0001]  and  TIME-GROUP  interaction 
[F(3,24)=7.36,  p=0.027].  The  TIME-GROUP  interaction  indicates  that  the  baseline 
level  of  R2  inhibition  significantly  influenced  the  extent  to  which  R2  inhibition 
increased  after  GPi  DBS.  Across  all  patients,  there  was  a  significant  correlation 
between percentage change in R2 ratio at 6 months with baseline value of R2 ratio for 
the 500 ms ISI  (r= 0.58 p=0.008), Figure 6.3.
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Figure  6.3.  Relationship  between percentage  change  in  R2  ratio  at  6  months  with  baseline 
value of  R2 ratio for the 500 ms ISI.
1446.4.4  Correlation of changes in R2 ratio and dystonia
The  relationship  between  changes  and  clinical  state  was  assessed  using  correlation 
analysis. There was a significant correlation between the change (pre -  post) in BFM 
movement  score  and  R2  ratio  at  the  time  points  1,  3,  6  months  for  ISI=500  ms, 
(Spearman correlation coefficient=0.48, p= 0.007), Figure 6.4.
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Figure 6.4. Relationship between change in BFM movement score and R2 ratio for ISI=500 ms. 
6.5 Discussion
The main finding  of the  present  study was that  in patients with primary  generalised 
dystonia,  blink  reflex  R2  inhibition  is  abnormally  reduced  compared  with  healthy 
subjects,  and that chronic  therapeutic  GPi DBS  resulted  in a progressive  increase  in 
blink  reflex  R2  inhibition  towards  normal  levels.  The  magnitude  of increase  in  R2 
inhibition (decrease in R2 ratio) was related to degree of baseline disinhibition, in that 
those with the most disinhibition had the largest decreases following GPi DBS. Finally
145the  changes  in  R2  inhibition  following  surgery  were  significantly  correlated  with 
changes in clinical dystonia as measured by BFM  score over the corresponding time 
course. These results demonstrate that chronic therapeutic GPi DBS partially reverses a 
well documented pathophysiological feature of dystonia, namely decreased inhibition 
of blink reflex circuits. Here it will be argued that the progressive nature of the changes 
in blink reflex excitability after GPi DBS point to neural reorganisation within basal 
ganglia and cortex.
6.5.1  Baseline abnormalities of R2 inhibition
In the present study, reduced blink reflex R2 inhibition was found in patients compared 
with healthy subjects. This finding confirms previous reports of reduced R2 inhibition 
in focal and segmental dystonia (Berardelli et al  1985, Tolosa et al  1988, Carella et al 
1994) and primary generalised dystonia as were  studied here (Nakashima et al  1990, 
Pauletti et al  1993).  In the present study,  only one patient had blepharospasm which 
emphasises that blink reflex disinhibition is often dissociated from clinical symptoms, a 
finding in agreement with an earlier study (Nakshima et al  1990). However, it should 
be remembered that these patients did have marked symptoms in body regions  other 
than orbicularis oculi, so while dissociated from clinical  symptoms in the territory of 
blink circuit motor output, the abnormalities were still linked to the presence of severe 
dystonia in the rest of the body. Blink reflex disinhibition can therefore be regarded as a 
physiological marker in generalised dystonia,  even in the  absence  of blepharospasm. 
The dissociation between blink reflex disinhibition and dystonia in the target muscles 
of these circuits argues against a primary brainstem defect as their cause. Furthermore, 
apart from the finding of brainstem inclusion bodies in DYT1 patients (McNaught et al 
2004) no pathology in the brainstem has been found in dystonia patients to explain the
146finding of disinhibition. Instead, abnormalities of blink reflex inhibition in dystonia are 
more  likely to  be the  result  of abnormal  descending  control  of blink circuits  due to 
abnormal  activity  within  basal  ganglia-thalamo-cortical  loop  and  its  projections 
(Berardelli et al 1985, Nakashima et al 1990). This notion is aligned with the view that 
dystonia  is  fundamentally  a  disorder  of  the  basal  ganglia,  leading  to  abnormal 
corticomotor  function  (Berardelli  et  al  1998).  Basal  ganglia  influence  on  the  blink 
reflex  may  involve  GPi,  thalamus  and  cortex,  in  turn  projecting  to  the  brainstem 
(Esteban  et  al  1999,  Berardelli  et  al  1983).  Animal  studies  have  shown  that  6- 
hydroxydopamine lesions of the SNc result in blink reflex R2 disinhibition via a nigro- 
collicular projection and the nucleus raphe magnus (Basso et al  1996, Schicatano et al 
1997). From these studies, it can be inferred that basal ganglia influence on blink reflex 
circuits may follow thalamo-cortical or subcortical routes, this point being of particular 
relevance to the effects of GPi DBS.
6.5.2  Longitudinal effects of GPi DBS on R2 inhibition and potential mechanisms 
In the present study, chronic therapeutic GPi DBS resulted in a progressive increase in 
R2  inhibition.  Increases  in  R2  inhibition  were  proportional  to  the  degree  of 
disinhibition at baseline.  These effects are likely to be the result of GPi DBS altering 
basal  ganglia output  and the  descending  influence  from basal  ganglia and  cortex  on 
blink reflex  intemeuronal  circuits.  The  observation that the  effect  of GPi  DBS  was 
greatest in those with the greatest R2 disinhibition suggests the existence of a spectrum 
of blink hyperexcitability ranging from severe to minimal, which in turn would reflect 
the degree of dysfunction of descending influence from basal  ganglia.  In this model, 
patients with severe blink disinhibition would be expected to change greatly after major 
modification  of basal  ganglia  output  (GPi  DBS),  whereas  those  minimally  affected
147would  not.  These  observations  are  consistent  with  the  view  that  blink  reflex 
disinhibition  in  dystonia  is  the  consequence  of basal  ganglia  dysfunction.  There  is 
evidence that GPi DBS may modify activity within the basal ganglia thalamo-cortical 
loop.  GPi  DBS  in  PGD  patients  has  been  shown  to  acutely  alter  motor  cortical 
excitability to transcranial magnetic stimulation as evidenced by an upward shift of the 
stimulus response curve and reduction in motor thresholds (Kuhn et al 2003). GPi DBS 
also reverses abnormal overactivation in the premotor cortex seen on positron emission 
tomography (Detante et al 2004b). These studies suggest that GPi DBS alters cortical 
activity via the thalamo-cortical pathway but do not preclude the possible contribution 
of direct projections from basal ganglia to brainstem (Basso et al 1996, Schicatano et al 
1997), which collectively would allow modification of descending influence on ponto- 
medullary blink reflex circuits.
6.5.3  Experimental limitations
A  frequent  problem  encountered  with  physiological  recordings  in  patients  with 
generalised  dystonia  is  involuntary  muscle  contractions  interfering  with  EMG 
recordings.  In  this  experiment,  only  one  patient  had  dystonia  involving  orbicularis 
occuli  which  was  mild,  and  did  not  interfere  with  recordings.  Therefore  it  seems 
unlikely  that  involuntary  muscle  contractions  influenced  the  experimental  data. 
Habituation of the blink reflex is an inevitable consequence of repeated stimulation and 
results  in  a  progressive  diminution  of  blink  reflex  amplitude  (Shahani  1970).  To 
minimise  habituation,  subjects  were  kept  alert  and  stimuli  were  delivered  10-20 
seconds  apart,  the  interval  varied  randomly  which  reduced  the  subjects’  ability  to 
predict the  timing  of stimuli.  In the  present  study,  healthy volunteers were  recorded 
only  once  whereas  patients  were  studied  longitudinally  at  four  time  points.  It  was
148assumed that blink reflex excitability in healthy subjects would not change over time. 
Confirmation  of  this,  however,  would  require  repeated  recordings  in  the  healthy 
subjects, which were not done. This potential limitation does not limit the comparison 
of patients  and  controls  at  baseline,  nor  of patients  before  and  after  surgery  which 
provide  the  main  results  in  this  study.  Finally,  the  possible  effect  of differences  in 
stimulus intensity between assessments needs to be considered. It has been shown that 
larger intensities (19-26 mA) of supraorbital nerve stimulation decrease the degree of 
R2 inhibition in healthy subjects and patients with blepharospasm (Sommer and Ferbert 
2001).  Although  the  exact  stimulus  intensity  used  in  each  experiment  was 
individualised to elicit the blink reflex, the intensity used ranged between 8-14 mA, and 
therefore stimulus intensity is unlikely to have influenced the observed changes in R2 
inhibition. Finally the potential confounding effects of dystonia medications should be 
considered.  Medications  such  as  Baclofen  are  known  to  suppress  the  human  blink 
reflex (Pellegrini and Evinger  1995) and other drugs enhancing GABAergic synapses 
such  as the  benzodiazepines  might be  expected to  have  similar  effects.  While  some 
effect of anti-dystonia medications  on blink reflexes  seems  likely,  such  effects were 
kept  constant  in  both  the  pre  and  post-operative  experiments  by  not  changing 
medication  during  the  study period.  Therefore  it  seems  very  unlikely  that  effects  of 
medication would explain the observed changes in R2 inhibition.
6.6  Conclusions
In the  present  study,  patients  with primary  generalised  dystonia  showed  abnormally 
decreased  blink  reflex  R2  inhibition  which  progressively  increased  towards  normal 
following  GPi  DBS.  Changes  in  R2  inhibition  and  clinical  scores  of dystonia  were 
significantly correlated. Since increased brainstem excitability is often dissociated from
149clinical dystonia, changes in R2 inhibition are unlikely to account directly for clinical 
improvement.  Instead  changes  in  R2  inhibition  probably  reflect  changes  in  basal 
ganglia and cortical  function underlying clinical  improvement,  which would  account 
for the correlation between R2 inhibition and clinical scores over time. Modification at 
the  cortex  and basal  ganglia level  seems  likely  since  dysfunction  in these  regions  is 
thought  to  underlie  dystonia,  and  would  be  expected  to  change  following  effective 
treatment  with  GPi  DBS.  Further  support  for  this  notion  comes  from  short-term 
ON/OFF  stimulation studies which confirm that GPi DBS modifies cortical  function, 
providing a pathway for long-term network alteration.  The observed progressive time 
course  suggests  a  progressive  effect  of  GPi  DBS,  most  likely  involving  synaptic 
plasticity within the cortex and basal ganglia.  Reorganisation in the basal ganglia and 
cortex would alter the descending control of brainstem excitability. The present results 
provide evidence of long-term plasticity within the nervous system in dystonia patients 
after GPi DBS.  This plasticity includes partial restoration of inhibition at the brainstem 
level  which  provides  further  support  for  the  view  that  multilevel  disinhibition 
represents an important physiological feature of dystonia.
150Chapter 7. Cortical evoked potentials from pallidal stimulation 
in patients with primary generalised dystonia *
7.1  Summary
Deep  brain  stimulation  (DBS)  of globus  pallidus  intemus  (GPi)  has  emerged  as  an 
effective  treatment  for  primary  generalised  dystonia;  however  the  physiological 
mechanisms of improvement remain poorly understood.  In the present study, cortical 
activity  in  response  to  GPi  stimulation  was  recorded  in  6  patients  with  primary 
generalised dystonia > 6 months after bilateral GPi DBS.  Scalp electroencephalogram 
was recorded using 60 surface electrodes during 10 Hz bipolar GPi DBS at each bipolar 
pair on both sides sequentially. Anatomical position of the electrode contacts in relation 
to  the  GPi,  internal  lamina  and  GPe  was  determined  from  the  post-operative 
stereotactic MRI. In all six patients, a potential was observed with onset latency  10.9 
ms  ±  0.77,  peak  latency  26.6  ms  ±  1.6,  distributed  mainly  over  the  ipsilateral 
hemisphere, maximal centrally. The mean amplitude of this potential was larger with 
stimulation in posteroventral  GPi than in GPe (-  3.46  pV vs  -  0.238  pV,  P0.0001). 
These results indicate that low frequency GPi stimulation produces an evoked potential 
distributed centrally over the ipsilateral hemisphere. The latency and distribution of this 
potential  are consistent with  stimulation of pallidothalamic  neurons projecting to the 
sensorimotor cortex. Because this potential is larger and more consistently present with 
stimulation  of posteroventral  GPi  than  GPe,  it  may  provide  a  physiological  tool  to 
identify contacts within the optimal surgical target.
*  This work was presented in poster form at the European Federation of Neuroscience 
Meeting, Glasgow, Scotland,  UK September 2006
1517.2  Introduction
The emergence of GPi DBS  as an effective therapy for primary generalised dystonia 
has  provided  another  example  of the  dramatic  improvement  in  movement  disorders 
which may result from DBS therapy. Despite the growing acceptance of GPi DBS as 
treatment  for  dystonia,  relatively  little  is  known  about  its  physiological  effects.  Its 
effects on the cortex are of particular interest since cortical dysfunction, possibly as the 
result  of an underlying  basal  ganglia  defect,  has  been  implicated  as  a  major  site  of 
abnormality  underlying  dystonia  (Berardelli  et  al  1998).  Moreover,  defective  basal 
ganglia  output  has  been  cited  as  the  primary  defect  in  dystonia  (Vitek  et  al  2002), 
which emphasises the importance of the GPi output to thalamus and cortex in both the 
pathogenesis of dystonia and mechanisms of GPi DBS  action.  There is evidence that 
high frequency  GPi  DBS  in humans  can alter cortical  excitability  (Chen et al 2001, 
Kuhn et al 2003) and regional cerebral blood flow (Fukuda et al 2001,  Detante et al 
2004), and these effects have been attributed to modification of pallidothalamocortical 
activity.  Whether  this  modification  represents  inhibition  or  excitation  of  the 
pallidothalamocortical  pathway  is  difficult to  ascertain  from  these  studies.  Neuronal 
excitation  has  attracted  increasing  attention  as  a  potential  mechanism  of GPi  DBS 
action  (Garcia  et  al  2003,  McIntyre  et  al  2004),  however to  date  there  has  been  no 
electrophysiological  confirmation  that  GPi  DBS  activates  neurons  in  the 
pallidothalamocortical pathway in vivo.  Cortical evoked potentials in response to STN 
stimulation have been identified (Ashby et al 2001, MacKinnon et al 2004) and suggest 
that neural  elements  linking  STN and cortex may be  activated  during low frequency 
DBS.  Whether  similar  effects  occur  with  GPi  stimulation  is  unknown.  In  this 
experiment,  cortical  EEG was recorded during unilateral  low frequency  GPi DBS  to 
explore the circuit interactions between GPi and cortex.
1527.3  Methods
7.3.1  Subjects
Six patients with primary generalised dystonia were selected for this study, the clinical 
patient details are shown in Table  1. All patients had undergone bilateral GPi DBS as 
outlined in the General Methods. Patients were studied > 6 months after GPi DBS once 
stable  improvement  in  dystonia  had  been  achieved.  Patients  3  and  5  underwent 
unilateral  left  and  right  thalamotomy  29  and  23  years  ago.  Subjects  gave  written 
informed consent and the study was approved by the Joint Research Committee of the 
National Hospital for Neurology and Neurosurgery and the Institute of Neurology.
Patient Gender Age
(years)
Disease
duration
(years)
DYT1  gene 
status
BFM score 
pre/6 months 
post-op (0-120)
Medications DBS parameters
1 F 52 36 + 29/7 None Rt: 5-, 3.4v, 60psec, 130 Hz 
Lt:  1-, 3.0v, 60psec,  130 Hz
2 F 63 4 ■ 23/1 L-dopa
Trihexyphenidyl
Rt: 6-, 4.6v, 90psec,  130 Hz 
Lt: 2-, 4.6v, 90psec, 130 Hz
3 F 54 43 - 24/9 None Rt: 4-, 3.7v, 60psec,  130 Hz 
Lt:  1-, 3.7v, 60psec, 130 Hz
4 F 36 25 + 20.5/1 Trihexyphenidyl Rt: 4-, 4.6v, 90psec, 130 Hz 
Lt: 0-, 4.2v, 90psec, 130 Hz
5 F 53 43 + 41 122 Diazepam Rt: 5-, 2.9v, 90|isec, 130 Hz 
Lt:  1-, 3.7v, 90psec, 130 Hz
6 F 22 15 + 51/11 Trihexyphenidyl Rt: 4-, 3.6v, 60psec, 130 Hz 
Lt: 0-, 3.6v, 60psec, 130 Hz
Table 7.1. Clinical patient data.
1537.3.2 Recordings
The EEG was recorded using the Neuroscan EEG system (Compumedics Ltd, El Paso, 
Texas  USA),  and  a  modified  10-20  montage  was  used  with  60  Ag/AgCl  scalp 
electrodes.  Recordings  were  referenced  to  linked  ears.  EEG  signals  were  amplified, 
band pass filtered 0.05-200 Hz and analogue to digital  converted at a sample rate of 
2500 Hz and recorded on computer. EEG recordings were made during 10 Hz unilateral 
pallidal stimulation with an amplitude of 3.5-4 V and pulse width 60-90 ps. Recordings 
lasting  90-120  seconds  were  made  during  stimulation  at  each  bipolar  pair  of the 
quadripolar electrode on both sides consecutively, with the other electrode set to zero 
amplitude.  The detailed methodology for this experiment is described in the  General 
Methods.
7.3.3 Statistical analysis
The continuous EEG was epoched to the stimulus artifact and averaged to derive the 
evoked  potential.  Each  averaged  EEG  was  baseline  corrected  with  respect  to  the 
prestimulus interval and examined qualitatively for the presence of an evoked potential. 
Waveforms  so  identified  were  then  subjected  to  quantitative  analysis  with  manual 
marking  of  latency  to  onset  and  peak  and  measurement  of peak  amplitude  using 
Neuroscan software (Compumedics Ltd, El Paso, Texas USA). The mean amplitude of 
the evoked potential was compared from contact pairs located in GPi or GPe using one­
way ANOVA. Grand averages were also derived for contact pairs in GPi or GPe. The 
identification  of position of contact  in relation to  GPi  and  GPe was  made  using the 
Stealth  workstation  (Framelink  TM,  Medtronic,  Minneapolis  USA)  as  described  in 
Chapters  2  and  4.  The  investigator  identifying  contact  location  was  blinded  to  the 
results of evoked potential recordings.
1547.4  Results
7.4.1  Characteristics and topography of cortical evoked potential 
In all six patients a distinct evoked potential was observed, distributed mainly over the 
ipsilateral  hemisphere,  maximal  centrally  (Figure  7.1).  The  evoked  potential  was 
present  with  both  right  and  left  pallidal  stimulation  in  all  patients  except  patient  5 
where it was absent on the right side. When measured in leads C3 and C4, the average 
onset latency was 10.9 ms ± 0.77 and peak latency 26.6 ms ± 1.6. (Figure 7.2).
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Figure  7.1.  (a) Averaged EEG of  patient 1 for stimulation of Left GPi (contacts 0-,  1+).  Note 
the stimulus artifact followed by the evoked potential, a negative waveform seen predominantly 
ipsilateral to the side of stimulation,  maximal centrally,  (b) 2D map of the same record,  again 
showing the transient negativity maximal ~26 ms after the stimulus, predominantly ipsilaterally 
and centrally.
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Figure 7.2. Evoked potential recordings from 4 patients recorded at C3 or C4 with stimulation 
of ventral contacts located in posteroventral GPi. Note the large stimulus artifact followed by 
the  evoked potential.  The cursors show  the  mean  onset and peak latency determined for all 
patients.
7.4.2  Effect of location of pallidal stimulation on the evoked potential 
Qualitative assessment of the averaged EEG records revealed that the largest and most 
consistent evoked potentials usually occurred with stimulation of ventral contact pairs. 
This  observation prompted a formal  comparison of the  characteristics  of the  evoked 
potential  with  stimulation  of  contacts  lying  within  the  posteroventral  GPi  (the 
therapeutic target) and dorsal contacts in GPe. For this comparison the evoked potential 
was again quantified in C3  and C4.  The mean amplitude of the evoked potential  for 
posteroventral GPi stimulation was significantly larger than for GPe stimulation (-3.46 
pV  vs  -0.238  pV,  One-way ANOVA p<0.0001).  The  amplitude  difference  was  also
157reflected  in  the  group  average  of actual  waveforms,  for  GPi  and  GPe  stimulation 
(Figure 7.3).
7.4.3  Relationship between clinically effective contacts and the evoked potential 
In all patients the  largest evoked potential  was  observed  with  stimulation of contact 
pairs including at least one of the therapeutically effective contacts. These contact pairs, 
in all patients, corresponded to stimulation of GPi rather the GPe. The contacts at which 
the largest EP was recorded, the clinically effective contacts and the contact location 
are shown in Table 7.2
Patient Right hemisphere 
Max  EP Effective
Left hemisphere 
Max EP Effective
1 4 5 5 0 1 1
GPi GPi/MML GPi/MML GPi GPi/MML GPi/MML
2 5 6 6 1 2 2
GPi GPi GPi GPi GPi GPi
3 4 5 4 1 2 1
GPi GPi/MML GPi GPi GPi/MML GPi
4 4 5 4 0 1 0
GPi MML/Gpe GPi GPi GPi GPi
5 EP absent 5 1 2 1
GPi GPi GPi GPi
6 4 5 4 0 1 0
GPi GPi/MML GPi GPi GPi/MML GPi
Table 7.2 Electrode contact pairs responsible for maximal EP and effective contact in use for 
chronic therapy. Contact location, in relation to pallidal anatomy, is stated beneath each 
contact. Note: in all sides the therapeutically effective contact was included in the bipolar pair 
subtending the largest EP and corresponded to GPi stimulation. Note that in patient 5 the EP 
on the Right side was absent, the same side as a previous thalamotomy. Patient one was 
effectively stimulated on contacts 4 and 0 but developed akinesia (see Chapters 3 and 4) and 
requiring change to contacts 5 and 1.
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Figure  7.3.  Grand average evoked potential from all patients at C3 and C4 for stimulation in 
GPi and GPe for left and right sides. Note the evoked potential is larger and more distinct for 
GPi stimulation, compared with GPe where it is almost absent.
7.5  Discussion
7.5.1  Neural pathways mediating the evoked potential
The main finding in the present study is the presence  of a cortical evoked potential 
arising from low frequency pallidal stimulation. The latency, laterality and topography 
of this potential  provide  some  clues  as to  the  likely neural  pathways  involved.  The 
average onset latency was around  11  ms, and is too slow for antidromic activation of 
myelinated  cortical  axons,  where  onset  latencies  in  the  vicinity  of 3  ms  would  be
159expected as observed by Ashby et al (1999) with STN stimulation while recording the 
scalp EEG. This makes antidromic stimulation of myelinated corticospinal axons of the 
internal capsule an unlikely candidate for mediating the observed evoked potential. The 
onset  latency  around  11  ms  is  more  compatible  with  activation  of pallidal  efferents 
relaying in the thalamus and thence cortex. The pallidothalamocortical route involves 
two synapses, which would explain the observed latency. The laterality of the observed 
response is also consistent with activation of the pallidothalamocortical pathway, since 
the majority of pallidofugal projections are to the ipsilateral thalamus and thence cortex 
(Parent  et  al  1999).  Moreover,  because  the  GPi  projects  heavily  to  the  ventral  tier 
thalamic  nuclei  which  in  turn  send  massive  projections  to  the  cortex,  the 
pallidothalamocortical efferents are the most abundant neuronal elements with access to 
the cortex in the vicinity of the electrode. The predominantly central topography of the 
evoked  potential  encompasses  the  sensorimotor  cortices,  which  would  be  expected 
targets of pallidothalamocortical activation originating in the "sensorimotor" portion of 
the  pallidum.  In  another  study,  using  similar  methodology,  single  STN  stimuli 
produced  cortical  evoked potentials  with  latencies  overlapping  with the  present data 
(onset  14  ±  3  ms  and  peak  23  ±  4  ms),  and  a  similar  distribution,  ipsilateral  and 
predominantly central  (MacKinnon et al 2004).  The  evoked potential was  larger and 
more  consistent  with  stimulation  of  dorsal  STN  electrode  contacts,  the  authors 
attributing the cortical evoked potential to stimulation of pallidothalamic fibres passing 
dorsal to the STN. These observations with regard to latency, topography and involved 
neural  substrates for STN derived evoked potentials  support the present findings and 
the  putative  role  of pallidothalamcortical  activation.  A  further  possible  clue  to  the 
involvement  of the  pallidothalamocortical  route  is  that  the  only  side  in  which  the 
evoked  potential  was  absent  was  in  patient  5,  on  the  same  side  as  a  previous
160thalamotomy. This raises the possibility that the thalamic lesion disrupted the pathway, 
thereby  abolishing  the  evoked  potential.  In  the  other  patient  with  previous 
thalamotomy, the evoked potential was recordable on the thalamotomy side.
7.5.2  Effect of location of pallidal stimulation on the evoked potential: mechanisms and 
clinical implications
In the present study, the evoked potential was larger and more consistently present with 
stimulation of GPi compared with GPe.  The likely explanation for this finding relates 
to pallidal anatomy; GPi projects heavily to the thalamus whereas GPe projects mainly 
to  STN,  GPi  and  SNr.  Thus  the  pallidothalamic  route,  the  putative  pathway  for the 
evoked potential, is of GPi origin. This explains the observed differences between the 
evoked  potential  for  GPi  and  GPe  stimulation  and  also  supports  the  view  that  the 
evoked  potential  is  mediated  by  the  pallidothalamic  route.  As  shown  in  Chapter  4, 
posteroventral  GPi  stimulation was the therapeutically more  effective.  In the present 
study,  clinically  effective  contacts  corresponded  well  to  those  in  which  the  evoked 
potential  was  observed,  which  reflects  that  elicitation  of the  evoked  potential  and 
clinical benefit were both associated with posteroventral GPi  site of stimulation.  The 
congruence  between  the  evoked  potential  and  clinically  effective  sites  of  pallidal 
stimulation is consistent with presumed mechanisms of GPi DBS action in dystonia. A 
major putative mechanism of GPi  DBS  effect in dystonia is modification of pallidal 
output,  which  would  entail  activation  of pallidofugal  neurons  and  their  targets  in 
thalamus and brainstem. A further implication of the present results is that the evoked 
potential could be used as a physiological marker for stimulation in posteroventral GPi 
and a tool to identify electrode contacts within the optimal surgical target.
1617.5.3  Experimental limitations
One aim of the present study was to delineate functionally operational circuits between 
GPi and cortex involved in therapeutic DBS.  A limitation in the present study was that 
low frequency stimulation,  required to  elicit evoked potentials,  has distinct and even 
opposing  effects  to  high  frequency  stimulation  (>100  Hz)  used  therapeutically. 
Therefore  the  observation  of pallidothalamic  activation  at  low  frequencies  does  not 
automatically  imply  that  the  same  circuits  are  operational  during  high  frequency 
stimulation. Despite this caveat, however, there is some evidence that neurons of DBS 
targets  can  be  activated  at  high  frequencies  by  direct  stimulation  of the  neuronal 
membrane (Garcia et al 2003).  A recent study in a dystonic patient found that high 
frequency GPi  stimulation produced inhibition or occasionally  excitation of thalamic 
receiving neurons, time-locked to  individual  stimuli (Montgomery 2006).  These data 
suggest that the pallidothalamocortical pathway, demonstrated at low frequencies in the 
present  study,  may  also  be  operationally  active  under  high  frequency,  therapeutic 
stimulation.  Activation of the pallidothalamocortical pathway with high frequency GPi 
DBS  is  consistent  with the  observed  short  term  changes  in  cortical  excitability  and 
regional cerebral blood flow with GPi DBS ON vs OFF  (Kuhn et al 2003, Detante et al 
2004b).  In the present study, the finding of congruence between the evoked potential 
and  therapeutic  effective  site  of pallidal  stimulation  (posteroventral  GPi)  raise  the 
possibility  of using  the  evoked  potential  as  a  tool  to  identify  contacts  within  the 
therapeutically efficient portion of the pallidum.  The present results would need to be 
replicated  in  larger  number  of patients  with  blinded  rating  of evoked  potential  and 
contact location to validate this approach.
1627.6 Conclusions
Low  frequency  GPi  stimulation  results  in  a  characteristic  medium  latency  evoked 
potential,  which  likely  reflects  activation  of pallidothalamic  neurons  projecting  the 
sensorimotor  cortex.  The  demonstration  of  activation  of  this  pathway  during  low 
frequency  stimulation  suggests  this  pathway  is  accessible  to  GPi  stimulation  and 
supports  its  putative  role  in  GPi  DBS  action.  However,  the  extent  to  which  the 
apparent  "driving"  activation  of  pallidothalamocortical  circuit  observed  at  low 
frequencies occurs with therapeutic high frequency GPi DBS remains speculative. The 
present  results  raise  interesting  possibilities  for  further  development  of the  cortical 
evoked potential during pallidal stimulation as a physiological marker for stimulation in 
the  posteroventral  GPi  corresponding  to  the  origin  of  sensorimotor  pallidofugal 
efferents.
163Chapter 8. The effects of GPi DBS on motor cortex plasticity
8.1  Summary
In  this  Chapter,  the  effect  of globus  pallidus  intemus  (GPi)  deep  brain  stimulation 
(DBS)  on motor cortex  plasticity  in patients  with primary  generalised  dystonia was 
studied.  Ten  patients  with  primary  generalised  dystonia  (5  DYT1+,  5  idiopathic,  6 
female, mean age 42) before and > 6 months after GPi DBS, and  10 healthy subjects 
were  studied.  Motor  cortex  plasticity  was  assessed  using  transcranial  magnetic 
stimulation (TMS) paired  associative  stimulation (PAS)  of motor cortex  and median 
nerve.  Thresholds  and  TMS  intensity  to  produce  a  resting  motor  evoked  potential 
(MEP) of lmV were determined. Resting MEP amplitude and stimulus response curves 
were  recorded  before  and  after  PAS.  Patients  were  recorded  ON  and  OFF  DBS  in 
separate sessions. The mean TMS intensity to produce a resting MEP of 1  mV was 54% 
of maximum stimulator output when OFF  and  52%  ON  DBS.  Fifteen minutes  after 
PAS,  the  resting  MEP  amplitude  increased  in  patients  OFF  DBS  and  in  control 
subjects,  whereas  it  decreased  in patients  ON  DBS.  Similarly,  after  PAS,  the  mean 
amplitude  of the  stimulus  response  curve  increased  OFF  DBS,  but  this  effect  was 
abolished with DBS ON. Furthermore, patients who had the largest clinical response to 
chronic DBS also had the largest difference in the effect of PAS with DBS ON v OFF. 
After  PAS,  patients  with  primary  generalised  dystonia  showed  a  similar  pattern  of 
increased motor cortex excitability as healthy subjects when GPi DBS was OFF but not 
with  GPi  DBS  ON.  These  results  suggest  GPi  DBS  reduces  LTP-like  motor  cortex 
plasticity, which may contribute to its mechanism of action in dystonia.
1648.2 Introduction
As  has  been  discussed  in  Chapter  1,  the  pathophysiology  of  primary  dystonia  is 
incompletely  understood,  but  various  lines  of evidence  point  to  a  contributing  role 
played by abnormal brain plasticity. Evidence for this comes from the demonstration of 
abnormal cortical sensorimotor representations in both animal models (Byl et al  1996) 
and human focal dystonia (Meunier et al 2001, Rosenkranz et al 2005). These studies 
suggest that abnormal cortical synaptic reorganisation may be an important feature of 
dystonia.  Taking into  account the documented abnormalities  of neural  inhibition and 
sensorimotor integration present  in dystonia,  it  is  easy to  imagine  how these  factors 
could contribute to the development of abnormal cortical sensorimotor representations. 
The  next  important  question  is  whether  dystonia  patients  may  be  predisposed  to 
abnormal  reorganisation  because  of an  excessive  propensity  for  synaptic  plasticity. 
Indeed,  there  is accumulating evidence that in dystonia such a defect of "excessive" 
plasticity exists.  The most direct evidence for this has come  from studies comparing 
dystonia  patients  and  healthy  subjects  using  TMS  to  experimentally  induce  motor 
cortex plasticity. Patients with focal dystonia have increased motor cortex plasticity in 
response  to  TMS  PAS  (Quartarone  et  al  2003,  Weise  et  al  2006).  Similarly,  motor 
cortex  plasticity  following  theta  burst  rTMS  is  increased  in  patients  with  DYT1 
dystonia and sporadic cervical dystonia, but reduced in non-manifesting carriers of the 
DYT1 gene (Edwards et al 2006). These studies suggest that excessive plasticity within 
the motor cortex may be one factor that contributes to the occurrence of dystonia, and 
that less plasticity might even be protective for the development of dystonia (Edwards 
et al 2006). If excessive synaptic plasticity does contribute to dystonia, then it would 
follow that  improvement  in  dystonia by  effective  therapy  might  be  associated  with 
reductions in motor cortex plasticity. To this end, the aim of the experiments presented
165in  this  chapter  was  to  determine  the  effect  of GPi  DBS  on  motor  cortex  plasticity 
measured using TMS PAS in patients with primary generalised dystonia.
8.3 Methods
8.3.1 Subjects
Ten patients with primary generalised dystonia (6 female, mean age 42 years range 18- 
64, five DYT1+) and  10 healthy participants (6 female, mean age 37 years, range 24- 
52) were enrolled in the study. The patient characteristics are shown in Table 1. Patient 
5 underwent unilateral thalamotomy 23  years ago. All patients gave written informed 
consent.  The  study  was  approved  by the  Joint Research  Committee  of the National 
Hospital for Neurology and Neurosurgery and the Institute of Neurology
8.3.2 Surgical procedures
All  patients  underwent  bilateral  implantation  of  electrodes  into  GPi  and  chronic 
stimulation. The DBS electrode model 3389 and Kinetra model 7428 implanted pulse 
generator  (Medtronic  Neurological  Division,  Minneapolis  USA)  were  used  in  all 
patients except in two where model 3387 electrodes were used. Surgery was performed 
using methods described in the General Methods section.
8.3.3 Stimulation parameters and clinical assessment
All patients received monopolar stimulation with one or two adjacent active contacts. 
Stimulation  parameters  were  individualised  in  each  patient  and  chosen  for  the  best 
clinical effect in the absence of any side effects. Patients were assessed clinically using 
the  Burke-Fahn-Marsden  (BFM)  dystonia  rating  scale  (Burke  et  al  1985).  The
166stimulation parameters and BFM scores before and 6 months after DBS in each patient 
are shown in Table 1.
Patient Gender Age
(years)
Disease
duration
(years)
DYT 1 gene 
status
BFM score 
pre/6 months 
post-op (0-120)
Medications DBS parameters
1 M 47 37 + 52 / 23.5 Diazepam
Tetrabenazine
Rt: 4-, 3.5v, 90psec, 130 Hz 
Lt: 0,1-, 3.3v, 60psec,  130 Hz
2 M 24 16 - 73/15 Clonazepam Rt: 4,5-, 3.9v, 90psec, 130 Hz 
Lt: 0,1-, 3.8v, 90psec, 130 Hz
3 F 52 36 + 29/7 None Rt: 5-, 3.4v, 60psec,  130 Hz 
Lt:  1-, 3.0v, 60psec, 130 Hz
4 F 63 4 ■ 23 /1 L-dopa
Trihexphenidyl
Rt: 6-, 4.6v, 90psec, 130 Hz 
Lt: 2-, 4.6v, 90psec,  130 Hz
5 F 54 43 - 24/9 None Rt: 4-, 3.7v, 60psec,  130 Hz 
Lt:  1-, 3.7v, 60p.sec, 130 Hz
6 F 36 25 + 20.5/1 Trihexphenidyl Rt: 4-, 4.6v, 90psec,  130 Hz 
Lt: 0-, 4.2v, 90psec,  130 Hz
7 M 47 26 - 25/12 None Rt: 4,5-, 3.5v, 90psec, 130 Hz 
Lt: 0,1-, 3.5v, 90psec, 130 Hz
8 M 62 7 - 64/30 None Rt: 4,5-, 3.5v, 60psec, 130 Hz 
Lt:  1,2-, 3.5v, 60psec,  130 Hz
9 F 16 7 + 20/1 L-dopa
Trihexphenidyl
Rt: 4-, 2.5v, 90psec, 130 Hz 
Lt: 0-, 2.5v, 90psec, 130 Hz
10 F 22 15 + 51  /11 Trihexphenidyl Rt: 4-, 3.6v, 60psec, 130 Hz 
Lt: 0-, 3.6v, 60psec, 130 Hz
Table 8.1. Clinical patient data
1678.3.4 Recordings
EMG  recordings  were  made  from  abductor  pollicis  brevis  (APB)  using  methods 
outlined  in the  General  Methods.  TMS  was  applied  over the  scalp  using  a  70  mm, 
hand-held figure-of-eight coil and Magstim 200 monopulse generator (Magstim UK). 
Thick  physical  shielding  was  fastened  over  the  implanted  pulse  generator  (IPG)  to 
eliminate  the  risk  of close  range  exposure  of the  IPG  to  damaging  magnetic  flux 
(Kumar et al  1999a).  For median nerve stimulation, electrical stimulation was applied 
to  the  median  nerve  at  the  wrist  using  a  constant  current  generator  (Digitimer  Ltd, 
Welwyn Garden City, Herts. UK).
8.3.4.1 Motor evoked potential (MEP) recordings
After localisation and marking of the "hotspot" for APB, the resting and active motor 
thresholds (RMT, AMT) were determined as the minimum stimulus to produce a 50 pV 
MEP  in  5  out  of  10  trials.  AMT  was  determined  during  20%  maximum  voluntary 
contraction  of APB.  The  resting  MEP  amplitude  was  recorded  over  30  trials,  the 
stimulus intensity adjusted to produce an MEP amplitude of 1   mV. This intensity was 
then used throughout the experiment. The stimulus response curve (SRC) was recorded 
with 5 trials in 9 steps of intensity from 10-90% TMS output.  Trials with any ongoing 
EMG artefact were rejected on line.
8.3.4.2 Paired associative stimulation (PAS)
Median nerve stimulation was applied at the wrist at 300% of perceptual threshold in 
the median distribution, stimulus duration 0.2 ms, delivered 25 ms before TMS over the 
APB "hotspot" at the intensity predetermined to yield a 1  mV resting MEP (Stefan et al 
2000). Two hundred paired stimuli were delivered at a rate of 0.25  Hz.  During PAS,
168patients  were  instructed  to  concentrate  on  the  APB  muscle  and  silently  count  the 
stimuli felt in the thumb.  The resting MEP amplitude was recorded before and 0,  15 
and 30 minutes after PAS.  The SRC was recorded before and  15  minutes after PAS. 
The  entire  experiment  was  performed  with  GPi  DBS  ON,  with  usual  stimulation 
parameters,  and  OFF  in  two  experimental  sessions  at  least  48  hours  apart.  The 
medication  was  not  altered  during  the  study.  The  order  of the  ON  and  OFF  was 
balanced between subjects so that approximately half had the OFF session first. For the 
OFF session GPi DBS was switched off at least 30 minutes prior to data collection.
8.3.5  Statistical analysis
Data were analysed off-line using custom-written software (Nucursor 2001). The peak- 
to-peak  amplitude  of individual  MEP's  were  determined  and  then  averaged  within 
patients.  Repeated  measures  ANOVA  was  used  to  identify  significant  effects  and 
interactions.  For post hoc  comparisons, t tests  and Tukey’s  multiple  comparison test 
were used.  Correlations between changes in MEP amplitude and clinical effect of DBS 
were  examined  using  the  Spearman  correlation  coefficient.  All  statistics  were 
performed using  SPSS  for Windows version  11.5.  A p value <0.05 was considered 
significant.
1698.4 Results
8.4.1  Motor thresholds
Although there was a slight tendency for AMT, RMT and the lmV MEP intensity to be 
higher with GPi DBS OFF (Figure 8.1), this difference was not significant. However, 
all values were higher than in healthy subjects (p<0.05 for all comparisons).
DBS OFF  DBS ON  Controls
■ RMT
□ AMT
□ 1 mV rMEP
Figure 8.1. Average resting and active motor thresholds  (RMT, AMT) and intensity for 1 mV 
resting MEP (1 mV MEP) in patients OFF and ON DBS and control subjects. Error bars show 
±1 SEM.
8.4.2  Resting MEP amplitudes
Figure  8.2 plots the change in the MEP amplitudes evoked before and at three times 
after  the  PAS  intervention.  We  first  compared  the  data  ON  and  OFF  DBS  in  the 
patients. A repeated measures ANOVA with main factors of TIME (pre, 0, 15, 30 mins 
post  PAS)  and  STIM  (DBS  ON  and  OFF)  showed  a  significant  TIME*STIM 
interaction [F(3,27)=3.49, p=0.029] that was due to the fact that PAS increased MEPs
170when the DBS stimulator was turned OFF, whereas MEPs decreased when it was ON. 
Post-hoc t-tests of MEP size after PAS with baseline values before PAS confirmed that 
when the DBS stimulator was OFF, MEP amplitude increased post-PAS (p=0.016 at 15 
min), whereas it decreased post-PAS when ON (p=0.026 at 0 min). The fifteen minutes 
post-PAS  MEP  amplitude  was  significantly  higher  OFF  DBS  than  ON  (p=0.01), 
whereas the baseline MEP amplitude pre-PAS was not different in the two states.
Since  the patients’  results  depended  on whether the  stimulator was  ON  or OFF,  we 
compared  each  state  separately  with  the  control  values.  When  patients  were  OFF 
stimulation, PAS had the same effect as in the control group, whereas this was not the 
case  when  ON  stimulation.  Thus  two  factor  ANOVAS  showed  a  significant 
TIME*GROUP interaction for the comparison of controls vs. ON DBS  [F(3,27)=8.41, 
p<0.001], but not for controls vs.  OFF DBS  [F(3,27)=0.62, p=0.58].  Post hoc t tests 
revealed this effect was due to  a significant reduction in MEP amplitude  15  minutes 
post  PAS  ON  DBS  compared  with  healthy  subjects  (p=0.004).  There  were  no 
differences between patients OFF DBS and controls.
Finally, we also tested whether there was any difference in behaviour of patients with 
and without the DYT1 mutation. Mixed model ANOVAs failed to show any significant 
differences, although given the small numbers involved this needs to be confirmed in a 
larger study.
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Figure 8.2. Average resting MEP amplitude  (mV)  in patients  OFF and ON DBS and control 
subjects before and after PAS. Error bars show ±1 SEM.  (p<0.05 *).
8.4.3  Stimulus response curves
The effects of GPi  DBS  on the stimulus-response curves before and after PAS  were 
examined.  This  showed  that  PAS  increased  corticospinal  excitability  when  patients 
were  OFF  stimulation,  whereas  excitability  decreased  when  ON  stimulation  (Figure 
8.3).  This was  confirmed in repeated measures ANOVA with main factors  of TIME 
(pre vs post PAS), STIM (DBS ON vs OFF) and INTENSITY (9 levels,  10-90%) that 
showed a significant 3-way interaction [F(8,72)=2.81, p=0.009].  Subsequent One-way 
ANOVA revealed a significant difference in means between the 4 states (F(3,24)=5.85, 
p=0.0038).  Tukey’s Multiple comparison test showed a significant increase post-OFF 
compared with pre-OFF (mean difference = -0.28 mV, 95% Cl -0.51  to -0.048 mV, 
q=4.72, p<0.05) and that pre-OFF was smaller than pre-ON (mean difference = -0.26
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mV, 95% Cl -0.49 to -0.032 mV, q=4.44, p<0.05). Post-OFF was greater than post-ON 
(mean difference = 0.23 mV), and post-ON less than pre-ON (mean difference = 0.21 
mV), but these differences did not reach significance.
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Figure 8.3. Stimulus response (input-output) curves before and after PAS (a) OFF DBS and (b) 
ON DBS. Note that OFF DBS (a) the stimulus response curve is shifted upwards after PAS (ie 
increased motor  cortex  excitability)  whereas  ON DBS  (b)  the  curve  shifts  in  the  opposite 
direction.  The pre-PAS curve ON DBS is also significantly upshifted compared with OFF DBS, 
indicating that GPi DBS increases motor cortical excitability.
8.4.4 Correlations of clinical outcome and physiological effects
To test whether the effect of DBS  on PAS  might be related to  the  clinical  effect of 
chronic treatment, we examined the relationship between clinical improvement and the 
difference in the PAS effect ON and OFF DBS  (Figure  8.4). There was a significant 
correlation between the change in clinical dystonia score (pre-op BFM - 6 months post-
173op BFM) and the  change in PAS effect with DBS  ON vs OFF (maximal  facilitation 
DBS OFF - maximum inhibition ON DBS), [Spearman's rho =0.69, p=0.026].
70
S'  60-1
CM
S-  50
O
w  40
30 m
c
a >
«  20
a o a 10
♦  ♦ 
♦
0.5  1   1.5  2
Change in PAS effect with GPi DBS ON (mV)
2.5
Figure 8.4.  Correlation  between change  in clinical dystonia score  (pre-op BFM -  6 months 
post-op BFM) and the change in PAS effect with DBS ON vs OFF (maximal facilitation DBS 
OFF -maximum inhibition ON DBS), [Spearmans rho =0.69, p=0.026J.
8.5  Discussion
The  main  finding  of the  present  study  was  that  PAS  produced  the  same  effects  as 
normal  on  MEP  amplitude  in  patients  with  primary  generalised  dystonia  when  GPi 
DBS  is switched OFF, but that the effect is reversed when stimulation is turned ON. 
Given that the after-effects of PAS are thought to reflect LTP-like plasticity at motor 
cortical synapses, this suggests that GPi DBS can modify the plastic response of motor 
cortical circuits to changes in their input. In addition, this effect may contribute to the
174clinical effectiveness of DBS in dystonia. The merits of these considerations are now 
discussed.
8.5.1  Abnormalities of motor cortex plasticity in dystonia
As noted in the Introduction, here are several lines of evidence to  suggest that brain 
plasticity may play a role in the pathophysiology of dystonia. Dramatic reorganisation 
of  somatotopic  domains  in  the  sensorimotor  cortex  of  monkeys  that  occurs  after 
excessive hand training has been linked to the appearance of dystonia-like involuntary 
movements  (Byl  et  al  1996).  Similarly,  abnormal  patterns  of cortical  reorganisation 
have  been  found  in  patients  who  have  developed  task  specific  focal  dystonia  after 
overleamed tasks such as writing or playing musical instruments (Meunier et al 2001, 
Rosenkrantz et al 2005). Physiological evidence for abnormal plasticity in dystonia has 
come from TMS  studies using PAS  or theta-burst repetitive TMS protocols to probe 
motor cortex plasticity. Patients with writer’s cramp show greater potentiation of MEP 
amplitude following PAS with 25 ms ISI than healthy subjects (Quartarone et al 2003, 
Weise et al 2006). Patients with sporadic cervical dystonia and DYT1  dystonia show 
more  intense  and  longer-lasting  inhibition  of MEP  amplitude  following  theta-burst 
repetitive  TMS  than healthy  subjects  or non-manifesting  carriers  of the  DYT1  gene 
(Edwards et al 2006). These results suggest short-term synaptic plasticity is increased 
in dystonia patients and could contribute to the  development of dystonia perhaps by 
promoting  maladaptive  reorganisation  of the  sensorimotor  cortex  (Quartarone  et  al 
2006b).
1758.5.2 Modification of motor cortex plasticity by GPi DBS
In the present study we observed that GPi DBS reduced or even reversed the normal 
facilitation of MEP  amplitude  following PAS.  In contrast,  when the DBS  stimulator 
was  turned  OFF,  facilitation  returned  to  normal.  This  suggests  that  the  chronic 
therapeutic GPi DBS results in reduced motor cortex plasticity, and that this effect is 
DBS dependant, because during arrest of stimulation (DBS OFF condition), plasticity 
returned  to  normal.  This  would  normalise  the  "excessive"  plasticity  that  has  been 
described in dystonia patients. Indeed, long term suppression of neural plasticity during 
DBS  in the  present  patients  may  explain  why  turning  OFF  DBS  did  not  lead  to  a 
facilitated  response  to  PAS.  Perhaps  chronic  stimulation  had  produced  long-term 
adaptation in these  circuits that did not fully reverse when the  DBS  was transiently 
turned  OFF.  Finally  it  was  noted  that  the  clinical  response  after  6  months  chronic 
stimulation  correlated well with the  ON/OFF  difference  in acute tests.  We  speculate 
that patients in whom the effects of DBS on synaptic plasticity are greatest are those 
who respond best to chronic stimulation.
We observed an inhibitory effect of PAS with DBS ON, which occurred immediately 
after PAS and was sustained at  15  minutes, then dissipated after thirty minutes.  DBS 
ON altered not only the direction but also the time-course of the PAS effect, because it 
occurred  earlier  than  DBS  OFF  post  PAS  facilitation.  The  fact  that  the  inhibition 
occurred  earlier  than  facilitation  suggests  differing  mechanisms  underlying  the 
opposing  effects.  The  bi-directional  plasticity  after  PAS  we  have  observed  may  be 
analogous to that which occurs with reversal of the temporal order of stimuli (Wolters 
et  al  2003),  but  via  a  different  mechanism:  additional  input  of  GPi  DBS  may 
orthodromically activate inhibitory pallidothalamocortical projections thereby altering 
the balance of excitation in the motor cortex, favouring sustained inhibition rather than
176facilitation after PAS.  In support of this,  functional  imaging  studies  in patients with 
primary generalised dystonia and GPi DBS have shown that during movement, pallidal 
stimulation  reduces  ipsilateral  overactivity  in  premotor  and  primary  motor  areas, 
suggesting  enhanced  thalamocortical  inhibition  (Kumar  et  al  1999b,  Detante  et  al 
2004b).  Recently,  reversal  of motor cortex  facilitation after PAS  has been  shown to 
occur  in  healthy  subjects  with  application  of  anodal  transcranial  direct  current 
stimulation during PAS  conditioning (Nitsche  et al 2007).  Anodal transcranial  direct 
current  stimulation  increases  background  excitability,  and  it  is  reasoned  that  this 
increased background activity interferes with plasticity by increasing the signal to noise 
ratio. Put simply, motor cortex plasticity is favoured under "quiet" conditions when the 
level of background activity is  low,  so  called homeostatic  plasticity.  There  are clear 
parallels with this study and the present findings; bilateral GPi DBS like anodal direct 
current  stimulation  is  a  major  diffuse  input  to  the  brain,  which  in  the  present  and 
previous studies has been shown to increase motor cortex excitability. Therefore when 
GPi DBS is applied concurrently with PAS conditioning, it might interact in the same 
way  as  anodal  direct  current  stimulation,  and  reverse  PAS  induced  plasticity  by 
increasing the background level of activation.
8.5.3  Effect of GPi DBS on measures of motor cortex excitability 
In the present study, patients had higher RMT, AMT and 1   mV resting MEP intensity 
than healthy subjects, which contrasts with an earlier TMS  study of dystonia patients 
with  GPi  DBS,  which  found  no  difference  (Kuhn  et  al  2003).  Methodological  and 
surgical  differences,  including  size  and  placement  of burr  hole  and  cap,  course  of 
connecting cables and the fact we recorded from APB rather than FDI may explain the 
differing  results.  Like  Kuhn  et  al  (2003),  however,  we  found  that  motor  cortical
177excitability  as  measured  by  the  stimulus  response  curve  was  significantly  increased 
when GPi DBS was ON compared to OFF.
8.5.4  Study Limitations
An important part of the present hypothesis is that patients would have had excessive 
PAS-induced plasticity before operation. Although this has been described in patients 
with  focal  dystonia,  there  are  no  reports  so  far  about  PAS  effects  in  generalised 
dystonia.  Future  investigations  of this  hypothesis  would  benefit  from  pre-operative 
assessment of patients. It would also be important to know whether the fact that DBS 
reverses the effect of PAS has any behavioural consequences, potentially even reducing 
the ability of patients to learn new tasks. Another important consideration in the present 
study is that an LTP-like mechanism for PAS  effects has only been demonstrated in 
healthy  subjects  and  not  in  dystonia  patients.  It  therefore  remains  possible  that 
pathophysiological  features  particular  to  dystonia  such  as  decreased  inhibition  or 
abnormal sensorimotor integration could play a role in both mediating the PAS effect 
and also the effect of GPi DBS on PAS.
An  additional  methodological  consideration  worthy  of  discussion  is  the  possible 
influence  of  dystonic  contractions  on  the  EMG  recordings  results.  One  potential 
concern is that recurrence  of dystonia with  GPi  DBS  OFF  might lead to  a spurious 
alteration of motor cortex plasticity. There are several reasons why this is unlikely to 
have  influenced  the  results.  Firstly,  unrelaxed  trials  in  all  conditions  were  rejected 
online.  Secondly,  clinical  recurrence  of dystonia was mild during the period  of GPi 
DBS  OFF,  and  in  no  patient  did  strong  dystonic  contractions  appear  in  APB  that 
prohibited recordings.  Lastly, if involuntary EMG had appeared with GPi  DBS  OFF 
then one would expect the pre-PAS cortical excitability to be increased with DBS OFF.
178However, the opposite was observed, in that motor cortex excitability, as evidenced by 
stimulus response  curves,  was  less with  DBS  OFF than  ON,  the  same result as  that 
observed in a previous study (Kuhn et al 2003).
8.6  Conclusions
The present findings of modification of short-term plasticity by GPi DBS may provide 
a potential mechanism for the observed neural reorganisation in spinal and brainstem 
excitability after GPi DBS described in Chapters 5  and 6. Existing evidence suggests 
that excessive short-term plasticity may be a contributing factor to dystonia.  Reversal 
of  LTP-like  plasticity  might  be  beneficial  by  reducing  the  strength  of  synaptic 
connections within aberrantly functioning networks, thereby partially normalising the 
“excessive plasticity”, gradually resulting in the emergence of a physiologically more 
normal pattern. This proposed mechanism is consistent with our finding of a significant 
correlation between the change in LTP-like plasticity with DBS and eventual clinical 
improvement of dystonia. In conclusion, GPi DBS in patients with primary generalised 
dystonia modifies  PAS  induced  LTP-like plasticity  in the  motor  cortex,  which  may 
contribute to its mechanism of action.
179Chapter 9. General Discussion
9.1  Therapeutic utility of GPi DBS for dystonia
The results presented in Chapter 3 confirm that GPi DBS is a safe and effective therapy 
in primary generalised dystonia and agree with previous  studies  (Coubes  et al  2000, 
Tronnier et al 2000, Vercueil et al 2001, Bereznai et al 2002, Cif et al 2003, Katayama 
et al 2003, Yianni et al 2003, Krause et al 2004, Coubes et al 2004, Starr et al 2005, 
Vidailhet et al 2005, Kupsch et al 2006). Sustained improvement occurred in all body 
regions, with major functional benefit and reduction of disability. Speech was improved 
but  not  significantly,  a  finding  in  agreement  with  a previous  study  (Vidailhet  et  al 
2005).  The time  course of improvement was progressive and  followed a logarithmic 
distribution.  Such  a  progressive  time  course  is  most  compatible  with  neural 
reorganisation (plasticity) as has been previously proposed (Bereznai et al 2002, Yianni 
et al 2003, Vidailhet et al 2005). It was shown that the progressive time-course was not 
a by-product of serial increases in stimulation intensity, but rather a distinctive feature 
of dystonia in response to  GPi  DBS.  It is  important to  note that similar progressive 
improvement has been observed after pallidotomy (Lozano et al  1997), suggesting that 
it is more a property of dystonia than GPi DBS per se.  A progressive time-course of 
improvement  following  either  type  of pallidal  intervention  is  still  compatible  with 
plasticity as the underlying mechanism. In Chapter 1   it was argued that dystonia can be 
viewed as a disorder of maladaptive plasticity in which there is an excessive propensity 
for  synaptic  reorganisation,  which  in  the  face  of faulty  processing  of sensorimotor 
information  by  the  basal  ganglia  leads  to  the  development  of  abnormal  cortical 
representations. Under this model, continued "misinformation" emanating from the GPi 
to  thalamus  and  cortex  might  perpetuate  the  abnormal  patterns  of  connectivity.
180Therefore  pallidal  interventions  which  produce  a  major  modification  of GPi  output 
might remove this "noisy" signal, allowing the sensorimotor cortex to reorganise into a 
more  normal  pattern.  Such  reorganisation  would  take  time,  accounting  for  the 
progressive time-course of clinical benefit.
The  logarithmic  time-course  of improvement  is  steep  initially,  with  almost  70%  of 
eventual  improvement  achieved  within  the  first  2  weeks,  and  then  more  gradual, 
leveling off at about 6 months. Why should improvement occur fast initially then slow 
in  this  logarithmic  fashion?  One  possibility  relates  to  the  observation  made  in  the 
present work and previous studies that mobile dystonia tends to improve more quickly 
than  tonic  aspects.  Limitations  of  the  BFM  scale  prevent  quantification  of  the 
contribution  of improvement  of mobile  dystonia  to  the  early  time-course  however, 
based on the consistent clinical observations, such an attribution seems likely. Mobile 
and  tonic  aspects  probably  differ  physiologically.  Several  studies  have  shown 
correlation  between  low  frequency  synchronised  activity  in  GPi  and EMG  recorded 
from dystonic muscles (Chen C et al 2006a, Foncke et al 2007) with coherence between 
LFP  and  EMG  occurring  preferentially  for mobile  dystonia  (Liu  et al  2006).  These 
studies  support  the  notion  that  mobile  aspects  of  dystonia  may  be  preferentially 
mediated  by  abnormally  synchronised  low  frequency  oscillatory  activity  within  the 
basal ganglia thalamocortical loop. The more rapid improvement of mobile aspects of 
dystonia could reflect disruption of this abnormal oscillatory activity that would occur 
quickly after the initiation of GPi DBS. This effect may be analogous to the immediate 
alleviation of mobile dyskinesias by GPi DBS, which can be observed in Parkinson's 
disease, where dyskinesias are associated with increased low frequency synchronised 
oscillatory  activity  (Silberstein  et  al  2003,  Alonso-Frech  et  al  2006)  that  is  rapidly 
"blocked"  by  DBS.  The  subsequent  slower  phase  of improvement  would  be  more
181related  to  synaptic  reorganisation  which  takes  longer  to  occur.  In  the  following 
sections,  the  physiological  evidence  which  supports  such  a  mechanism  will  be  put 
forward.
9.2  Mechanisms of action of GPi DBS for dystonia
9.2.1  Short-term effects
Kuhn  et  al  (2003)  examined  the  effects  of GPi  DBS  on  TMS  measures  of cortical 
excitability  and  spinal  excitability,  as  determined  by  forearm  H-reflexes,  in patients 
with  severe  primary  dystonia.  The  patients  were  studied  at  least  three  months  after 
implantation,  with  stimulation  ON  effective  chronic  stimulation  parameters,  and 
stimulation  OFF.  With  GPi  DBS  ON,  the  resting  motor threshold  for  TMS  elicited 
cortical  MEP  was  significantly  reduced  and  the  stimulus  response  curve  of  MEP 
amplitude was shifted upwards, such that larger MEPs were observed for a given TMS 
intensity.  These  effects  were  rapidly  reversible  when  GPi  DBS  was  switched  OFF. 
Intracortical  inhibition and  facilitation,  the  duration  of the  cortical  silent  period  and 
forearm FI-reflex amplitude were unchanged with GPi DBS ON or OFF.
These results demonstrate that GPi DBS increases excitability of the motor cortex in a 
rapid and reversible manner, whilst the stability of spinal excitability measures suggest 
the effect is mediated at the cortical level. Direct activation of corticospinal axons in 
the internal capsule, which lies in close proximity medial to the  GPi  DBS  electrode, 
could explain the observed cortical facilitation. Against this, however, the intensity of 
GPi  DBS  used  was  significantly  less  than  required  to  produce  observable  motor 
responses,  and  facilitation  was  not  observed  with  stimulation  of the  Vim  thalamic 
nucleus,  in  which  corticospinal  stimulation  might  also  be  expected  to  occur.  The 
observed cortical facilitation is more likely the result of DBS altering pallidal output to
182thalamus and cortex. If GPi DBS increases cortical excitability, and the motor cortex is 
already disinhibited in dystonia, why is DBS beneficial? The explanation may relate to 
differences between short and long-term effects of GPi DBS. The ON/OFF paradigm 
used  by  Kuhn  et  al  is  only  able  to  resolve  short-term  effects  therefore  it  remains 
possible that motor cortex excitability may have decreased  ON  DBS  compared with 
levels before  surgery.  Indirect evidence  for this  is that the  stimulus response  curves 
DBS  ON  were  very  similar  to  healthy  control  subjects,  possibly  suggesting  some 
normalisation had occurred.
Two  PET  studies  have  examined  the  short-term  effects  of  GPi  DBS  on  regional 
cerebral blood flow.  The  first by Kumar et al  (1999b),  studied a single patient with 
primary generalized dystonia 12 months after surgery, ON and OFF DBS, during a free 
selection joystick  task  and  rest.  In  this  patient  bilateral  GPi  DBS,  during joystick 
movement,  reduced  activity  bilaterally  in  the  primary  sensorimotor  and  prefrontal 
cortex. Detante et al (2004b) studied 6 patients with primary generalized dystonia using 
similar methods except that GPi DBS was switched on unilaterally. In this study, GPi 
DBS, during movement, reduced abnormal overactivation in ipsilateral prefrontal areas. 
At  rest the  pattern  was  quite  different;  GPi  DBS  reduced  activity  in  the  ipsilateral 
primary  motor  cortex  and  increased  activity  in  the  contralateral  prefrontal  cortex, 
ipsilateral pallidum and thalamus. The pattern at rest appears at odds with the findings 
of Kuhn in that primary motor cortex activity decreased rather than increased. As stated 
in Chapter 7, however,  its is difficult to ascertain whether decreases in activation on 
PET  correspond  to  inhibition  or excitation,  so  caution  is  needed  before  considering 
these studies in conflict.
A  consistent  finding  between  the  available  PET  studies  is  that  GPi  DBS,  during 
movement, reverses abnormal overactivity in prefrontal areas, previously described in
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areas suggests inappropriate recruitment of motor association areas during movement, 
possibly  to  compensate  for  inefficient  processing  in  primary  sensorimotor  cortex. 
Reduced motor cortex activity, and increased thalamic activity at rest may reflect a shift 
in the balance of excitatory and inhibitory output from the thalamus, towards enhanced 
thalamocortical  inhibition,  with  attendant  improvement  in  clinical  dystonia.  During 
movement,  the  improved  thalamocortical  inhibition  would  facilitate  focused  motor 
selection and execution, and reduce the need for compensatory activation of prefrontal 
areas  or  allow  them  to  be  inhibited  directly.  With  the  caveats  already  mentioned 
concering  ambiguity  of sign in PET  studies,  the  imaging  results  are  congruent with 
physiological models of dystonia in which reduced thalamocortical  inhibition plays a 
role and its reversal a potential mechanism of action of GPi DBS. A limitation of these 
studies is the lack of pre-operative imaging to assess the long-term effects of GPi DBS. 
The chronic effects of DBS may explain why in the study of Detante et al, patterns of 
cerebral activation in patients OFF DBS during movement differed from earlier studies, 
which  showed  additional  abnormal  activation  in  premotor  cortex,  cerebellum  and 
lentiform nuclei (Ceballos-Baumann et al 1995b).
In the  present  study,  short-term  effects  of GPi  DBS  on  motor  cortex  function  were 
studied further. Motor cortex excitability, as determined by TMS evoked resting MEP 
amplitude and stimulus response curves, was measured before and after PAS, a method 
shown in healthy  subjects to produce plastic  facilitation of motor cortex excitability. 
Measurements  were  made  with  GPi  DBS  under  chronic  stimulation  (ON)  or  with 
chronic stimulation interrupted (OFF). The study confirmed the earlier finding of Kuhn 
et al (2003) of an increase in motor cortex excitability with GPi DBS ON, as evidenced 
by an upward  shift of the  stimulus response curve.  More  importantly,  GPi  DBS  was
184found to  abolish the  normal  facilitation  of motor cortex  excitability  following  PAS. 
This suggests that GPi DBS may reduce LTP-like plasticity in the motor cortex, thereby 
reversing the tendency to  excessive  cortical plasticity  found  in  dystonia.  The  results 
also suggest that LTP-like plasticity remains suppressed under chronic stimulation, but 
returns to more normal levels when stimulation is stopped. The lack of pre-operative 
recordings in these patients prevents the determination of when these effects occurred 
in the time-course after commencement of GPi DBS, but at the very least the results 
suggest that chronic  clinically effective  stimulation is associated with suppression of 
motor  cortex  LTP-like  plasticity.  Such  an  effect might be  beneficial  in  dystonia  by 
reducing the propensity to maintain abnormal patterns of connectivity, thereby allowing 
a more physiological pattern to emerge. It is well described that induction of LTP may 
be associated with axonal sprouting (Adams et al  1997) so conceivably an intervention 
which opposes LTP might reduce axonal sprouting, providing a possible mechanism for 
devolution of maladaptive synaptic connectivity.
In Chapter 7, it was shown that at low frequencies, GPi DBS is capable of activating 
the sensorimotor cortex, probably via the pallidothalamic route, generating an evoked 
potential  over  the  sensorimotor  cortex.  It  is  conceivable  that  similar  activation  of 
sensorimotor cortex during therapeutic high frequency stimulation may also occur. This 
would be in keeping with increased motor cortical excitability during high frequency 
GPi DBS (Kuhn et al 2003, Tisch et al 2007) and changes in cortical activation seen 
with  functional  imaging  (Detante  et  al  2004b,  Kumar  et  al  1999b).  Collectively, 
previous studies and the present work suggest that GPi DBS produces modification of 
cortical function. The likely general mechanism of these effects is major modification 
of  pallidal  output  to  the  thalamus  and  thence  cortex.  Changes  in  motor  cortex 
excitability and synaptic plasticity, and the overall topography of activation under GPi
185DBS probably underlie the mechanisms of GPi DBS action. Although long-term studies 
of changes in cortical function are lacking, the effects demonstrated during interruption 
of chronic stimulation would provide a means of engendering long-term modifications 
of cortical-basal ganglia connectivity.
9.2.2  Long-term effects
In Chapters 5 and 6, the first longitudinal physiological studies in dystonia before and 
after GPi DBS are presented. The findings in both studies shared some similarities. At 
baseline,  the  primary  generalised  dystonia  patients  displayed  abnormally  reduced 
inhibition at the spinal cord and brain stem level, a finding in agreement with previous 
studies.  After  GPi  DBS,  progressive  normalisation  of excitability  occurred  for  both 
spinal and brainstem reflex activity. For spinal reciprocal inhibition, levels returned to 
normal, while for blink reflex, reductions did not reach normal levels. Changes in both 
spinal  and  brainstem  reflex  excitability  correlated  with  the  magnitude  of  clinical 
improvement  in  dystonia,  suggesting  a  link  with  clinical  symptoms.  These  studies 
provide  the  first  evidence  that  GPi  DBS  is  capable  of  long-term  reversal  of  a 
pathophysiological  substrate  of  dystonia,  namely  defective  inhibition.  It  is  well 
established that  abnormally  reduced  spinal  reciprocal  inhibition  and brainstem  blink 
reflex  inhibition  can  be  dissociated  from  clinical  symptoms.  As  such  these 
abnormalities are more likely to be a reflection of abnormal descending control from 
basal  ganglia and  cortex  rather than  a primary  defect.  It  follows  that  the  observed 
changes in spinal and brainstem excitability after GPi DBS are likely to be mediated by 
alteration of descending control from basal ganglia and cortex. This would explain why 
GPi DBS is able to exert an effect even though stimulation does not have direct access 
to brainstem or spinal levels.  It also helps explain the correlation of changes in spinal
186and brainstem excitability with clinical improvement. Rather than these changes being 
responsible  for  improvement,  the  two  phenomena  could  be  the  mutual  result  of 
alterations occurring at the basal ganglia and cortical level.
9.2.3  Role of neural plasticity in GPi DBS action
Several lines of evidence point to a role for neural plasticity in mediating the effect of 
GPi  DBS  in dystonia.  Firstly,  dystonia itself is  characterised  by  abnormal  plasticity 
both in terms of excessive responsiveness to an external plastic force and the propensity 
to  reorganise  into  abnormal  functional  representations.  Therefore,  it  is  reasonable to 
propose that any effective therapy for dystonia might be expected to impact on these 
abnormalities in some way to achieve a therapeutic response. Secondly, the progressive 
logarithmic time course of improvement after GPi DBS which is similar to that seen in 
settings where neural plasticity is thought to occur, such as stroke recovery. Thirdly, the 
progressive  changes  in  spinal  and  brainstem  excitability  after  GPi  DBS  suggest 
reorganisation of synaptic weightings to these circuits. Fourthly, the demonstration of 
reduced motor cortex LTP-like plasticity during chronic clinically effective GPi DBS 
suggests  that  alteration  of synaptic  plasticity  may  play  a  role  in  GPi  DBS  effect. 
Moreover, suppression of motor cortex LTP-like plasticity might provide one means by 
which  long-term  reorganisation  within  cortical-basal  ganglia  networks  could  occur. 
Lastly, the pattern of recurrence of dystonia when GPi DBS is stopped provide further 
clues to a long-term plastic effect. Although the clinical effects of DBS take weeks to 
reach a maximum after implantation, worsening of symptoms (by up to 70%) usually 
takes only hours if the DBS  is then switched OFF (Vidailhet et al 2005,  Grips et al 
2007).  Similarly, patients return to maximum benefit within hours of switching DBS 
back ON.  Why is the initial response to DBS slow whereas the subsequent effects of
187turning the stimulus ON and OFF are much more rapid?  One possibility is that when 
DBS  is  started,  there  is  a  slow  process  of synaptic  reorganisation  that  normalises 
function over several weeks. However, this normalisation takes place in the context of 
continuous DBS of the GPi. The outcome is that the activity within the "new" network 
is stimulation dependent so that when DBS  is  stopped, dystonia recurs quite rapidly. 
Similarly when DBS is recommenced, dystonia improves rapidly (rather than weeks to 
months)  because  the  "new"  network  is  already  in  place  and  can  be  functionally 
reinstated with the addition of the DBS input. Interestingly, the phasic mobile elements 
of dystonia recur more  quickly than the tonic  components  (Grips  et al  2007)  which 
supports the notion that differing mechanisms may underlie these features, namely that 
the  mobile  aspects  are  more  determined  by  abnormal  oscillatory  activity  which 
reappears rapidly once stimulation is discontinued.
9.3  Future studies
Dystonia is both clinically and physiologically heterogeneous, making it a challenging 
disorder to study and understand. GPi DBS represents a major advance in the treatment 
of  severe  forms  of primary  dystonia,  however  its  mechanisms  of  action  are  only 
beginning to be understood.  A successful model  of GPi DBS  action must be able to 
explain  the  characteristic,  progressive  time  course  of  clinical  improvement,  which 
occurs in dystonia. The available evidence suggests that GPi DBS exerts its effects by 
altering basal ganglia output, leading to modification of thalamocortical and subcortical 
activity.  Chronic  progressive  changes  in  spinal  and  brainstem  excitability  following 
GPi DBS  suggest brain plasticity may play an important role in GPi DBS action and 
provide  a  physiological  explanation  for  progressive  clinical  improvement.  Further 
longitudinal  studies  in these patients,  using  combinations  of functional  imaging  and
188TMS  are needed to validate this model.  Specifically, the demonstration of long-term 
changes in cortical excitability with TMS, and alteration in the pattern of regional brain 
activation with functional imaging studies would provide further evidence for the role 
of plasticity in the mechanism of GPi DBS for dystonia. It would also be important to 
validate  the  presumption  that  cortical  synaptic  plasticity  is  abnormally  increased  in 
patients with primary generalised dystonia, since this would lend further support to the 
notion  that  reversal  of  "excessive"  plasticity  in  dystonia  may  be  an  important 
mechanism of GPi DBS action. In this regard it would be valuable in future studies to 
confirm the findings made with PAS, using an alternative TMS plasticity protocol, such 
as theta burst rTMS. Additional safety studies would be needed before using theta burst 
rTMS in patients with GPi DBS, however an advantage of this technique would be the 
ability to study LTD-like effects, a direction of plasticity which GPi DBS may favour, 
as suggested by the present PAS experiments. In future studies, baseline abnormalities 
before  surgery,  of cortical  plasticity  in  dystonia  should  be  correlated  with  eventual 
clinical improvement, to determine if measures of plasticity could be a useful predictive 
tool to identify patients likely to benefit.  Such a biomarker would complement other 
predictive factors such as primary dystonia and DYT1,  and potentially aid in patient 
selection.  In this regard it would be interesting to compare motor cortex plasticity in 
primary and secondary dystonia to identify differences which might provide clues to 
the poorer response to GPi DBS in secondary dystonia.  In those patients selected for 
DBS, the  identification of superiority  of stimulation  in the  more  posteroventral  GPi 
may  assist  in  optimising  both  surgical  targeting  and  choice  of contacts  for  chronic 
stimulation. The evoked potential from low frequency GPi DBS may provide another 
means of identifying the contacts within GPi. It would be valuable in future studies to
189record the evoked potential in a larger number of patients to determine its predictive 
value for identification of clinically effective contacts.
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